Health - General (GHG) — Title 13. Miscellaneous Health Care Programs
Statutes in effect as of October 1, 2026.
Subtitle 1. Hereditary and Congenital Disorders Programs
Md. Code Ann., Health-Gen. § 13-101 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–101LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Advisory Council” means the State Advisory Council on Hereditary and Congenital Disorders.
(c)
“Commission” means the State Commission on Hereditary and Congenital Disorders.
(d)
(1)
“Congenital disorder” means a significant structural or functional abnormality of the body that is present at birth.
(2)
“Congenital disorder” does not include a condition that results from:
(i)
An intrauterine infection; or
(ii)
A birth injury.
(e)
“Hereditary disorder” means any disorder that:
(1)
Is transmitted through the genetic material deoxyribonucleic acid (DNA); or
(2)
Arises through the improper processing of the information in the genetic material.
Md. Code Ann., Health-Gen. § 13-102 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–102LinkCopy Citation
The General Assembly finds that:
(1)
Everyone in this State is entitled to the highest level of health care attainable and protection from inadequate health services;
(2)
Hereditary and congenital disorders are often costly and tragic and sometimes deadly burdens to the health and well-being of the citizens of this State;
(3)
Detection through screening for hereditary and congenital disorders can:
(i)
Lead to alleviation of the disability of some hereditary and congenital disorders; and
(ii)
Further the understanding of and accumulation of medical knowledge about other hereditary and congenital disorders that may lead to their eventual alleviation or cure;
(4)
Hereditary and congenital disorders differ in severity, in that:
(i)
Some have little effect on the normal functioning of an individual; and
(ii)
Some may be alleviated, wholly or partly, through medical intervention and treatment;
(5)
Most, if not all, individuals are carriers of some hereditary disorder and are substantially unaffected by that fact;
(6)
A carrier of a hereditary disorder should not be discriminated against or stigmatized;
(7)
Medical knowledge of the discovery, diagnosis, treatment, and cure of hereditary and congenital disorders is expanding rapidly and often at an uneven rate, so that hereditary and congenital disorders are discovered long before their treatment or cure can be found;
(8)
Legislation designed to alleviate the problems associated with specific hereditary and congenital disorders may tend to be inflexible in the face of rapidly expanding medical knowledge;
(9)
The policy of this State on hereditary and congenital disorders should be:
(i)
Made with full public knowledge, in light of expert opinion; and
(ii)
Reviewed constantly to consider changing medical knowledge and ensure full public protection;
(10)
Participation in a hereditary and congenital disorders program should be wholly voluntary, and all information obtained about any individual in a hereditary and congenital disorders program should be kept confidential; and
(11)
A commission is needed:
(i)
To ensure that the policies and programs of this State for hereditary and congenital disorders comply with the principles established in this subtitle; and
(ii)
To preserve and protect the freedom, health, and well-being of the citizens of this State from improper treatment or advice, discrimination, violation of privacy, or undue anxiety that results from any hereditary and congenital disorders program.
Md. Code Ann., Health-Gen. § 13-103 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–103LinkCopy Citation
There is a State Advisory Council on Hereditary and Congenital Disorders.
Md. Code Ann., Health-Gen. § 13-104 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–104LinkCopy Citation
(a)
(1)
The Advisory Council consists of 11 voting members and 4 nonvoting members.
(2)
Of the 11 voting members:
(i)
1 shall be a member of the Senate appointed by the President of the Senate;
(ii)
1 shall be a member of the House of Delegates appointed by the Speaker of the House;
(iii)
4 shall be professional individuals in the field of hereditary or congenital disorders appointed by the Secretary; and
(iv)
5 shall be individuals appointed by the Secretary, none of whom may be:
(1)
A health professional or spouse of a health professional; or
(2)
An individual or spouse of an individual involved in the administration or ownership of any health care institution or health insurance organization.
(3)
(i)
Except as provided in subparagraph (iv) of this paragraph, the Secretary shall appoint 1 professional member from a list of qualified individuals submitted to the Secretary by each of the following organizations:
(1)
Children’s National Health System;
(2)
The Medical and Chirurgical Faculty of the State of Maryland;
(3)
The faculty of the University of Maryland School of Medicine; and
(4)
The faculties of the Johns Hopkins Medical Institutions.
(ii)
The number of names on a list shall be 3.
(iii)
An organization shall submit its list:
(1)
At least 3 months before the expiration of the term of the professional member who represents the organization; and
(2)
If a vacancy is for a reason other than expiration of the term, at any time before the Secretary makes the appointment, if the organization complies with the reasonable request of the Secretary for the list.
(iv)
If a list is not submitted to the Secretary as required under subparagraph (iii) of this paragraph, within 3 months after a request is made by the Secretary, the Secretary may appoint any professional individual who meets the requirements under subsection (b) of this section.
(4)
The 4 nonvoting members shall be representatives of the Department, appointed by the Secretary.
(b)
Each professional individual selected for the Advisory Council shall be knowledgeable in the diagnosis and treatment of hereditary and congenital disorders.
(c)
(1)
The term of a voting member is 4 years.
(2)
The terms of the voting members are staggered as required by the terms provided for voting members of the Advisory Council on July 1, 1982. The terms of those members end as follows:
(i)
3 in 1983;
(ii)
3 in 1984;
(iii)
3 in 1985; and
(iv)
2 in 1986.
(3)
At the end of a term, a voting member continues to serve until a successor is appointed and qualifies.
(4)
A voting member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
(5)
A voting member who serves 2 consecutive full 4–year terms may not be reappointed for 4 years after completion of those terms.
(6)
When a vacancy occurs, a successor shall be appointed promptly.
Md. Code Ann., Health-Gen. § 13-105 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–105LinkCopy Citation
From among its voting members, the Advisory Council shall elect every 2 years a chairman and a vice chairman.
Md. Code Ann., Health-Gen. § 13-106 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–106LinkCopy Citation
(a)
A majority of the full authorized voting membership of the Advisory Council is a quorum to do business.
(b)
The Advisory Council shall meet at least twice a year, at the times and places that it determines.
(c)
A member of the Advisory Council:
(1)
May not receive compensation; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(d)
The Secretary shall designate the staff necessary to carry out this subtitle.
Md. Code Ann., Health-Gen. § 13-107 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–107LinkCopy Citation
The Advisory Council may establish subcommittees.
Md. Code Ann., Health-Gen. § 13-108 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–108LinkCopy Citation
To preserve and protect the health and welfare of the citizens of this State, the Advisory Council may:
(1)
Gather and give out information to further the public’s understanding of hereditary and congenital disorders;
(2)
Reevaluate continually the need for and the effectiveness of State hereditary and congenital disorders programs;
(3)
Make any necessary recommendation to end any unjustified discrimination that might result from identification of an individual as a carrier of a hereditary disorder, but this item does not affect any right of anyone to seek or have any other redress for this discrimination;
(4)
Advise the Secretary as to the need for rules, regulations, and standards for the detection and management of hereditary and congenital disorders;
(5)
Participate actively in the development of the rules and regulations adopted by the Department; and
(6)
Assist the Department in prioritizing its efforts.
Md. Code Ann., Health-Gen. § 13-109 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–109LinkCopy Citation
(a)
Subject to the requirements of this section, the Department may adopt rules, regulations, and standards for the detection and management of hereditary and congenital disorders.
(b)
(1)
Before the Department adopts a rule, regulation, or standard, the Department shall consult:
(i)
The public, especially communities and groups who particularly are affected by hereditary and congenital disorders programs;
(ii)
Where appropriate, experts in the medical, psychological, ethical, social, and economic effects of programs for the detection and management of hereditary and congenital disorders; and
(iii)
The Advisory Council.
(2)
Before the Department adopts a rule, regulation, or standard, the Department shall consider:
(i)
The incidence of each hereditary or congenital disorder; and
(ii)
The cost of detection and management of each hereditary or congenital disorder.
(c)
(1)
The rules, regulations, and standards of the Department shall require the Department and each person who conducts a hereditary and congenital disorders program to keep in code and treat as a confidential medical record all information that is gathered in the program and identifies an individual. However, this requirement does not prevent the disclosure of information if the individual or, if the individual is a minor or disabled person, a parent or guardian of the person:
(i)
Is informed of the scope of information to be released and the purpose of the release; and
(ii)
Consents to the release.
(2)
The rules, regulations, and standards of the Department shall provide that, subject to the restrictions on disclosure of confidential information, information on the operation of a hereditary and congenital disorders program shall be open and freely available to the public.
(d)
The rules, regulations, and standards of the Department shall provide that procedures for a hereditary and congenital disorders program shall:
(1)
Be accurate;
(2)
Provide maximum information;
(3)
Be set forth clearly; and
(4)
Be reviewed regularly.
(e)
The rules, regulations, and standards of the Department shall:
(1)
Require that, before an individual participates in a hereditary and congenital disorders program, the person who conducts the program shall inform the individual or, if the individual is a minor or disabled person, a parent or guardian of the person of the requirement that participation in the program be wholly voluntary and of any risk that is involved in participation;
(2)
Prohibit the testing of an individual for a hereditary or congenital disorder unless the individual or, if the individual is a minor or disabled person, a parent or guardian of the person:
(i)
Is informed fully of the purpose of the test and the nature and consequences of being affected by a hereditary or congenital disorder or being a carrier of a hereditary disorder;
(ii)
Is given a reasonable opportunity to object; and
(iii)
Does not object to the test; and
(3)
Require unambiguous diagnostic results to be made available through a physician or other source of health care to the individual or, if the individual is a minor or disabled person, to a parent or guardian of the person.
(f)
The rules, regulations, and standards of the Department shall provide that a hereditary and congenital disorders program may not:
(1)
Require participation in the program;
(2)
Require restriction of childbearing; or
(3)
Be prerequisite for eligibility for any service or other program.
(g)
The rules, regulations, and standards of the Department shall provide that:
(1)
Each participant in a hereditary and congenital disorders program shall be:
(i)
Protected from undue physical or mental harm; and
(ii)
Informed of the nature, cost, benefits, and risks of any therapy or maintenance program available for an individual affected by a hereditary or congenital disorder; and
(2)
Each participant in a screening program for a hereditary or congenital disorder shall have available counseling services that:
(i)
Are nondirective;
(ii)
Emphasize informing the individual; and
(iii)
Do not require restriction of childbearing.
(h)
Only the Department may adopt rules, regulations, and standards under this subtitle.
Md. Code Ann., Health-Gen. § 13-110 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–110LinkCopy Citation
The Secretary:
(1)
Is responsible for the operation of hereditary and congenital disorders programs within the rules, regulations, and standards that the Department adopts;
(2)
Shall disburse and collect any funds available to the Department;
(3)
Shall enforce the rules, regulations, and standards that the Department adopts; and
(4)
Shall keep the Advisory Council informed of:
(i)
The progress of hereditary and congenital disorders programs; and
(ii)
Any need for a change in the Department’s rules, regulations, and standards.
Md. Code Ann., Health-Gen. § 13-111 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–111LinkCopy Citation
(a)
The Department shall establish a coordinated statewide system for screening all newborn infants in the State for certain hereditary and congenital disorders associated with severe problems of health or development, except when the parent or guardian of the newborn infant objects.
(b)
Except as provided in § 13–112 of this subtitle, the Department’s public health laboratory is the sole laboratory authorized to perform tests on specimens from newborn infants collected to screen for hereditary and congenital disorders as determined under subsection (d)(2) of this section.
(c)
The system for newborn screening shall include:
(1)
Laboratory testing and the reporting of test results; and
(2)
Follow–up activities to facilitate the rapid identification and treatment of an affected child.
(d)
In consultation with the State Advisory Council on Hereditary and Congenital Disorders, the Department shall:
(1)
Establish protocols for a health care provider to obtain and deliver test specimens to the Department’s public health laboratory;
(2)
Determine the screening tests that the Department’s public health laboratory is required to perform;
(3)
Maintain a coordinated statewide system for newborn screening that carries out the purpose described in subsection (c) of this section that includes:
(i)
Communicating the results of screening tests to the health care provider of the newborn infant;
(ii)
Locating newborn infants with abnormal test results;
(iii)
Sharing newborn screening information between hospitals, health care providers, treatment centers, and laboratory personnel;
(iv)
Delivering needed clinical, diagnostic, and treatment information to health care providers, parents, and caregivers; and
(v)
Notifying parents and guardians of newborn infants that laboratories other than the Department’s public health laboratory are authorized to perform postscreening confirmatory or diagnostic tests on newborn infants for hereditary and congenital disorders; and
(4)
Adopt regulations that set forth the standards and requirements for newborn screening for hereditary and congenital disorders that are required under this subtitle, including:
(i)
Performing newborn screening tests;
(ii)
Coordinating the reporting, follow–up, and treatment activities with parents, caregivers, and health care providers; and
(iii)
Establishing fees for newborn screening that do not exceed an amount sufficient to cover the administrative, laboratory, and follow–up costs associated with the performance of screening tests under this subtitle.
(e)
(1)
(i)
The Department shall screen for each core condition listed in the U.S. Department of Health and Human Services’ Recommended Uniform Screening Panel.
(ii)
Subject to subparagraph (iii) of this paragraph, the Department shall implement testing for a core condition within 1 year and 6 months after the core condition is added to the Recommended Uniform Screening Panel.
(iii)
(1)
If the Department is unable to implement testing within 1 year and 6 months after a core condition is added to the Recommended Uniform Screening Panel due to a delay in the procurement of equipment or supplies needed to implement the testing, the Department shall report to the Senate Finance Committee and the House Health and Government Operations Committee, in accordance with § 2–1257 of the State Government Article, within 1 year and 3 months after the addition of the core condition to the Recommended Uniform Screening Panel and every 3 months thereafter until the testing for the core condition is implemented.
(2)
A report required under subsubparagraph 1 of this subparagraph shall include the reason for the delay and the anticipated timeline for implementation.
(2)
Notwithstanding any other provision of law, if the Secretary of Health and Human Services issues federal recommendations on critical congenital heart disease screening of newborns, the Department shall adopt the federal screening recommendations.
(3)
The Department may screen for any condition recommended by the Advisory Council and approved by the Secretary.
(f)
(1)
The Secretary shall pay all fees collected under the provisions of this subtitle to the Comptroller.
(2)
The Comptroller shall distribute the fees to the Newborn Screening Program Fund established under § 13–113 of this subtitle.
Md. Code Ann., Health-Gen. § 13-112 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–112LinkCopy Citation
(a)
The Secretary may contract or delegate the screening required under § 13–111 of this subtitle to another entity with the approval of the State Advisory Council on Hereditary and Congenital Disorders.
(b)
Subject to subsection (c) of this section, a laboratory other than the Department’s public health laboratory may perform postscreening confirmatory or diagnostic tests on newborn infants for hereditary and congenital disorders.
(c)
Before offering or performing a postscreening test on a newborn infant for hereditary and congenital disorders under subsection (b) of this section, a laboratory shall:
(1)
Obtain and maintain a license issued by the Secretary as required by Title 17 of this article; and
(2)
Meet all the standards and requirements for a laboratory to perform tests on newborn infants for hereditary and congenital disorders that are established by the Secretary.
Md. Code Ann., Health-Gen. § 13-113 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 1. Hereditary and Congenital Disorders Programs
§ 13–113LinkCopy Citation
(a)
In this section, “Fund” means the Newborn Screening Program Fund.
(b)
There is a Newborn Screening Program Fund.
(c)
The purpose of the Fund is to provide funding for the screening of newborn infants in the State for certain hereditary and congenital disorders.
(d)
The Secretary shall administer the Fund.
(e)
(1)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(2)
The State Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(f)
The Fund consists of:
(1)
Revenue distributed to the Fund under § 13–111(f) of this subtitle;
(2)
Money appropriated in the State budget to the Fund;
(3)
Interest earnings of the Fund; and
(4)
Any other money from any other source accepted for the benefit of the Fund.
(g)
The Fund may be used only to cover the administrative, laboratory, and follow–up costs associated with the performance of newborn screening tests conducted under this subtitle.
(h)
(1)
The State Treasurer shall invest the money of the Fund in the same manner as other State money may be invested.
(2)
Any interest earnings of the Fund shall be credited to the Fund.
(i)
Expenditures from the Fund may be made only in accordance with the State budget.
(j)
The accounts and transactions of the Fund shall be subject to audit by the legislative auditor as provided in § 2–1220 of the State Government Article.
Subtitle 2. State Advisory Council on Health and Wellness
Md. Code Ann., Health-Gen. § 13-201 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 2. State Advisory Council on Health and Wellness
§ 13–201LinkCopy Citation
In this subtitle, “Advisory Council” means the State Advisory Council on Health and Wellness.
Md. Code Ann., Health-Gen. § 13-202 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 2. State Advisory Council on Health and Wellness
§ 13–202LinkCopy Citation
There is a State Advisory Council on Health and Wellness.
Md. Code Ann., Health-Gen. § 13-203 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 2. State Advisory Council on Health and Wellness
§ 13–203LinkCopy Citation
(a)
The Advisory Council consists of voting members appointed by the Secretary.
(b)
The following members shall serve without term limits:
(1)
The Secretary, or the Secretary’s designee;
(2)
The State Superintendent of Schools, or the State Superintendent’s designee;
(3)
The Secretary of Aging, or the Secretary’s designee;
(4)
The Secretary of Disabilities, or the Secretary’s designee;
(5)
A representative of the Maryland Office of Minority Health and Health Disparities;
(6)
A representative of the Maryland Association of County Health Officers; and
(7)
The Executive Director of the Maryland Commission for Women, or the Executive Director’s designee.
(c)
The following members are subject to term limits:
(1)
One representative of the American Heart Association Mid–Atlantic, Inc., nominated by the Executive Director of the Association;
(2)
One representative of the Arthritis Foundation, Mid–Atlantic Region, Maryland, nominated by the Executive Director of the Foundation;
(3)
One representative of the American Diabetes Association, Maryland Chapter, nominated by the Executive Director of the Association;
(4)
One representative of Johns Hopkins Medicine, nominated by the Chief Executive Officer of Johns Hopkins Medicine;
(5)
One representative of MedChi, the Maryland State Medical Society, nominated by the Executive Director of MedChi;
(6)
One representative of the University of Maryland Medical Center and University of Maryland School of Medicine, nominated by the Chief Executive Officer of the Medical Center and the Dean of the School of Medicine;
(7)
One representative of the Maryland Chapter of the American Academy of Pediatrics, nominated by the Executive Director of the Chapter;
(8)
One representative of the Maryland Nurses Association, nominated by the Executive Director of the Association;
(9)
One representative of the Maryland Academy of Nutrition and Dietetics, nominated by the President of the Academy;
(10)
One representative of the Maryland Chapter of the American College of Emergency Physicians, nominated by the President of the Chapter;
(11)
One representative with expertise in perimenopausal, menopausal, and postmenopausal evaluation and treatment; and
(12)
Seventeen members of the public, who may include:
(i)
Individuals with a chronic disease or family members of an individual with a chronic disease;
(ii)
Licensed health care providers;
(iii)
Individuals with a physical fitness background;
(iv)
Employers or representatives of the business sector;
(v)
Representatives of health insurers;
(vi)
Representatives of community–based organizations; and
(vii)
Individuals with expressed interest in health and wellness.
(d)
(1)
This subsection applies to members who are subject to term limits.
(2)
The term of a member is 4 years.
(3)
The terms of members are staggered as required by the terms provided for members of the Advisory Council on October 1, 2017.
(4)
A member may serve two consecutive full terms.
(5)
At the end of a term, a member continues to serve until a successor is appointed and qualifies.
(6)
A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
(7)
A member who serves two consecutive full 4–year terms may not be reappointed for 4 years after the completion of those terms.
(e)
If a vacancy occurs, the Secretary promptly shall appoint a successor.
Md. Code Ann., Health-Gen. § 13-204 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 2. State Advisory Council on Health and Wellness
§ 13–204LinkCopy Citation
(a)
A member of the Advisory Council:
(1)
May not receive compensation; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(b)
(1)
The Advisory Council shall create committees as it determines to organize its work, including at a minimum the following four committees:
(i)
Arthritis;
(ii)
Diabetes;
(iii)
Heart Disease and Stroke; and
(iv)
Physical Fitness.
(2)
Each Advisory Council member shall serve on at least one committee.
(c)
The Secretary shall designate the staff necessary to carry out this subtitle.
Md. Code Ann., Health-Gen. § 13-205 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 2. State Advisory Council on Health and Wellness
§ 13–205LinkCopy Citation
The Advisory Council shall:
(1)
Promote evidence–based programs for healthy lifestyles and the prevention, early detection, and treatment of chronic disease; and
(2)
Make recommendations to the Department related to chronic disease prevention, health, and wellness.
Md. Code Ann., Health-Gen. § 13-206 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 2. State Advisory Council on Health and Wellness
§ 13–206LinkCopy Citation
The Secretary shall adopt regulations governing the role and operations of the Advisory Council.
Subtitle 3. Kidney Disease Program
Md. Code Ann., Health-Gen. § 13-301 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–301LinkCopy Citation
The Kidney Disease Program is a program in the Department for the purpose of providing funding of kidney disease treatment for qualified individuals who elect to enroll in the Program and agree to pay fees which are described in this subtitle.
Md. Code Ann., Health-Gen. § 13-302 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–302LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Commission” means the State Commission on Kidney Disease.
(c)
“Department” means the department responsible for administering the Kidney Disease Program.
(d)
(1)
“Liquid assets” includes cash, bank accounts, and investments such as stocks and bonds that can be readily converted to cash.
(2)
“Liquid assets” does not include an individual’s:
(i)
Principal residence; or
(ii)
Principal car.
(e)
“Program” means the Kidney Disease Program.
(f)
“Recipient” means an individual with chronic kidney disease who has been certified to receive benefits under the Kidney Disease Program.
Md. Code Ann., Health-Gen. § 13-303 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–303LinkCopy Citation
(a)
The General Assembly finds that:
(1)
One of the most serious and tragic problems facing the public health and welfare is the death of hundreds of people in this State each year from chronic kidney disease, when the present state of medical art and technology could return these individuals to a socially productive life;
(2)
Advances and discoveries in the treatment of patients who have chronic kidney disease allow not mere survival, but rehabilitation to normal occupations and activities;
(3)
Treatment for persons with kidney disease is very expensive and continues throughout a person’s life;
(4)
Private insurance coverage for kidney disease treatment is difficult to obtain; and
(5)
Individuals who receive State benefits for kidney disease treatment should be responsible for bearing some of the cost of that care taking into account their ability to pay.
(b)
(1)
This State recognizes its responsibilities:
(i)
To allow its citizens to keep their health without being made paupers; and
(ii)
To use its resources and organization to aid in gathering and giving out information on the treatment of chronic kidney disease.
(2)
The General Assembly seeks to meet these responsibilities by making the treatment of chronic kidney disease easily available through the education, treatment, and reimbursement programs under this subtitle, thus, lowering the cost of this treatment.
Md. Code Ann., Health-Gen. § 13-304 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–304LinkCopy Citation
There is a State Commission on Kidney Disease.
Md. Code Ann., Health-Gen. § 13-305 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–305LinkCopy Citation
(a)
(1)
The Commission consists of 12 members appointed by the Governor.
(2)
Of the 12 Commission members:
(i)
1 shall be an individual from the Renal Administrators Association;
(ii)
3 shall be individuals who are laypersons to the field of medicine;
(iii)
3 shall be individuals appointed at the discretion of the Governor who:
(1)
Are medical specialists or other patient care providers in nephrology or kidney transplants; and
(2)
Do not have direct ownership of more than 30% in renal dialysis or kidney transplant centers that do business in the State;
(iv)
4 shall be individuals appointed as provided in paragraph (3) of this subsection; and
(v)
1 shall be a renal social worker nominated by the Maryland Chapter of the Council of Nephrology Social Workers or the National Capital Area Chapter of the Council of Nephrology Social Workers.
(3)
(i)
Except as provided in subparagraph (iv) of this paragraph, the Governor shall appoint 1 member from a list of individuals submitted to the Governor by each of the following organizations:
(1)
The Kidney Foundation of Maryland;
(2)
The faculty of the University of Maryland School of Medicine;
(3)
The faculty of the Johns Hopkins University School of Medicine; and
(4)
The Medical and Chirurgical Faculty of the State of Maryland.
(ii)
The number of names on a list shall be at least 2.
(iii)
An organization shall submit its list at least 3 months before the expiration of the term of the member who represents the organization.
(iv)
If a list is not submitted to the Governor as required under subparagraph (iii) of this paragraph or if a vacancy occurs for a reason other than expiration of the term, the Governor may appoint any individual without the list.
(b)
(1)
The term of a member is 4 years.
(2)
The terms of the members are staggered as required by the terms provided for members of the Commission on July 1, 1982. The terms of one fourth of those members end each year.
(3)
At the end of a term, a member continues to serve until a successor is appointed and qualifies.
(4)
A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
(5)
A member who serves 2 consecutive full 4–year terms may not be reappointed for 4 years after completion of those terms.
(6)
(i)
If a vacancy occurs, the Governor promptly shall appoint a successor who will serve until the term expires.
(ii)
The successor may be reappointed for a full term.
Md. Code Ann., Health-Gen. § 13-306 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–306LinkCopy Citation
(a)
The members present at a meeting are a quorum to do business.
(b)
The Commission shall meet at least twice a year, at the times and places that it determines.
(c)
A member of the Commission:
(1)
May not receive compensation; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(d)
The Secretary shall designate the staff necessary to carry out this subtitle.
Md. Code Ann., Health-Gen. § 13-307 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–307LinkCopy Citation
(a)
The Commission:
(1)
Shall institute and supervise education programs for health providers and the public on the prevention and treatment of chronic kidney disease; and
(2)
May use existing programs and groups for this purpose.
(b)
The Commission shall:
(1)
Evaluate annually the Kidney Disease Program under this subtitle; and
(2)
Submit an annual report of the evaluation to the Governor.
Md. Code Ann., Health-Gen. § 13-308 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–308LinkCopy Citation
(a)
Subject to the limitations provided in this section, the Commission may adopt rules and regulations to carry out the provisions of this subtitle.
(b)
The Commission shall adopt physical and medical standards for the operation of dialysis and transplant centers.
(c)
(1)
The Commission shall adopt reasonable medical standards for acceptance of an individual for treatment.
(2)
The Commission may not adopt any standard that prevents an individual from receiving federal medical or financial aid.
(d)
The Commission may adopt rules and regulations for:
(1)
Coverage of treatment that is given outside this State; and
(2)
Approval or disapproval, for purposes of State payment under this subtitle, of a dialysis or transplant center that is outside this State.
(e)
The Department, in consultation with the Commission, shall adopt rules and regulations under this subtitle governing:
(1)
Nonmedical eligibility criteria for recipients; and
(2)
Reimbursement of providers and recovery of Program expenditures from recipients and third parties.
Md. Code Ann., Health-Gen. § 13-309 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–309LinkCopy Citation
The Secretary:
(1)
Is responsible for the operation of the Kidney Disease Program under this subtitle within the rules, regulations, and standards that the Commission and the Department adopt;
(2)
Shall disburse and collect any funds under this subtitle; and
(3)
Shall keep the Commission informed of:
(i)
The progress of the Kidney Disease Program; and
(ii)
Any need for a change in its rules, regulations, or standards.
Md. Code Ann., Health-Gen. § 13-310 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–310LinkCopy Citation
The Department shall certify a dialysis or transplant center that meets the standards that the Commission adopts under this subtitle.
Md. Code Ann., Health-Gen. § 13-310.1 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–310.1LinkCopy Citation
(a)
In this section, “Fund” means the Kidney Disease Fund.
(b)
There is a Kidney Disease Fund.
(c)
(1)
Subject to the provisions of paragraphs (2) and (3) of this subsection, the Commission shall set by regulation reasonable fees to be paid by all certified kidney dialysis and transplant centers as an additional requirement for annual certification.
(2)
The provisions of this section do not apply to:
(i)
State–owned facilities; or
(ii)
Hospital services under the jurisdiction of the Health Services Cost Review Commission.
(3)
The fee set by the Commission may not exceed $1500 per year.
(d)
The Department shall collect the fee set by the Commission under subsection (c) of this section and transfer the fee into the Fund.
(e)
(1)
The Fund is a continuing, nonlapsing fund, not subject to § 7–302 of the State Finance and Procurement Article.
(2)
(i)
The Fund shall be used exclusively to offset and partially cover the actual documented direct costs of fulfilling the statutory and regulatory duties of the Commission as described in this subtitle.
(ii)
The Department shall pay the indirect costs the Commission incurs in fulfilling the statutory and regulatory duties of the Commission as described in this subtitle.
(3)
Any unspent portions of the Fund may not be transferred or revert to the General Fund of the State, but shall remain in the Fund to be used for the purposes specified in paragraph (2)(i) of this subsection.
(f)
(1)
The Chairman of the Commission or the designee of the Chairman shall administer the Fund.
(2)
Money in the Fund may be expended only for the purposes specified in subsection (e)(2)(i) of this section.
(g)
The Legislative Auditor shall audit the accounts and transactions of the Fund as provided in § 2–1220 of the State Government Article.
Md. Code Ann., Health-Gen. § 13-311 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–311LinkCopy Citation
(a)
The Department shall certify an individual as eligible for benefits under the Program if the Department determines that:
(1)
The individual has chronic kidney disease as defined in the Commission’s regulations; and
(2)
The individual meets the residency, citizenship, and other nonmedical eligibility requirements established by the Department.
(b)
(1)
The certification of an individual under this section shall be for a period of 1 year.
(2)
The certification is renewable after each 1-year period if the individual meets the requirements of subsection (a) of this section.
Md. Code Ann., Health-Gen. § 13-312 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–312LinkCopy Citation
(a)
Except as provided in subsection (b) of this section, the Department shall require Program recipients to apply for eligibility in the Maryland Medical Assistance Program, the Medicare Part B Program, and the Medicare Part D Program within 60 days of notification to do so by the Department.
(b)
The Department may not require Program recipients to apply for eligibility in the Medicare Part B Program or the Medicare Part D Program if the Department determines the Program recipient has comparable insurance coverage.
Md. Code Ann., Health-Gen. § 13-313 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–313LinkCopy Citation
(a)
(1)
Prior to receiving Program benefits, each recipient whose family income exceeds 175 percent of the federal poverty income guidelines shall be required to pay an annual fee equal to the sum of:
(i)
5 percent of the amount by which the sum of the recipient’s adjusted gross income as defined in the Internal Revenue Code for federal income tax purposes plus Social Security benefits and tier 1 railroad retirement benefits not otherwise included in the recipient’s gross income under § 86 of the Internal Revenue Code exceeds 175 percent of the federal poverty guidelines adjusted for family size; and
(ii)
5 percent of the value of the recipient’s liquid assets above 200 percent of the federal poverty guidelines adjusted for family size.
(2)
The annual fee required under paragraph (1) of this subsection shall be collected quarterly by the Department.
(b)
A recipient is required to submit copies of the most recent tax returns of the recipient and of persons in the recipient’s family.
(c)
The Department shall provide recipients with a grace period after the deadline for a fee payment.
(d)
A recipient who has not paid overdue fees by the end of the grace period shall be terminated from the Program.
(e)
The Department shall extend the grace period in an appropriate hardship case.
Md. Code Ann., Health-Gen. § 13-314 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–314LinkCopy Citation
(a)
This State shall pay the incurred cost of all treatment related to kidney disease that a certified patient is given, for any cause, on or after the date of certification of that patient, if the treatment is given in:
(1)
A certified dialysis or transplant center that is in this State;
(2)
A dialysis or transplant center that is in a contiguous state and is approved by that contiguous state and the Commission; or
(3)
A home dialysis program that is approved by the Commission.
(b)
The State shall pay the incurred cost of all approved hospital services provided in any Maryland hospital, other than routine chronic maintenance dialysis, which a certified patient may require as a direct result of end stage renal disease.
(c)
The State shall pay the incurred costs of all prescription drugs and other pharmaceutical products that are determined to be medically necessary by the recipient’s physician for treatment related to kidney disease in accordance with rates established by the Department.
(d)
The Secretary may not pay for any treatment that an individual receives at a facility or program that is not certified or otherwise approved.
(e)
(1)
Except for an invoice submitted to a Medicare intermediary or any other insurance provider, the Secretary may not make any payment for an invoice that the Secretary receives more than 6 months after the dates of the services given.
(2)
An invoice shall be submitted to the Secretary within 3 months after payment or rejection by the Medicare intermediary or other insurance providers.
(3)
A provider who fails to submit an invoice within the required time may not recover the amount later from either the patient or the Secretary.
Md. Code Ann., Health-Gen. § 13-315 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–315LinkCopy Citation
(a)
The Program shall be the payor of last resort. The Department is authorized to require providers to seek all available third party reimbursement prior to billing the Program.
(b)
If it is determined to be in the Department’s best interest, the Department may pay the health insurance premiums of recipients, including Part B premiums, to insurance carriers or employers under the Program.
Md. Code Ann., Health-Gen. § 13-316 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 3. Kidney Disease Program
§ 13–316LinkCopy Citation
The Department shall specifically request the Governor to appropriate and identify in a separate line item in the annual budget the money necessary to carry out this subtitle.
Subtitle 4. Physical Fitness
Md. Code Ann., Health-Gen. § 13-401 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 4. Physical Fitness
§ 13–401LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“County advisory council” means an advisory council on physical fitness for a county.
(c)
“State Advisory Council” means the State Advisory Council on Health and Wellness.
Md. Code Ann., Health-Gen. § 13-402 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 4. Physical Fitness
§ 13–402LinkCopy Citation
The purposes of this subtitle and of the advisory councils that it creates are to protect and improve physical fitness, including:
(1)
Improvement of habits in recreation, exercise, sports, and the use of leisure time;
(2)
Protection and improvement of physique and health; and
(3)
Improvement of instruction for any of these purposes.
Md. Code Ann., Health-Gen. § 13-403 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 4. Physical Fitness
§ 13–403LinkCopy Citation
There may be an advisory council for physical fitness for each county and Baltimore City.
Md. Code Ann., Health-Gen. § 13-404 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 4. Physical Fitness
§ 13–404LinkCopy Citation
The county and Baltimore City advisory councils shall consult with the State Advisory Council on Health and Wellness.
Md. Code Ann., Health-Gen. § 13-405 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 4. Physical Fitness
§ 13–405LinkCopy Citation
If the federal government, any of its agencies or officers, or any other person offers to this State or to any county any services, equipment, supplies, materials, or funds by way of gift or grant for purposes of physical fitness, this State, acting in accordance with the requirements of law, may:
(1)
Accept the offer; and
(2)
Authorize any officer of this State or of a county to receive and use the aid and assistance.
Subtitle 5. Arthritis Prevention and Control Act
Md. Code Ann., Health-Gen. § 13-501 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 5. Arthritis Prevention and Control Act
§ 13–501LinkCopy Citation
The Arthritis Prevention and Control Program is a program in the Department for the purpose of raising public awareness, educating consumers, and educating and training health professionals, teachers, and providers about arthritis.
Md. Code Ann., Health-Gen. § 13-502 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 5. Arthritis Prevention and Control Act
§ 13–502LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Advisory Council” means the State Advisory Council on Health and Wellness.
(c)
“Program” means the Arthritis Prevention and Control Program.
Md. Code Ann., Health-Gen. § 13-503 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 5. Arthritis Prevention and Control Act
§ 13–503LinkCopy Citation
The General Assembly finds that:
(1)
Arthritis encompasses more than 100 diseases and conditions that affect joints, the surrounding tissues, and other connective tissues;
(2)
As one of the most common family of diseases in the United States, arthritis affects nearly one of every six Americans and will impact an estimated 60,000,000 people by the year 2020;
(3)
Arthritis is the leading cause of disability in the United States, limiting daily activities for more than 7,000,000 people;
(4)
Although prevailing myths inaccurately portray arthritis as an old person’s disease, arthritis is a multigenerational disease that has become one of the country’s most pressing health problems;
(5)
Arthritis has a significant impact on quality of life for the individual experiencing the painful symptoms and for the family members and caregivers providing for that individual;
(6)
The economic and social costs associated with treating arthritis and the complications of arthritis are estimated at almost $80,000,000,000 annually;
(7)
Currently, the challenge exists to ensure delivery of effective, but often underutilized, interventions that are necessary in the prevention or reduction of arthritis-related pain and disability;
(8)
The large quantity of public information and programs about arthritis remain inadequately disseminated and are insufficient in addressing the needs of specific diverse populations and other underserved groups;
(9)
The Arthritis Foundation, the Centers for Disease Control and Prevention, and the Association of State and Territorial Health Officials have led the development of a public health strategy, the National Arthritis Action Plan, to ensure the delivery of effective, but often underutilized interventions that are necessary in the prevention or reduction of arthritis-related pain and disability; and
(10)
Educating the public and health care community throughout the State about arthritis is of paramount importance and is in every respect in the public interest and to the benefit of all residents of the State.
Md. Code Ann., Health-Gen. § 13-504 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 5. Arthritis Prevention and Control Act
§ 13–504LinkCopy Citation
The purposes of this subtitle are to:
(1)
Create and foster a statewide program that promotes public awareness and increases knowledge about the causes of arthritis, the importance of early diagnosis and appropriate management, effective prevention strategies, and pain prevention and management;
(2)
Enhance understanding of arthritis by disseminating to patients, health professionals, and the public:
(i)
Educational materials;
(ii)
Information on research results;
(iii)
Information on services provided; and
(iv)
Strategies for prevention and control;
(3)
Establish a solid scientific base of knowledge on the prevention of arthritis and related disability through surveillance, epidemiology, and prevention research;
(4)
Utilize educational and training resources and services developed by organizations with appropriate expertise and knowledge of arthritis and use available technical assistance;
(5)
Evaluate the need for improving the quality and accessibility of existing community-based arthritis services;
(6)
Increase awareness about the prevention, detection, and treatment of arthritis among State and local health officials, providers, professionals, and policy makers;
(7)
Implement and coordinate State and local programs and services to reduce the public health burden of arthritis; and
(8)
Improve the quality of life and contain health care costs for individuals with arthritis and their families.
Md. Code Ann., Health-Gen. § 13-505 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 5. Arthritis Prevention and Control Act
§ 13–505LinkCopy Citation
The Secretary shall:
(1)
Provide sufficient staff to implement the Program;
(2)
Provide appropriate training for staff of the Program;
(3)
Identify the appropriate organizations to carry out the Program;
(4)
Base the Program on the most current scientific information and findings;
(5)
Work to increase and improve community–based services available to people with arthritis and their family members;
(6)
Work with governmental offices, national voluntary health organizations and their local chapters, community and business leaders, community organizations, and health care and human service providers to coordinate efforts and maximize State resources in the areas of prevention, education, detection, pain management, and treatment of arthritis; and
(7)
Identify and, when appropriate, use evidence–based arthritis programs and obtain related materials and services from organizations with appropriate expertise and knowledge of arthritis.
Md. Code Ann., Health-Gen. § 13-506 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 5. Arthritis Prevention and Control Act
§ 13–506LinkCopy Citation
The operation, management, and administration of the Program shall be funded as provided for in the State budget.
Md. Code Ann., Health-Gen. § 13-507 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 5. Arthritis Prevention and Control Act
§ 13–507LinkCopy Citation
This subtitle may be cited as the “Maryland Arthritis Prevention and Control Act”.
Subtitle 6. Early Hearing Detection and Intervention Program
Md. Code Ann., Health-Gen. § 13-601 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 6. Early Hearing Detection and Intervention Program
§ 13–601LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Hearing status” means the state of an individual’s ability to perceive sound, based on audiological assessment.
(c)
“Infant” means a child who is under the age of 1 year.
(d)
“Newborn” means a child up to 29 days old who is born in the State.
(e)
“Program” means the program that the Secretary establishes to provide for universal hearing screening of newborns and early identification and follow–up of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills.
Md. Code Ann., Health-Gen. § 13-602 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 6. Early Hearing Detection and Intervention Program
§ 13–602LinkCopy Citation
(a)
The Secretary shall establish a program for the universal hearing screening of newborns and early identification and follow–up of newborns and infants who have, or who are at risk for developing, a permanent hearing status that affects speech–language skills.
(b)
The program shall be based on the model system developed by the Department.
Md. Code Ann., Health-Gen. § 13-603 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 6. Early Hearing Detection and Intervention Program
§ 13–603LinkCopy Citation
(a)
There is an Early Hearing Detection and Intervention Advisory Council for the Program.
(b)
(1)
The Advisory Council consists of 12 members appointed by the Secretary.
(2)
Of the 12 members:
(i)
1 shall be a physician with expertise in childhood hearing status that affects speech–language skills;
(ii)
3 shall be from the field of education:
(1)
1 shall be from the Maryland State Department of Education;
(2)
1 shall be from the Maryland School for the Deaf; and
(3)
1 shall be an educator of the deaf from a local education agency;
(iii)
1 shall be from the Maryland Department of Health;
(iv)
1 shall be a mental health professional with expertise in the area of deafness;
(v)
2 shall be parents of children with a permanent hearing status that affects speech–language skills;
(vi)
1 shall be from the Maryland Association of the Deaf;
(vii)
1 shall be an audiologist with expertise in childhood hearing status that affects speech–language skills;
(viii)
1 shall be from the Alexander Graham Bell Association of Maryland; and
(ix)
1 shall be from the Governor’s Office of the Deaf, Deafblind, and Hard of Hearing.
(c)
(1)
The term of a member is 3 years.
(2)
The term of a member begins July 1.
(3)
The terms of members are staggered as required by the terms provided for members of the Advisory Council on July 1, 2014.
(4)
At the end of a term, a member continues to serve until a successor is appointed and qualifies.
(5)
A member who is appointed after a term has begun serves only for the rest of the term or until a successor is appointed and qualifies.
(6)
A member who serves 2 consecutive 3–year terms may not be reappointed for 3 years after completion of those terms.
(d)
The Advisory Council shall elect a chairperson from among its members.
(e)
The Advisory Council shall meet at least 4 times a year at the times and places that it determines.
(f)
A member of the Advisory Council:
(1)
May not receive compensation; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(g)
The Advisory Council shall:
(1)
Advise the Department on the implementation of the Program;
(2)
Advise the Department on the development of protocols to assist hospitals, health care providers, and audiologists in conducting universal newborn hearing screening and follow–up hearing evaluations of infants;
(3)
Provide consultation to the Department in the establishment of an educational program for families, professionals, and the public that can be integrated with existing State and local education agency programs; and
(4)
Review any materials the Department may distribute to the public concerning the Program.
(h)
In consultation with the Advisory Council, the Department shall develop guidelines for the operations of the Advisory Council.
Md. Code Ann., Health-Gen. § 13-604 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 6. Early Hearing Detection and Intervention Program
§ 13–604LinkCopy Citation
(a)
The Secretary may contract with any qualified person to administer the Program.
(b)
The Secretary shall:
(1)
Develop a system to gather and maintain data;
(2)
Develop methods to:
(i)
Contact parents or guardians of newborns and their identified primary care providers regarding the results of the newborn hearing screening;
(ii)
Contact parents or guardians of newborns and infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills; and
(iii)
Ensure families are referred to appropriate services;
(3)
Establish a toll–free telephone line to communicate information about hearing status that affects speech–language skills and services for infants who have, or are at risk for developing, a permanent hearing status that affects speech–language skills;
(4)
Appoint an Advisory Council for the Program;
(5)
Meet annually with the Advisory Council; and
(6)
In consultation with the Advisory Council, adopt rules and regulations necessary to implement the Program.
Md. Code Ann., Health-Gen. § 13-605 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 6. Early Hearing Detection and Intervention Program
§ 13–605LinkCopy Citation
(a)
As part of the supplemental information required to be submitted to the Department as part of the birth event, a hospital shall include the results of the hearing screening of the newborn.
(b)
The Department may adopt regulations for results reporting procedures for hospitals, birthing sites, and audiologists.
Subtitle 7. Emergency and Allergy Treatment Program
Md. Code Ann., Health-Gen. § 13-701 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7. Emergency and Allergy Treatment Program
§ 13–701LinkCopy Citation
The Emergency and Allergy Treatment Program is a program in the Department for the purpose of providing a means of authorizing certain individuals to administer life–saving treatment to individuals who have severe adverse reactions to allergens or insect stings when physician, physician assistant, registered nurse practitioner, or emergency medical services are not immediately available in a youth camp.
Md. Code Ann., Health-Gen. § 13-702 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7. Emergency and Allergy Treatment Program
§ 13–702LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Agent” means an individual who:
(1)
Is at least 18 years of age;
(2)
Has successfully completed, at the expense of an applicant, an educational training program approved by the Department; and
(3)
Is appointed by a certificate holder to administer emergency use epinephrine in accordance with the provisions of this subtitle.
(c)
“Anaphylaxis” means a sudden, severe, and potentially life–threatening allergic reaction that occurs when an individual is exposed to an allergen.
(d)
“Certificate” means a certificate or an endorsement on the operating certificate of a youth camp issued by the Department to an individual who operates a youth camp under Title 14, Subtitle 4 of this article to obtain, store, and administer emergency use epinephrine.
(e)
“Certificate holder” means an individual who is authorized by the Department to obtain, store, and administer emergency use epinephrine to be used in an emergency situation.
(f)
“Emergency use epinephrine” means a portable, disposable drug delivery device or product approved by the federal Food and Drug Administration that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.
(g)
“Program” means the Emergency and Allergy Treatment Program.
(h)
“Registered nurse practitioner” has the meaning stated in § 8–101 of the Health Occupations Article.
(i)
“Youth camp” has the meaning stated in § 14–401 of this article.
Md. Code Ann., Health-Gen. § 13-703 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7. Emergency and Allergy Treatment Program
§ 13–703LinkCopy Citation
(a)
The Department may:
(1)
Adopt regulations for the administration of the Program;
(2)
Collect fees necessary for the administration of the Program;
(3)
Issue and renew a certificate to a person meeting the requirements of this subtitle; and
(4)
Approve educational training programs, including programs conducted by other State agencies or private entities.
(b)
A certificate issued by the Department shall be valid for up to 1 year.
Md. Code Ann., Health-Gen. § 13-704 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7. Emergency and Allergy Treatment Program
§ 13–704LinkCopy Citation
(a)
To qualify for a certificate, an individual shall meet the requirements of this section.
(b)
The applicant shall operate a youth camp.
(c)
The applicant shall be at least 18 years old.
(d)
The applicant shall successfully complete, at the expense of the applicant, an educational training program approved by the Department.
(e)
An applicant shall have a written policy that includes:
(1)
Authorization for the certificate holder or agent to administer emergency use epinephrine, if available, to an individual who has been determined to be or is believed to be experiencing anaphylaxis, whether or not the individual:
(i)
Has previously been known to have experienced anaphylaxis; or
(ii)
Has a prescription for epinephrine prescribed by an authorized health care practitioner licensed under the Health Occupations Article;
(2)
A requirement that youth camp personnel complete training on how to recognize the symptoms of anaphylaxis;
(3)
Procedures for the emergency administration of emergency use epinephrine;
(4)
Procedures for proper emergency follow–up;
(5)
Authorization for a certificate holder to obtain and store emergency use epinephrine to be used in an emergency; and
(6)
A requirement that each certificate holder implement a method for notifying the parent or guardian of a camper of the youth camp’s policy under this section before the camper’s attendance.
Md. Code Ann., Health-Gen. § 13-705 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7. Emergency and Allergy Treatment Program
§ 13–705LinkCopy Citation
(a)
(1)
A registered nurse practitioner, physician assistant, or a physician licensed to practice in the State may prescribe emergency use epinephrine in the name of a certificate holder.
(2)
A registered nurse practitioner, a pharmacist, a physician assistant, or a physician licensed to practice in the State may dispense emergency use epinephrine under a prescription issued to a certificate holder.
(b)
A certificate holder may:
(1)
On presentment of a certificate, receive from any registered nurse practitioner, physician assistant, or any physician licensed to practice in the State a prescription for emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine; and
(2)
Possess and store prescribed emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine.
(c)
In an emergency situation when registered nurse practitioner, physician, physician assistant, or emergency medical services are not immediately available, a certificate holder or agent may administer emergency use epinephrine to an individual who is experiencing or believed in good faith by the certificate holder or agent to be experiencing anaphylaxis.
Md. Code Ann., Health-Gen. § 13-706 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7. Emergency and Allergy Treatment Program
§ 13–706LinkCopy Citation
(a)
A certificate holder shall submit to the Department, on a form required by the Department, a report of each incident that occurs while the youth camp is in session that required the administration of emergency use epinephrine.
(b)
The Department shall include in the report required under § 13–7A–03 of this title a summary of the information obtained from the reports submitted to the Department under subsection (a) of this section.
Md. Code Ann., Health-Gen. § 13-707 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7. Emergency and Allergy Treatment Program
§ 13–707LinkCopy Citation
(a)
A cause of action may not arise against a certificate holder or agent authorized under this subtitle for any act or omission when the certificate holder or agent is acting in good faith while administering emergency use epinephrine to an individual experiencing or believed by the certificate holder or agent to be experiencing anaphylaxis, except where the conduct of the certificate holder or agent amounts to gross negligence, willful or wanton misconduct, or intentionally tortious conduct.
(b)
(1)
A cause of action may not arise against any physician or physician assistant for any act or omission when the physician or physician assistant in good faith prescribes or dispenses emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine to a person certified by the Department under this subtitle.
(2)
A cause of action may not arise against any pharmacist for any act or omission when the pharmacist in good faith dispenses emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine to a person certified by the Department under this subtitle.
(3)
A cause of action may not arise against any nurse practitioner for any act or omission when the nurse practitioner in good faith prescribes or dispenses emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine to a person certified by the Department under this subtitle.
(c)
This section does not affect, and may not be construed as affecting, any immunities from civil liability or defenses established by any other provision of the Code or by common law to which a volunteer, registered nurse practitioner, physician, physician assistant, or pharmacist may be entitled.
Md. Code Ann., Health-Gen. § 13-708 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7. Emergency and Allergy Treatment Program
§ 13–708LinkCopy Citation
(a)
This subtitle may not be construed to create a duty upon any individual to obtain a certificate under this subtitle, and an individual may not be held civilly liable for failing to obtain a certificate under this subtitle.
(b)
An individual may not be held civilly liable in any action arising from or in connection with the administration of emergency use epinephrine by the individual solely because the individual did not possess a certificate issued under this subtitle.
Subtitle 7A. Emergency Use Epinephrine Program
Md. Code Ann., Health-Gen. § 13-7A-01 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-01LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Agent” means an individual who:
(1)
Is at least 18 years of age;
(2)
Has successfully completed, at the expense of the participating facility, an educational training program approved by the Department under § 13–7A–03 of this subtitle; and
(3)
Is designated by a certificate holder to administer emergency use epinephrine in accordance with the provisions of this subtitle.
(c)
“Anaphylaxis” means a sudden, severe, and potentially life–threatening allergic reaction that occurs when an individual is exposed to an allergen.
(d)
“Certificate” means a certificate issued by the Department to an individual to obtain, store, and administer emergency use epinephrine.
(e)
“Certificate holder” means an individual who is authorized by the Department to obtain, store, and administer emergency use epinephrine to be used in an emergency situation.
(f)
“Eligible institution” means an institution of higher education that has a food service facility or a recreation and wellness facility on the premises and that is authorized under this subtitle to obtain and store emergency use epinephrine.
(g)
“Emergency use epinephrine” means a portable, disposable drug delivery device or product approved by the federal Food and Drug Administration that contains a premeasured single dose of epinephrine that is used to treat anaphylaxis in an emergency situation.
(h)
“Food service facility” has the meaning indicated in § 21–301 of this article.
(i)
“Participating facility” means a recreation or wellness facility at an eligible institution or a food service facility, including a food service facility at an eligible institution, in the State that voluntarily participates in the Program.
(j)
“Program” means the Emergency Use Epinephrine Program established under § 13–7A–02 of this subtitle.
Md. Code Ann., Health-Gen. § 13-7A-02 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-02LinkCopy Citation
(a)
There is an Emergency Use Epinephrine Program.
(b)
The purpose of the Program is to authorize individuals employed by a participating facility to obtain and store emergency use epinephrine and administer emergency use epinephrine to individuals who are experiencing or are believed to be experiencing anaphylaxis when a physician or emergency medical services are not immediately available.
(c)
(1)
Subject to paragraph (4) of this subsection, each participating facility may obtain:
(i)
A prescription for a supply of emergency use epinephrine from a licensed physician as provided in § 13–7A–06 of this subtitle; and
(ii)
A supply of emergency use epinephrine from a licensed pharmacist or a licensed physician as provided in § 13–7A–06 of this subtitle.
(2)
Each participating facility shall store a supply of emergency use epinephrine obtained under paragraph (1)(ii) of this subsection:
(i)
In accordance with the manufacturer’s instructions; and
(ii)
In a location that is readily accessible to employees or affiliated individuals in an emergency situation.
(3)
Each participating facility shall designate the employees who are certificate holders or designated affiliated individuals who are certificate holders who will be responsible for the storage, maintenance, and control of the supply of emergency use epinephrine.
(4)
A participating facility may not obtain or store emergency use epinephrine unless the participating facility has at least two employees or designated affiliated individuals who are certificate holders.
(5)
Each participating facility shall maintain a copy of the certificate issued to an employee or a designated affiliated individual under § 13–7A–05 of this subtitle.
Md. Code Ann., Health-Gen. § 13-7A-03 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-03LinkCopy Citation
(a)
The Department shall:
(1)
Adopt regulations for the administration of the Program;
(2)
Collect fees necessary for the administration of the Program;
(3)
Issue a certificate to, or renew the certificate of, an individual meeting the requirements of § 13–7A–04 of this subtitle;
(4)
Approve educational training programs, including programs conducted by other State agencies or private entities;
(5)
Develop a method by which certificate holders may submit a report to the Department about each incident that occurred on the premises of a participating facility that involved the administration of emergency use epinephrine by a certificate holder or an agent; and
(6)
On or before January 31 each year, publish a report summarizing the information obtained from reports submitted to the Department under item (5) of this subsection.
(b)
The Department may:
(1)
Set an application fee for a certificate;
(2)
Establish a fee for the renewal or replacement of a certificate; and
(3)
Require applicants to apply to the Program in the manner the Department chooses.
(c)
An educational training program approved by the Department under subsection (a)(4) of this section may be an online training program.
Md. Code Ann., Health-Gen. § 13-7A-04 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-04LinkCopy Citation
(a)
To qualify for a certificate, an applicant shall:
(1)
Be employed by a participating facility;
(2)
Successfully complete, at the expense of the participating facility, an educational training program approved by the Department under § 13–7A–03 of this subtitle;
(3)
Submit an application to the Department in a manner required by the Department under § 13–7A–03 of this subtitle; and
(4)
Subject to subsection (b) of this section, pay to the Department an application fee required under § 13–7A–03 of this subtitle.
(b)
(1)
A participating facility may pay the application fee on behalf of the applicant.
(2)
If the participating facility is a food service facility that is part of an eligible institution, either entity may pay the application fee on behalf of the applicant.
Md. Code Ann., Health-Gen. § 13-7A-05 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-05LinkCopy Citation
(a)
The Department shall issue a certificate to any applicant who meets the requirements of § 13–7A–04 of this subtitle.
(b)
Each certificate shall include:
(1)
The full name of the certificate holder; and
(2)
A serial number.
(c)
A replacement certificate may be issued to replace a lost, destroyed, or mutilated certificate if the certificate holder pays a certificate replacement fee set by the Department.
(d)
(1)
A certificate shall be valid for a term of 1 year.
(2)
To renew a certificate for an additional 1–year term, the renewal applicant shall successfully complete a refresher educational training program approved by the Department under § 13–7A–03 of this subtitle.
Md. Code Ann., Health-Gen. § 13-7A-06 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-06LinkCopy Citation
(a)
(1)
A physician licensed to practice medicine in the State may prescribe emergency use epinephrine in the name of a certificate holder.
(2)
A pharmacist licensed to practice pharmacy in the State or a physician may dispense emergency use epinephrine under a prescription issued to a certificate holder.
(b)
A certificate holder may:
(1)
On presentment of a certificate, receive from any physician licensed to practice medicine in the State a prescription for emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine; and
(2)
Possess and store prescribed emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine.
(c)
In an emergency situation when a physician or emergency medical services are not immediately available, a certificate holder or an agent may administer emergency use epinephrine to an individual who is experiencing or is believed in good faith by the certificate holder or agent to be experiencing anaphylaxis.
Md. Code Ann., Health-Gen. § 13-7A-07 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-07LinkCopy Citation
(a)
(1)
Except as provided in paragraph (2) of this subsection, a cause of action may not arise against a certificate holder for any act or omission if the certificate holder or agent is acting in good faith while administering emergency use epinephrine to an individual who is experiencing or believed by the certificate holder or agent to be experiencing anaphylaxis except where the conduct of the certificate holder or agent amounts to gross negligence, willful or wanton misconduct, or intentionally tortious conduct.
(2)
The provisions of paragraph (1) of this subsection do not apply if a certificate holder or participating facility that makes available, or a certificate holder who administers, emergency use epinephrine to an individual who is experiencing or is believed by the certificate holder or participating facility to be experiencing anaphylaxis:
(i)
Fails to follow standards and procedures for storage and administration of emergency use epinephrine; or
(ii)
Administers emergency use epinephrine that is beyond the manufacturer’s expiration date.
(b)
(1)
A cause of action may not arise against any physician for any act or omission if the physician in good faith prescribes or dispenses emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine to a certificate holder or participating facility under this subtitle.
(2)
A cause of action may not arise against any pharmacist for any act or omission if the pharmacist in good faith dispenses emergency use epinephrine and the necessary paraphernalia for the administration of emergency use epinephrine to a certificate holder or a participating facility under this subtitle.
(c)
This section does not affect and may not be construed as affecting any immunities from civil liability or defenses established by any other provision of law or by common law to which a physician or pharmacist may be entitled.
Md. Code Ann., Health-Gen. § 13-7A-08 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-08LinkCopy Citation
(a)
This subtitle may not be construed to create a duty on any individual employed by a recreation or wellness facility at an eligible institution or food service facility to obtain a certificate under this subtitle, and an individual employed by a recreation or wellness facility at an eligible institution or food service facility may not be held civilly liable for failing to obtain a certificate under this subtitle.
(b)
An individual may not be held civilly liable in any action arising from or in connection with the administration of emergency use epinephrine by the individual solely because the individual did not possess a certificate issued under this subtitle.
Md. Code Ann., Health-Gen. § 13-7A-09 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 7A. Emergency Use Epinephrine Program
§ 13–7A-09LinkCopy Citation
A certificate holder shall submit to the Department, in the manner required under § 13–7A–03 of this subtitle, a report of each incident that occurred on the premises of a participating facility that involved the administration of emergency use epinephrine by a certificate holder or an agent.
Subtitle 9. Organ and Tissue Donation Awareness
Md. Code Ann., Health-Gen. § 13-901 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 9. Organ and Tissue Donation Awareness
§ 13–901LinkCopy Citation
(a)
(1)
There is an Organ and Tissue Donation Awareness Fund.
(2)
The Fund consists of:
(i)
Money collected under § 16–111.2(f) of the Transportation Article; and
(ii)
Funds appropriated in accordance with subsection (c) of this section.
(3)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(4)
The State Treasurer shall separately hold and the State Comptroller shall account for the Fund.
(5)
The Fund shall be invested and reinvested in the same manner as other State funds.
(6)
Any investment earnings shall be retained to the credit of the Fund.
(b)
(1)
The Fund shall be managed and supervised by the Secretary or the Secretary’s designee.
(2)
(i)
The Fund shall be used to promote public education and awareness about organ, tissue, and eye donations and to fund the establishment, operation, and maintenance of a donor registry as provided in § 4–516 of the Estates and Trusts Article.
(ii)
(1)
Beginning in fiscal year 2024, at least $500,000 shall be distributed annually from the Fund to the qualified nonprofit entity described in § 4–516 of the Estates and Trusts Article.
(2)
Any unused funds distributed to the qualified nonprofit entity under subsubparagraph 1 of this subparagraph shall revert to the Fund at the end of each fiscal year.
(3)
The Fund shall be subject to audit by the Office of Legislative Audits under Title 2, Subtitle 12 of the State Government Article.
(c)
For each of fiscal years 2024 through 2027, the Governor shall include in the annual budget bill an appropriation to the Fund in an amount equal to the difference between:
(1)
The funds collected under § 16–111.2(f) of the Transportation Article in the second immediately preceding fiscal year; and
(2)
$500,000.
Subtitle 10. Tobacco Use Prevention and Cessation Program
Md. Code Ann., Health-Gen. § 13-1001 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1001LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Administrative Component” means the component of the Program that is established under § 13-1014 of this subtitle.
(c)
“Baseline Tobacco Study” means the study that is conducted under § 13-1003 of this subtitle.
(d)
“Cigarette Restitution Fund” means the fund that is established under § 7-317 of the State Finance and Procurement Article.
(e)
“Community Health Coalition” means a coalition established under § 13-1008(b)(1) of this subtitle.
(f)
“Comprehensive Plan for Tobacco Use Prevention and Cessation” means a plan that is developed under § 13-1008(b)(2) of this subtitle.
(g)
“Counter-Marketing and Media Component” means the component of the Program that is established under § 13-1013 of this subtitle.
(h)
“County” includes Baltimore City.
(i)
“Local health officer” means:
(1)
The head of a county health department; or
(2)
A person designated by the Department under § 13-1008(g) of this subtitle.
(j)
“Local Public Health Component” means the component of the Program that is established under § 13-1006 of this subtitle.
(k)
“Local Public Health Tobacco Grant” means a grant distributed by the Department to a county under §§ 13-1006 through 13-1012 of this subtitle.
(l)
“Maryland Adolescent Survey” means the Maryland Adolescent Survey that is administered by the Maryland State Department of Education.
(m)
“Master Settlement Agreement” means the Master Settlement Agreement executed by the State and participating tobacco manufacturers.
(n)
“Minority individual” means a woman or an individual of African American, Hispanic, Native American, or Asian descent.
(o)
“National Public Education Fund” means the National Public Education Fund that was established under the Master Settlement Agreement.
(p)
“Program” means the Tobacco Use Prevention and Cessation Program established under § 13-1002 of this subtitle.
(q)
“Statewide Public Health Component” means the component of the Program that is established under § 13-1005 of this subtitle.
(r)
“Surveillance and Evaluation Component” means the component of the Program that is established under § 13-1003 of this subtitle.
(s)
(1)
“Targeted minority population” means a minority population to which the tobacco industry disproportionately marketed tobacco products.
(2)
“Targeted minority population” includes:
(i)
Women; and
(ii)
Individuals of African American, Hispanic, Native American, and Asian descent.
(t)
“Task Force Report” means the report entitled “Making Maryland the Tobacco Free State” that was issued in December 1999 by the Governor’s Task Force to End Smoking in Maryland.
(u)
(1)
“Tobacco product” means any product that is:
(i)
Intended for human inhalation, absorption, ingestion, smoking, heating, chewing, dissolving, or any other manner of consumption that is made of, derived from, or contains:
(1)
Tobacco; or
(2)
Nicotine; or
(ii)
An accessory or component used in any manner of consumption of a product described in item (i) of this paragraph.
(2)
“Tobacco product” includes:
(i)
Cigarettes, cigars, pipe tobacco, chewing tobacco, snuff, and snus;
(ii)
Electronic smoking devices; and
(iii)
Filters, rolling papers, pipes, and liquids used in electronic smoking devices regardless of nicotine content.
(3)
“Tobacco product” does not include a drug, device, or combination product authorized for sale by the U.S. Food and Drug Administration under the Federal Food, Drug, and Cosmetic Act.
(v)
“Uninsured individual” means an individual:
(1)
For whom the appropriate treatment is not covered by private health insurance, Medicaid, Medicare, or the Maryland Children’s Health Program; and
(2)
Who the Department determines does not have the financial means to pay for appropriate treatment.
(w)
“Youth Tobacco Survey” means the Youth Tobacco Survey developed by the Centers for Disease Control and Prevention and administered by the Department with the assistance of the Maryland State Department of Education.
Md. Code Ann., Health-Gen. § 13-1002 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1002LinkCopy Citation
(a)
There is a Tobacco Use Prevention and Cessation Program in the Department.
(b)
The purpose of the Program is to coordinate the State’s use of the Cigarette Restitution Fund to address issues relating to tobacco use prevention and cessation so as to create a lasting legacy of public health initiatives that result in a reduction of tobacco use in the State and otherwise benefit the health and welfare of the State’s residents.
(c)
The Program consists of:
(1)
A Surveillance and Evaluation Component;
(2)
A Statewide Public Health Component;
(3)
A Counter–Marketing and Media Component;
(4)
A Local Public Health Component; and
(5)
An Administrative Component.
(d)
(1)
The Program shall be funded as provided in the State budget with money from the Cigarette Restitution Fund.
(2)
The Legislative Auditor is authorized to audit the appropriations and expenditures made for the purpose of implementing the Program, including the use of any funds received by a person under any component of this Program.
(e)
(1)
The annual budget bill shall specify the amount of funding that is allocated to each component of the Program.
(2)
Except as provided in paragraph (3) of this subsection, money that is allocated to a component of the Program in the State budget:
(i)
May only be expended for the purpose for which it is appropriated; and
(ii)
May not be transferred to any other component of the Program, any other program in the Department, or any other unit of State government.
(3)
(i)
Except as provided in subparagraph (ii) of this paragraph, the Department may transfer a maximum of 10% of the total amount of money that is allocated to the Program in the State budget among components of the Program if the transfer is specifically authorized in the annual budget bill as enacted.
(ii)
The Department may not transfer money to the Administrative Component from any other component of the Program.
(iii)
If the Department transfers any money among the components of the Program as authorized under subparagraph (i) of this paragraph, the Department shall report the transfer to the Senate Budget and Taxation Committee, Senate Finance Committee, House Appropriations Committee, and House Health Committee within 60 days of the transfer.
(iv)
The Department may transfer money that is allocated to a component of the Program in the State budget to another program in the Department, or another unit of State government if the transfer is specifically authorized by:
(1)
A provision of this subtitle; or
(2)
A provision of the annual budget bill as enacted that relates specifically to the transfer of funds from that component.
(f)
(1)
Money that is allocated to a component of the Program in the State budget that remains unspent and unobligated at the end of the applicable fiscal year shall revert to the Cigarette Restitution Fund.
(2)
Money that reverts to the Cigarette Restitution Fund under paragraph (1) of this subsection shall be used to fund the Program in the fiscal year to which the next annual budget bill relates.
(3)
The Governor shall include in the next annual budget bill an appropriation for the Program that is at least equal to the amount of money that reverted to the Cigarette Restitution Fund under paragraph (1) of this subsection.
(g)
No later than January 31 of each year, the Department shall report to the Governor and, subject to § 2–1257 of the State Government Article, the Senate Budget and Taxation Committee, Senate Finance Committee, House Appropriations Committee, and House Health Committee:
(1)
The amount of money that was allocated to each component of the Program during:
(i)
The prior fiscal year that remained unspent and unobligated at the end of that year; and
(ii)
The current fiscal year that remained unspent and unobligated as of December 31 of the preceding calendar year; and
(2)
The amount of money that was distributed to a county as a Local Public Health Tobacco Grant during:
(i)
The prior fiscal year that remained unspent and unobligated at the end of that year; and
(ii)
The current fiscal year that remained unspent and unobligated as of December 31 of the preceding calendar year.
(h)
The Department shall adopt regulations that establish the criteria that the Department will use to determine whether, for the purpose of qualifying as an uninsured individual under § 13–1001(v) of this subtitle, an individual has the financial means to pay for appropriate treatment.
Md. Code Ann., Health-Gen. § 13-1003 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1003LinkCopy Citation
(a)
There is a Surveillance and Evaluation Component in the Program.
(b)
The purposes of the Surveillance and Evaluation Component are to:
(1)
Collect, analyze, and monitor data relating to tobacco use and tobacco use prevention and cessation in the State;
(2)
Measure and evaluate the results of the Program, including the results of each component of the Program;
(3)
Conduct a Baseline Tobacco Study, as provided under subsections (c) through (e) of this section; and
(4)
Conduct a Tobacco Study, as provided under § 13–1004 of this subtitle.
(c)
(1)
To initiate the Surveillance and Evaluation Component, the Department shall conduct a comprehensive statewide Baseline Tobacco Study as provided under this section.
(2)
The Baseline Tobacco Study shall measure:
(i)
The number and percentage of individuals attending middle school or high school who smoke or otherwise use tobacco products, both statewide and in each county;
(ii)
The number and percentage of minority individuals attending middle school or high school who smoke or otherwise use tobacco products, both statewide and in each county;
(iii)
The number and percentage of individuals who smoke or otherwise use tobacco products, both statewide and in each county;
(iv)
The number and percentage of minority individuals who smoke or otherwise use tobacco products, both statewide and in each county;
(v)
The number and percentage of pregnant women who smoke or otherwise use tobacco products, both statewide and in each county;
(vi)
The number and percentage of households with individuals attending middle school or high school in which at least one household member who is at least 18 years old smokes tobacco products, both statewide and in each county;
(vii)
The number and percentage of individuals who, within an established amount of time before the start of the Baseline Tobacco Study, started to smoke or otherwise use tobacco products;
(viii)
The number and percentage of individuals who smoke or otherwise use tobacco on a regular basis and who, within an established amount of time before the start of the Baseline Tobacco Study, voluntarily stopped smoking or otherwise using tobacco products for a significant amount of time, as determined by the Department, both statewide and in each county; and
(ix)
Any other factor that the Department determines to be important for measuring tobacco use or evaluating whether the Program meets its objectives.
(d)
(1)
In conducting the Baseline Tobacco Study, the Department may consider any data collected after March 1, 2000, through the administration of the Maryland Adolescent Survey or the Youth Tobacco Survey.
(2)
The Maryland State Department of Education, county boards of education, and each school selected to participate in the Maryland Adolescent Survey or the Youth Tobacco Survey shall cooperate with the Department in administering the surveys.
(3)
(i)
Subject to subparagraph (ii) of this paragraph, the Maryland State Department of Education may not discontinue administration of the Maryland Adolescent Survey until after it has submitted a report to the Governor and, subject to § 2–1257 of the State Government Article, the General Assembly that states the reason for discontinuing the survey.
(ii)
If the Maryland State Department of Education submits a report as provided under subparagraph (i) of this paragraph, it may discontinue the Maryland Adolescent Survey in the first school year that begins after the report has been submitted.
(e)
(1)
Subject to paragraphs (2) through (4) of this subsection, the Department shall contract with a higher education institution or private entity to conduct the Baseline Tobacco Study.
(2)
The Department shall issue a request for proposal to select the entity that will conduct the Baseline Tobacco Study.
(3)
The request for proposal shall require that any methodology or model that is used by the entity to conduct the Baseline Tobacco Study, any data collected under the Study, and any electronic files, codes, and definitions relating to the Study be provided to the State for use in subsequent studies, regardless of whether the subsequent studies are conducted by the same entity.
(4)
The Department may contract with an entity to conduct the Baseline Tobacco Study and one or more biennial tobacco studies as required under § 13–1004 of this subtitle.
(5)
(i)
The Department shall use the criteria established in subparagraph (ii) of this paragraph as a guide in administering the request for proposal process for the Baseline Tobacco Study.
(ii)
The Department shall give preference to an entity that:
(1)
Is a Maryland–based vendor;
(2)
Has previous work experience relating to tobacco or health activities;
(3)
Has previous work experience relating to youth and adolescents;
(4)
Demonstrates a capability for innovative activities and use of state–of–the–art technologies;
(5)
Has demonstrated the ability to provide culturally–specific and effective services to targeted minority populations;
(6)
Has previous work experience with the public sector;
(7)
Demonstrates performance in the specific content area for at least 3 years;
(8)
Has previous work experience with rural or urban communities;
(9)
Will maximize the use of State funds through the use of preexisting materials, funding partnerships, and resource matching; and
(10)
Has no history of working for the tobacco industry.
Md. Code Ann., Health-Gen. § 13-1004 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1004LinkCopy Citation
(a)
Beginning in fiscal year 2007 and in every second year thereafter, the Department shall conduct a Tobacco Study which shall measure the same factors that are set forth in § 13–1003(c) of this subtitle and use the same methodology or model that was used for the Baseline Tobacco Study.
(b)
To carry out the evaluation and surveillance functions of this subtitle, the Department may conduct any other tobacco study measuring the factors set forth in § 13–1003(c) of this subtitle and using a methodology or model that is consistent with but need not be identical to that used to conduct the Baseline Tobacco Study.
(c)
(1)
Subject to paragraphs (2) through (4) of this subsection, the Department shall contract with a higher education institution or private entity to conduct the Biennial Tobacco Study.
(2)
The Department shall issue a request for proposal to select the entity that will conduct the Biennial Tobacco Study.
(3)
The Department may contract with an entity to conduct one or more biennial tobacco studies.
(4)
The Department shall use the criteria established in § 13–1003(e)(5) of this subtitle as a guide in administering the request for proposal process.
(d)
On or before May 31 of each even–numbered fiscal year, beginning in fiscal year 2008, the Department shall submit a report to the Governor and, subject to § 2–1257 of the State Government Article, the General Assembly on:
(1)
The results of the Biennial Tobacco Study; and
(2)
Beginning in fiscal year 2024, a State– and county–level data summary and trends report on data collected under § 7–420 of the Education Article.
Md. Code Ann., Health-Gen. § 13-1005 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1005LinkCopy Citation
(a)
There is a Statewide Public Health Component in the Program.
(b)
The purpose of the Statewide Public Health Component is to maximize the effectiveness of the anti-tobacco initiatives in the State by authorizing the Department to take steps to ensure that the Program is implemented in a coordinated and integrated manner throughout the State.
(c)
Subject to subsections (d) and (e) of this section and as necessary to ensure a coordinated and integrated statewide effort to implement tobacco use prevention and cessation programs, the Department may develop and implement statewide anti-tobacco initiatives that are consistent with the findings and recommendations of the Task Force Report and the recommendations of the Centers for Disease Control and Prevention regarding best practices for comprehensive tobacco control programs as they relate to statewide programs, including programs that support the implementation of the Local Public Health Component.
(d)
(1)
To implement this section, the Department may issue a request for proposal, distribute a grant, or enter into a contract.
(2)
The request for proposal, grant, or contract shall state with specificity the objectives and performance criteria that will be used to measure the success of the Program to which the request for proposal, grant, or contract relates.
(3)
If the Department issues a request for proposal to select an entity to implement an initiative under this section, the Department shall use the criteria established in § 13-1003(e)(5) of this subtitle as a guide in administering the request for proposal process.
(e)
(1)
Except as provided under paragraph (2) of this subsection, the Department may not spend any of the money that is allocated to the Statewide Public Health Component in the State budget until after the Baseline Tobacco Study is completed.
(2)
(i)
Subject to subparagraph (ii) of this paragraph and before the Baseline Tobacco Study is completed, the Department may use money that is allocated to the Statewide Public Health Component in the State budget for fiscal year 2001 to distribute grants that will be used to provide outreach and start-up technical assistance to communities for the purpose of organizing participation in community health coalitions.
(ii)
The Department shall use at least $750,000 of the money that is allocated to the Statewide Public Health Component in the State budget for fiscal year 2001 to provide outreach and start-up technical assistance to African American communities in the State for the purpose of organizing participation in community health coalitions that are formed under § 13-1008(b), § 13-1109(c), or § 13-1115(b) of this title.
Md. Code Ann., Health-Gen. § 13-1006 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1006LinkCopy Citation
(a)
There is a Local Public Health Component in the Program.
(b)
The purpose of the Local Public Health Component is to maximize the effectiveness of anti-tobacco initiatives in the State by authorizing local health coalitions to develop and implement tobacco use prevention and cessation programs in coordination with the Department.
(c)
Subject to §§ 13-1007 through 13-1012 of this subtitle, the Department may distribute grants to counties for tobacco use prevention and cessation programs, including:
(1)
Community-based programs;
(2)
School-based programs which may include tobacco use prevention and cessation components of school-based health care services and programs established under §§ 7-401 and 7-415 of the Education Article; and
(3)
Programs relating to enforcement of tobacco control laws.
(d)
(1)
Except as provided under paragraph (2) of this subsection, the Department may not spend any funds that are allocated to the Local Public Health Component in the State budget until after the Baseline Tobacco Study has been completed.
(2)
Before the Baseline Tobacco Study is completed, the Department may distribute a planning grant of not more than $10,000 to each local health department.
Md. Code Ann., Health-Gen. § 13-1007 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1007LinkCopy Citation
(a)
After the Baseline Tobacco Study has been completed and before soliciting applications for Local Public Health Tobacco Grants, the Department, in consultation with the local health departments, shall:
(1)
Establish short–term and long–term tobacco use prevention and cessation goals for each county;
(2)
Establish other requirements for each county that the Department determines to be necessary to meet the goals established under paragraph (1) of this subsection; and
(3)
Provide for the distribution of Local Public Health Tobacco Grants to eligible counties based on the formula established under subsection (b) of this section.
(b)
Subject to subsections (c) through (e) of this section and §§ 13–1008 through 13–1012 of this subtitle, the Department shall distribute a Local Public Health Tobacco Grant to each county that is equal to the sum of:
(1)
A base amount of funding as determined by the Department for each county and Baltimore City;
(2)
The product of:
(i)
One–half of the amount remaining from the allocation to the Local Public Health Component in the State budget after the base amount under item (1) of this subsection is distributed to each county and Baltimore City; and
(ii)
The number of individuals in the county attending middle school or high school who smoke or otherwise use tobacco products divided by the number of individuals in the State attending middle school or high school who smoke or otherwise use tobacco products; and
(3)
The product of:
(i)
One–half of the amount remaining from the allocation to the Local Public Health Component in the State budget after the base amount under item (1) of this subsection is distributed to each county and Baltimore City; and
(ii)
The number of individuals in the county who smoke or otherwise use tobacco products divided by the number of individuals in the State who smoke or otherwise use tobacco products.
(c)
Beginning in fiscal year 2005, the calculations of the numbers of individuals smoking or using tobacco products required in subsection (b)(2)(ii) and (3)(ii) of this section shall be based on the most recent data averaged over a multiyear period as determined by the Department.
(d)
The allocation formula calculated in accordance with subsection (b) of this section for fiscal year 2005 shall remain in effect for the following 3 years and thereafter shall be recalculated every 4th year in accordance with the provisions of this section.
Md. Code Ann., Health-Gen. § 13-1008 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1008LinkCopy Citation
(a)
(1)
Subject to the other provisions of this section, a local health officer may apply to the Department for a Local Public Health Tobacco Grant.
(2)
The amount of the Local Public Health Tobacco Grant shall be determined by the Department using the formula established under § 13–1007 of this subtitle.
(b)
Before applying for a Local Public Health Tobacco Grant, a local health officer shall:
(1)
Establish a Community Health Coalition, as provided under § 13–1010 of this subtitle, or identify another coalition approved by the Department; and
(2)
With the assistance of the coalition established or identified under item (1) of this subsection:
(i)
Identify all existing tobacco use prevention and cessation programs in the county that are publicly funded;
(ii)
Evaluate the effectiveness of the publicly funded programs identified under item (i) of this paragraph; and
(iii)
Develop a Comprehensive Plan for Tobacco Use Prevention and Cessation that outlines a strategy for meeting the tobacco use prevention and cessation goals and requirements established for the county under § 13–1007 of this subtitle.
(c)
A Comprehensive Plan for Tobacco Use Prevention and Cessation shall:
(1)
Include a list of the members of the coalition established or identified under subsection (b)(1) of this section and their organizational affiliations;
(2)
Include an evaluation of any county program funded with a Local Public Health Tobacco Grant in the prior year;
(3)
Each year, after the first year of funding, demonstrate that progress has been made toward meeting the tobacco use prevention and cessation goals established for the county under § 13–1007 of this subtitle;
(4)
Include a budget plan that provides specific levels of funding for each initiative described in the Plan and an explanation as to how each initiative is expected to help meet the tobacco use prevention and cessation goals and requirements established for the county under § 13–1007 of this subtitle;
(5)
Demonstrate that the county has met the base–year funding requirement established under § 13–1011 of this subtitle;
(6)
Each year, after the first year of funding, identify all persons who received money under a Local Public Health Tobacco Grant in the prior year and state the amount of money that was received by each person under the grant;
(7)
Each year, after the first year of funding, state the amount of money that was received by a county under a Local Public Health Tobacco Grant in the prior fiscal year that remained unspent and unobligated at the end of that year;
(8)
Describe how the Plan will help to reduce tobacco use among women, minority individuals, and individuals attending middle school or high school, with particular emphasis on how the Plan seeks to address the relevant findings and recommendations of the Task Force Report;
(9)
Describe how the Plan will help to increase availability of and access to cessation programs for uninsured individuals and medically underserved populations, with particular emphasis on how the Plan seeks to address the relevant findings and recommendations of the Task Force Report;
(10)
Allocate resources in a manner that is consistent with:
(i)
The needs of different populations in the county, including targeted minority populations, as identified in the Baseline Tobacco Study and annual tobacco studies; and
(ii)
The recommendations of the Centers for Disease Control and Prevention regarding best practices for a comprehensive tobacco control program; and
(11)
Contain any data or other information required by the Department.
(d)
If a Comprehensive Plan for Tobacco Use Prevention and Cessation does not allocate resources in a manner that is consistent with the recommendations of the Centers for Disease Control and Prevention regarding best practices for a comprehensive tobacco control program, the Plan shall:
(1)
State the reason for not allocating resources in this manner; and
(2)
Identify the extent to which other resources assist the county in meeting this requirement.
(e)
A local health officer who seeks to obtain a Local Public Health Tobacco Grant shall apply to the Department by submitting a copy of the county’s Comprehensive Plan for Tobacco Use Prevention and Cessation for approval.
(f)
Each year, a local health officer, in consultation with the coalition established or identified under subsection (b)(1) of this section, shall update the Comprehensive Plan for Tobacco Use Prevention and Cessation.
(g)
(1)
The Department may designate a person other than the head of a county health department to coordinate a county’s tobacco use prevention and cessation efforts if:
(i)
The county health department is unwilling to coordinate these efforts;
(ii)
The county health department has been unsuccessful in implementing tobacco use prevention and cessation initiatives that satisfy performance standards established by the Department; or
(iii)
The county health department lacks sufficient staff or resources to coordinate these efforts.
(2)
Subject to paragraph (3) of this subsection, the Department shall establish procedures for making a designation under this subsection.
(3)
If the Department determines that it is necessary to designate a person other than the local health officer to coordinate a county’s tobacco use prevention and cessation efforts, the Department may designate the Department as the entity that will coordinate the county’s efforts.
Md. Code Ann., Health-Gen. § 13-1009 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1009LinkCopy Citation
(a)
The local health officers of two or more counties may join together as a region to apply for a Local Public Health Tobacco Grant.
(b)
The amount of the Local Public Health Tobacco Grant that is distributed to a region under subsection (a) of this section shall be equal to the sum of the Local Public Health Tobacco Grants that otherwise would have been distributed to each county under § 13–1007 of this subtitle.
(c)
If the local health officers of two or more counties join together as a region to apply for a Local Public Health Tobacco Grant, the local health officers shall act jointly to:
(1)
Develop a Comprehensive Plan for Tobacco Use Prevention and Cessation, as required under § 13–1008 of this subtitle;
(2)
Establish a Community Health Coalition, as required under § 13–1008 of this subtitle, or identify another coalition approved by the Department;
(3)
Demonstrate that the base–year funding requirement of § 13–1011 of this subtitle has been met; and
(4)
Otherwise satisfy the requirements of §§ 13–1006 through 13–1012 of this subtitle.
Md. Code Ann., Health-Gen. § 13-1010 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1010LinkCopy Citation
(a)
The membership of a Community Health Coalition established under § 13-1008(b) of this subtitle shall:
(1)
Reflect the demographics of the county; and
(2)
Include representatives of community-based groups, including minority, rural, and medically underserved populations, that, taken together, are familiar with all of the different communities and cultures in the county.
(b)
The membership of a Community Health Coalition established under § 13–1008(b) of this subtitle may include:
(1)
Representatives of:
(i)
A local management board established under Title 8, Subtitle 3 of the Human Services Article;
(ii)
The local public school system;
(iii)
Local hospitals, clinics, physicians, and other health care providers;
(iv)
Local law enforcement;
(v)
Local businesses;
(vi)
Local religious organizations;
(vii)
Local media;
(viii)
Institutions of higher education; and
(ix)
Hospitals and other entities located outside the county that could enhance the county’s tobacco use prevention and cessation efforts; and
(2)
Any other person that the local health officer believes would help the county meet the tobacco use prevention and cessation goals and requirements established for the county under § 13–1007 of this subtitle.
Md. Code Ann., Health-Gen. § 13-1011 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1011LinkCopy Citation
(a)
(1)
Before receiving a Local Public Health Tobacco Grant, a local health officer shall submit to the Department an inventory of all publicly funded tobacco use prevention and cessation programs in the county that were identified under § 13-1008(b)(2) of this subtitle.
(2)
The inventory shall specify the amount of county funds that are being spent on each of the programs included in the inventory.
(b)
The level of funding specified under subsection (a)(2) of this section shall be the county’s base-year funding for tobacco use prevention and cessation programs.
(c)
A Local Public Health Tobacco Grant may not be used to supplant a county’s base-year funding for tobacco use prevention and cessation programs.
(d)
The Department may not distribute a Local Public Health Tobacco Grant to a county unless the Department determines that the county will spend, in the applicable fiscal year, at least its base-year funding for tobacco use prevention and cessation programs.
Md. Code Ann., Health-Gen. § 13-1012 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1012LinkCopy Citation
(a)
The Department shall review a Comprehensive Plan for Tobacco Use Prevention and Cessation submitted under § 13-1008(d) of this subtitle and determine whether:
(1)
The Plan addresses the goals and requirements established for the county under § 13-1007 of this subtitle;
(2)
The Plan allocates resources in a manner that is consistent with the needs of the different populations in the county, including targeted minority populations, as identified in the Baseline Tobacco Study and biennial tobacco studies;
(3)
The Plan allocates resources in a manner that is consistent with the recommendations of the Centers for Disease Control and Prevention regarding best practices for a comprehensive tobacco control program or states a reason for not meeting this requirement and identifies other resources that, taken together, meet this requirement; and
(4)
The local health officer has complied with the other requirements of §§ 13-1007 through 13-1011 of this subtitle.
(b)
The Department may not distribute a county’s share of money for a Local Public Health Tobacco Grant, as provided under § 13-1007 of this subtitle, if the Department determines that the requirements of subsection (a) of this section have not been met.
Md. Code Ann., Health-Gen. § 13-1013 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1013LinkCopy Citation
(a)
There is a Counter–Marketing and Media Component in the Program.
(b)
The purpose of the Counter–Marketing and Media Component is to coordinate a statewide counter–marketing and media campaign to counter tobacco advertisements and discourage the use of tobacco products.
(c)
(1)
Except as provided in paragraph (2) of this subsection, the Department may not spend any money that is allocated to the Counter–Marketing and Media Component in the State budget until after the Baseline Tobacco Study is completed.
(2)
Before the Baseline Tobacco Study is completed, the Department may spend money that is allocated to the Counter–Marketing and Media Component in the State budget to conduct formative research relating to the Counter–Marketing and Media Component.
(d)
(1)
The Department may contract with a higher education institution or private entity to implement any part of the Counter–Marketing and Media Component.
(2)
If the Department determines that any part of the Counter–Marketing and Media Component should be implemented by a higher education institution or private entity, the Department shall issue a request for proposal to select the entity that will implement that part of the Component.
(3)
At a minimum, the request for proposal shall:
(i)
State with specificity the goals of the Counter–Marketing and Media Component;
(ii)
State with specificity the objectives and performance criteria that will be used to measure the success of the program to which the request for proposal relates; and
(iii)
Require that the response to the request for proposal include a plan to reach the targeted audiences identified by the Department.
(4)
If the Department issues a request for proposal to select an entity to implement any part of the Counter–Marketing and Media Component, the Department shall use the criteria established in § 13–1003(e)(5) of this subtitle as a guide in administering the request for proposal process.
(e)
To the extent practicable, the Department shall take steps to maximize the cost effectiveness of the Counter–Marketing and Media Component, including:
(1)
Using advertisements and other communications and public relations products and services that have been developed by and shown to be effective in other states;
(2)
Subject to subsection (f) of this section, using money that is allocated to the Counter–Marketing and Media Component to obtain money from the federal government, the National Public Education Fund, or any other entity; and
(3)
Coordinating the purchase of broadcast time with other states.
(f)
The Department may not accept money from the federal government, the National Public Education Fund, or any other entity if the Department is required to accept, as a condition of receiving the money, restrictions on the content of advertisements, communications, or other public relations products or services that are funded with money from the Cigarette Restitution Fund if the restrictions are inconsistent with the purposes of this subtitle.
Md. Code Ann., Health-Gen. § 13-1014 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1014LinkCopy Citation
(a)
There is an Administrative Component in the Program.
(b)
The purpose of the Administrative Component is to provide the necessary administrative structure in the Department for effective management of the Program.
(c)
Funds that are allocated to the Administrative Component in the State budget shall be used to cover administrative costs incurred by the Department in administering the Program.
(d)
Unless otherwise specified in the annual budget bill as enacted, the amount of funds that are allocated to the Administrative Component in the State budget may not exceed 7% of the total amount that is allocated to the Program in the State budget.
(e)
A county that receives funds under a Local Public Health Tobacco Grant, a person who receives funds under a Local Public Health Tobacco Grant, and any other person who receives funds under any component of the Program may not use more than 7% of the funds to cover administrative costs.
Md. Code Ann., Health-Gen. § 13-1015 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 10. Tobacco Use Prevention and Cessation Program
§ 13–1015LinkCopy Citation
(a)
For fiscal year 2011 and fiscal year 2012, the Governor shall include at least $6,000,000 in the annual budget in appropriations for activities aimed at reducing tobacco use in Maryland as recommended by the Centers for Disease Control and Prevention, including:
(1)
Media campaigns aimed at reducing smoking initiation and encouraging smokers to quit smoking;
(2)
Media campaigns educating the public about the dangers of secondhand smoke exposure;
(3)
Enforcement of existing laws banning the sale or distribution of tobacco products to individuals under the age of 21 years;
(4)
Promotion and implementation of smoking cessation programs; and
(5)
Implementation of school–based tobacco education programs.
(b)
(1)
For fiscal years 2013 through 2021, the Governor shall include at least $10,000,000 in the annual budget in appropriations for the purposes described in subsection (a) of this section.
(2)
For fiscal years 2022 through 2026, the Governor shall include at least $18,250,000 in the annual budget in appropriations for the purposes described in subsection (a) of this section.
(3)
For fiscal year 2027 and each fiscal year thereafter, the Governor shall include at least $17,520,000 in the annual budget in appropriations for the purposes described in subsection (a) of this section.
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
Md. Code Ann., Health-Gen. § 13-1101 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1101LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Administrative Component” means the component of the Program established under § 13–1119 of this subtitle.
(c)
“Baseline Cancer Study” means the study conducted under § 13–1103 of this subtitle.
(d)
“Cancer Research Plan” means a plan developed under § 13–1116 of this subtitle.
(e)
“Cigarette Restitution Fund” means the fund that is established under § 7–317 of the State Finance and Procurement Article.
(f)
“Community Health Coalition” means a coalition established under § 13–1109(c)(1) or § 13–1115(b)(1) of this subtitle.
(g)
“Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment” means a plan developed under § 13–1109(c)(2) or § 13–1115(b)(2) of this subtitle.
(h)
“County” includes Baltimore City.
(i)
“Education” means information provided to the public regarding the purpose of, availability of, and access to screening programs.
(j)
“Federally qualified health center” has the meaning stated in 42 U.S.C. § 254b.
(k)
“Johns Hopkins Institutions” means the Johns Hopkins University and the Johns Hopkins Health System.
(l)
“Local health officer” means:
(1)
The head of a county health department; or
(2)
A person designated by the Department under § 13–1109(g) or § 13–1115(f) of this subtitle.
(m)
“Local Public Health Cancer Grant” means a grant distributed by the Department to a county under §§ 13–1107 through 13–1113 of this subtitle.
(n)
“Local Public Health Component” means the component of the Program that is established under § 13–1107 of this subtitle.
(o)
“Maryland Cancer Registry” means the computerized data system, operated by the Department with the assistance of the Maryland State Council on Cancer Control, that registers cases of cancer that are diagnosed and treated in the State.
(p)
“Maryland Technology Development Corporation” means the entity that is established under Title 10, Subtitle 4 of the Economic Development Article.
(q)
“Minority individual” means a woman or an individual of African American, Hispanic, Native American, or Asian descent.
(r)
“Outreach efforts” means activities that are related to encouraging individuals to seek screening services.
(s)
“Prevention” means activities relating to early detection, screening, and risk factor reduction.
(t)
“Program” means the Cancer Prevention, Education, Screening, and Treatment Program that is established under § 13–1102 of this subtitle.
(u)
“Screening” includes screening, early detection, identification, diagnosis, and outreach efforts associated with screening and early detection programs.
(v)
“Statewide Academic Health Center” means the University of Maryland Medical Group or the Johns Hopkins Institutions.
(w)
“Statewide Academic Health Center Cancer Research Grant” means a grant that is distributed under § 13–1116 of this subtitle.
(x)
“Statewide Academic Health Center Component” means the component established under § 13–1114 of this subtitle.
(y)
“Statewide Academic Health Center Public Health Grant” means a grant that is distributed under § 13–1115 of this subtitle.
(z)
“Statewide Academic Health Center Tobacco–Related Diseases Research Grant” means a grant that is distributed under § 13–1017 of this title.
(aa)
“Statewide Public Health Component” means the component of the Program that is established under § 13–1106 of this subtitle.
(bb)
“Surveillance and Evaluation Component” means the component of the Program that is established under § 13–1103 of this subtitle.
(cc)
“Targeted cancer” means a cancer that is identified by the Department under § 13–1102(d) of this subtitle.
(dd)
“Task Force Report” means the report entitled “Report of the Governor’s Task Force to Conquer Cancer” that was issued in December 1999.
(ee)
“Tobacco–related diseases” means cardiovascular disease, chronic pulmonary disease, peripheral vascular disease, stroke, and infant mortality due to low birth weight.
(ff)
“Treatment” includes appropriate access to:
(1)
Local hospitals, community clinics, physicians, and other health care providers; and
(2)
Clinical trials, transportation, case management, hospice care, and cancer support groups.
(gg)
“Underinsured individual” means an individual:
(1)
For whom the appropriate treatment is not adequately covered by private health insurance, Medicaid, Medicare, or the Maryland Children’s Health Program due to out–of–pocket costs, including required copayments, coinsurance, or deductibles; and
(2)
Who the Department determines does not have the financial means to pay for appropriate treatment.
(hh)
“Uninsured individual” means an individual:
(1)
For whom the appropriate treatment is not covered by private health insurance, Medicaid, Medicare, or the Maryland Children’s Health Program; and
(2)
Who the Department determines does not have the financial means to pay for appropriate treatment.
(ii)
“University of Maryland Medical Group” means the University of Maryland Medical System Corporation, the University of Maryland Medical School, and the University of Maryland, Baltimore Campus.
Md. Code Ann., Health-Gen. § 13-1102 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1102LinkCopy Citation
(a)
There is a Cancer Prevention, Education, Screening, and Treatment Program in the Department.
(b)
The purpose of the Program is to coordinate the State’s use of the Cigarette Restitution Fund so as to create a lasting legacy of public health initiatives that reduce mortality and morbidity rates for cancer and tobacco–related diseases in the State and otherwise benefit the health and welfare of the State’s residents.
(c)
The Program consists of:
(1)
A Surveillance and Evaluation Component;
(2)
A Statewide Public Health Component;
(3)
A Local Public Health Component;
(4)
A Statewide Academic Health Center Component; and
(5)
An Administrative Component.
(d)
To initiate the Program, the Department shall identify the types of cancers that will be targeted under the Program.
(e)
(1)
The Program shall be funded as provided in the State budget with money from the Cigarette Restitution Fund.
(2)
The Legislative Auditor is authorized to audit the appropriations and expenditures made for the purpose of implementing the Program, including the use of any funds received by a person under any component of the Program.
(f)
(1)
The annual budget bill shall specify the amount of funding that is allocated to each component of the Program.
(2)
Except as provided in paragraph (3) of this subsection, money that is allocated to a component of the Program in the State budget:
(i)
May only be expended for the purpose for which it is appropriated; and
(ii)
May not be transferred to any other component in the Program, any other program in the Department, or any unit of State government.
(3)
(i)
Except as provided in subparagraph (ii) of this paragraph, the Department may transfer a maximum of 10% of the total amount of money that is allocated to the Program among the components of the Program if the transfer is specifically authorized in the annual budget bill as enacted.
(ii)
The Department may not transfer funds to the Statewide Academic Health Center Component or the Administrative Component from any other component of the Program.
(iii)
If the Department transfers any money among the components of the Program as authorized under subparagraph (i) of this paragraph, the Department shall report the transfer to the Senate Budget and Taxation Committee, Senate Finance Committee, House Appropriations Committee, and House Health Committee within 60 days after the transfer.
(iv)
The Department may transfer money that is allocated to a component of the Program in the State budget to another program in the Department or another unit of State government if the transfer is specifically authorized by:
(1)
A provision of this subtitle; or
(2)
A provision of the annual budget bill as enacted that relates specifically to the transfer of funds from that component.
(g)
(1)
Money that is allocated to a component of the Program in the State budget that remains unspent and unobligated at the end of the applicable fiscal year shall revert to the Cigarette Restitution Fund.
(2)
Money that reverts to the Cigarette Restitution Fund under paragraph (1) of this subsection shall be used to fund the Program in the fiscal year to which the next annual budget bill relates.
(3)
The Governor shall include in the next annual budget bill an appropriation for the Program that is at least equal to the amount of money that reverted to the Cigarette Restitution Fund under paragraph (1) of this subsection.
(h)
No later than January 31 of each year, the Department shall report to the Governor and, subject to § 2–1257 of the State Government Article, Senate Budget and Taxation Committee, Senate Finance Committee, House Appropriations Committee, and House Health Committee:
(1)
The amount of money that was allocated to each component of the Program during:
(i)
The prior fiscal year that remained unspent and unobligated at the end of that year; and
(ii)
The current fiscal year that remained unspent and unobligated as of December 31 of the preceding calendar year; and
(2)
The amount of money that was distributed to a county as a Local Public Health Cancer Grant during:
(i)
The prior fiscal year that remained unspent and unobligated at the end of that year; and
(ii)
The current fiscal year that remained unspent and unobligated as of December 31 of the preceding calendar year.
(i)
The Department shall adopt regulations that establish the criteria that the Department will use to determine whether, for the purpose of qualifying as an uninsured individual under § 13–1101(hh) of this subtitle, an individual has the financial means to pay for appropriate treatment.
Md. Code Ann., Health-Gen. § 13-1103 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1103LinkCopy Citation
(a)
There is a Surveillance and Evaluation Component in the Program.
(b)
The purpose of the Surveillance and Evaluation Component is to:
(1)
Collect, analyze, and monitor data relating to:
(i)
Targeted cancers;
(ii)
As determined by the Department, nontargeted cancers; and
(iii)
Cancer prevention, education, screening, and treatment programs in the State;
(2)
Measure and evaluate the results of the Program, including the results of each component of the Program;
(3)
Conduct the Baseline Cancer Study, as provided under subsections (c) and (d) of this section; and
(4)
Conduct a Biennial Cancer Study, as provided under § 13-1104 of this subtitle.
(c)
(1)
To initiate the Surveillance and Evaluation Component, the Department shall conduct a comprehensive statewide Baseline Cancer Study as provided in this section.
(2)
The Department may:
(i)
Conduct the Baseline Cancer Study or any part of the Study; or
(ii)
Contract with a higher education institution or private entity to conduct the Baseline Cancer Study or any part of the Study.
(d)
The Baseline Cancer Study shall measure:
(1)
The number and percentage of individuals who have each targeted cancer, both statewide and in each county;
(2)
The number and percentage of individuals within each minority population who have each targeted cancer, both statewide and in each county;
(3)
The mortality rate for each targeted cancer, both statewide and in each county;
(4)
The mortality rate for different minority populations for each targeted cancer, both statewide and in each county;
(5)
The number of identifiable cancers with a high incidence in the State for which there are effective methods of:
(i)
Early detection; and
(ii)
Prevention and treatment after detection;
(6)
Any aspect of targeted and nontargeted cancers that the Department seeks to measure; and
(7)
Any other factor that the Department determines to be important for measuring rates of cancers in the State or for evaluating whether the Program meets its objectives.
(e)
In order to maximize the cost effectiveness of the Baseline Cancer Study, the Department may use data in the Maryland Cancer Registry or provided by other sources, to the extent that these sources provide reliable data relating to the factors listed in subsection (d) of this section.
(f)
(1)
If the Department chooses to have a higher education institution or private entity conduct the Baseline Cancer Study or any part of the Study, the Department shall issue a request for proposal to select the entity that will conduct the Study or the relevant part of the Study.
(2)
The request for proposal shall require that any methodology or model that is used by the entity to conduct the Baseline Cancer Study or the relevant part of the Study, any data collected under the Study, and any electronic files, codes, and definitions relating to the Study be provided to the State for use in subsequent studies, regardless of whether the studies are conducted by the same entity.
(3)
The Department may contract with an entity to conduct the Baseline Cancer Study and one or more biennial cancer studies as required under § 13-1104 of this subtitle.
Md. Code Ann., Health-Gen. § 13-1104 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1104LinkCopy Citation
(a)
Beginning in fiscal year 2004 and biennially thereafter, the Department shall conduct a Biennial Cancer Study.
(b)
The Biennial Cancer Study shall:
(1)
Measure the same factors that are set forth in § 13–1103(d) of this subtitle; and
(2)
Use the same methodology or model that is used to conduct the Baseline Cancer Study.
(c)
The Department may:
(1)
Conduct the Biennial Cancer Study or any part of the Study; or
(2)
Contract with a higher education institution or private entity to conduct the Biennial Cancer Study or any part of the Study.
(d)
(1)
If the Department chooses to have a higher education institution or private entity conduct the Biennial Cancer Study or any part of the Study, the Department shall issue a request for proposal to select the entity that will conduct the Study or the relevant part of the Study.
(2)
The Department may contract with an entity to conduct one or more biennial cancer studies or a part of one or more biennial cancer studies.
(e)
On or before December 31 of each odd numbered fiscal year, beginning in fiscal year 2005, the Department shall submit a report to the Governor and, subject to § 2–1257 of the State Government Article, the General Assembly, on the results of the Biennial Cancer Study.
Md. Code Ann., Health-Gen. § 13-1105 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1105LinkCopy Citation
Before the Department distributes a Local Public Health Cancer Grant to any county under §§ 13-1107 through 13-1113 of this subtitle, the Department shall develop an inventory of publicly funded screening programs that includes information relating to:
(1)
The number and types of publicly funded screening programs for each targeted cancer, both statewide and in each county, and the number of individuals screened each year in these programs; and
(2)
The existence of mechanisms to ensure that uninsured individuals receive appropriate treatment for any cancer that is detected in the screening programs identified under item (1) of this section.
Md. Code Ann., Health-Gen. § 13-1106 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1106LinkCopy Citation
(a)
There is a Statewide Public Health Component in the Program.
(b)
The purpose of the Statewide Public Health Component is to maximize the effectiveness of the anti-cancer initiatives in the State by authorizing the Department to take steps to ensure that the Program is implemented in a coordinated and integrated manner throughout the State.
(c)
Subject to subsection (d) of this section and as necessary to ensure a coordinated and integrated statewide effort to implement cancer prevention, identification, and treatment programs for targeted cancers, the Department may develop and implement statewide anti-cancer initiatives that are consistent with the findings and recommendations of the Task Force Report, including programs that support the implementation of the Local Public Health Component of the Program.
(d)
If the Department issues a request for proposal, distributes a grant, or enters into a contract as authorized under subsection (c) of this section, the request for proposal, grant, or contract shall state with specificity the objectives and performance criteria that will be used to measure the success of the program to which the request for proposal, grant, or contract relates.
(e)
The Department may not spend any money that is allocated to the Statewide Public Health Component in the State budget until the Baseline Cancer Study has been completed.
Md. Code Ann., Health-Gen. § 13-1107 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1107LinkCopy Citation
(a)
There is a Local Public Health Component in the Program.
(b)
The purpose of the Local Public Health Component is to maximize the effectiveness of anti–cancer initiatives in the State by empowering local health coalitions to develop and implement cancer prevention, education, screening, and treatment programs in coordination with the Department.
(c)
Subject to §§ 13–1108 through 13–1113 of this subtitle, the Department may distribute grants to counties for cancer prevention, education, screening, and treatment programs.
(d)
(1)
Except as provided under paragraph (2) of this subsection, the Department may not spend any funds that are allocated to the Local Public Health Component in the State budget until after the Baseline Cancer Study has been completed.
(2)
Before the Baseline Cancer Study is completed, the Department may distribute a planning grant of not more than $10,000 to each local health department other than the Baltimore City Health Department.
(e)
Prior to each fiscal year, the Department shall determine the percentage of funds that shall be allocated to cancer screening, diagnosis, and treatment by a county or Statewide Academic Health Center that receives funds under a Local Public Health Cancer Grant.
Md. Code Ann., Health-Gen. § 13-1108 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1108LinkCopy Citation
(a)
After the Baseline Cancer Study has been completed and before soliciting applications for Local Public Health Cancer Grants, the Department, in consultation with local health departments, shall:
(1)
Establish short-term and long-term cancer prevention, education, screening, and treatment goals for each county;
(2)
Establish other requirements for each county that the Department determines to be necessary to meet the goals established under paragraph (1) of this subsection; and
(3)
Provide for the distribution of Local Public Health Cancer Grants to eligible counties based on the formula established under subsection (b) of this section.
(b)
Subject to subsections (c) through (e) of this section and §§ 13-1109 through 13-1113 of this subtitle, the Department shall distribute a Local Public Health Cancer Grant to each county that is equal to the sum of:
(1)
A base amount of funding as determined by the Department for each county;
(2)
The product of:
(i)
One-half of the amount remaining from the allocation to the Local Public Health Component in the State budget after the base amount under item (1) of this subsection is distributed to each county; and
(ii)
The number of individuals in the county who have any of the targeted cancers divided by the number of individuals in the State residing outside of Baltimore City who have any of the targeted cancers; and
(3)
The product of:
(i)
One-half of the amount remaining from the allocation to the Local Public Health Component in the State budget after the base amount under item (1) of this subsection is distributed to each county; and
(ii)
The number of individuals in the county who died from any of the targeted cancers during the prior year divided by the number of individuals in the State residing outside of Baltimore City who died from any of the targeted cancers during the prior year.
(c)
(1)
Except as provided in this subsection, Baltimore City is not eligible to receive money from the Department based on the formula established under subsection (b) of this section.
(2)
Each year, before calculating the amount of money that may be distributed to each county as a Local Public Health Cancer Grant under subsection (b) of this section, the Department shall calculate the amount of money that would have been distributed to each county if Baltimore City were included in the formula.
(3)
For fiscal year 2007 or any subsequent fiscal year, if the amount of money that would have been distributed to Baltimore City using the formula established under subsection (b) of this section if Baltimore City were included in the formula exceeds 19%, the Department shall transfer the difference between that amount and 19% from the Local Public Health Component to the Statewide Academic Health Center Component.
(d)
Beginning in fiscal year 2004, the calculations required in subsection (b)(2)(ii) and (3)(ii) of this section of the numbers of individuals having any of the targeted cancers or who died from any of the targeted cancers shall be based on the most recent data averaged over a multiyear period as determined by the Department.
(e)
The allocation formula calculated in accordance with subsection (b) of this section for fiscal year 2004 shall remain in effect for the following 3 years and thereafter be recalculated every 4th year in accordance with the provisions of this section.
(f)
The Department may reallocate projected unspent funds awarded to a county to another county as needed during the fiscal year in order to address any unmet county funding needs as determined under § 13–1107 of this subtitle.
Md. Code Ann., Health-Gen. § 13-1109 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1109LinkCopy Citation
(a)
Except as provided in § 13–1115(f) of this subtitle, this section does not apply to Baltimore City.
(b)
(1)
Subject to the other provisions of this section, a local health officer may apply to the Department for a Local Public Health Cancer Grant.
(2)
The amount of a Local Public Health Cancer Grant shall be determined by the Department using the formula that is established under § 13–1108 of this subtitle.
(c)
Before applying for a Local Public Health Cancer Grant, a local health officer shall:
(1)
Establish a Community Health Coalition, as provided under § 13–1111 of this subtitle, or identify another coalition approved by the Department; and
(2)
With the assistance of the coalition established or identified under item (1) of this subsection:
(i)
Identify all existing cancer prevention, education, screening, and treatment programs that relate to targeted cancers in the county that are publicly funded;
(ii)
Evaluate the effectiveness of the publicly funded programs identified under item (i) of this paragraph; and
(iii)
Develop a Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment that outlines a strategy for meeting the cancer prevention, education, screening, and treatment goals and requirements established for the county under § 13–1108 of this subtitle.
(d)
A Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment shall:
(1)
Include a list of the members of the coalition established or identified under subsection (c)(1) of this section and their organizational affiliations;
(2)
Include the evaluation of any program funded with a Local Public Health Cancer Grant in the prior year;
(3)
Each year, after the first year of funding, demonstrate that progress has been made toward meeting the cancer prevention, education, screening, and treatment goals established for the county under § 13–1108 of this subtitle;
(4)
Include a budget plan that provides specific levels of funding for each initiative described in the Plan and an explanation as to how each initiative is expected to help meet the cancer prevention, education, screening, and treatment goals and requirements established for the county under § 13–1108 of this subtitle;
(5)
Demonstrate that the county has met the base–year funding requirement established under § 13–1112 of this subtitle;
(6)
Demonstrate that any early detection or screening program that is or will be funded under a Local Public Health Cancer Grant provides necessary treatment or linkages to necessary treatment for uninsured individuals who are diagnosed with a targeted or non–targeted cancer as a result of the screening process;
(7)
Each year, after the first year of funding, identify all persons who received money under a Local Public Health Cancer Grant in the prior year and state the amount of money that was received by each person under the Grant;
(8)
Each year, after the first year of funding, state the amount of money that was received by a county under a Local Public Health Cancer Grant in the prior fiscal year that remained unspent and unobligated at the end of that year;
(9)
Describe how the Plan will help to eliminate the greater incidence of and higher morbidity rates for cancer in minority populations and rural areas, with particular emphasis on how the Plan seeks to address the relevant findings and recommendations of the Task Force Report;
(10)
Describe how the Plan will help to increase availability of and access to health care services for uninsured and underinsured individuals and medically underserved populations, with particular emphasis on how the Plan seeks to address the relevant findings and recommendations of the Task Force Report;
(11)
Demonstrate that priority consideration was given to persons, including federally qualified health centers, that have demonstrated a commitment to providing cancer prevention, education, screening, and treatment services to uninsured and underinsured individuals in the county and a proven ability to do so; and
(12)
Contain any data or other information required by the Department.
(e)
A local health officer who seeks to obtain a Local Public Health Cancer Grant shall apply to the Department by submitting a copy of the county’s Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment for approval.
(f)
Each year, a local health officer, in consultation with the coalition established or identified under subsection (c)(1) of this section, shall update the Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment.
(g)
(1)
The Department may designate a person other than the head of a county health department to coordinate a county’s cancer prevention, education, screening, and treatment efforts if:
(i)
The county health department is unwilling to coordinate these efforts;
(ii)
The county health department has been unsuccessful in implementing cancer prevention, education, screening, and treatment initiatives that satisfy performance standards established by the Department; or
(iii)
The county health department lacks sufficient staff or resources to coordinate these efforts.
(2)
Subject to paragraph (3) of this subsection, the Department shall establish procedures for making a designation under this subsection.
(3)
If the Department determines that it is necessary to designate a person other than the local health officer to coordinate a county’s cancer prevention, education, screening, and treatment efforts, the Department may designate the Department as the entity that will coordinate the county’s efforts.
Md. Code Ann., Health-Gen. § 13-1110 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1110LinkCopy Citation
(a)
The local health officers of two or more counties may join together as a region to apply for a Local Public Health Cancer Grant.
(b)
The Department may require that two or more counties join together as a region to apply for a Local Public Health Cancer Grant if the Department determines that:
(1)
It would be cost–effective to fund cancer prevention, education, screening, and treatment programs for targeted cancers on a regional basis; and
(2)
It would serve the public health interests of the counties to fund cancer prevention, education, screening, and treatment programs for targeted cancers on a regional basis.
(c)
The amount of a Local Public Health Cancer Grant that is distributed to a region under this section shall be equal to the sum of the Local Public Health Cancer Grants that otherwise would have been distributed to each county under the formula established under § 13–1108 of this subtitle.
(d)
If the local health officers of two or more counties choose to join together as a region to apply for a Local Public Health Cancer Grant or are required to do so by the Department, the local health officers shall act jointly to:
(1)
Develop a Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment, as required under § 13–1109(c) of this subtitle;
(2)
Establish a Community Health Coalition, as provided under § 13–1111 of this subtitle, or identify another coalition approved by the Department;
(3)
Demonstrate that the base–year funding requirement established under § 13–1112 of this subtitle has been met; and
(4)
Otherwise satisfy the requirements of §§ 13–1107 through 13–1113 of this subtitle.
Md. Code Ann., Health-Gen. § 13-1111 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1111LinkCopy Citation
(a)
(1)
The membership of a Community Health Coalition established under § 13-1109(c) of this subtitle shall:
(i)
Reflect the demographics of the county; and
(ii)
Include representatives of community-based groups, including minority, rural, and medically underserved populations, that, taken together, are familiar with all of the different communities and cultures in the county.
(2)
(i)
In addition to the requirements of paragraph (1) of this subsection, in Baltimore City and in Baltimore, Montgomery, and Prince George’s counties, the Community Health Coalition shall include representatives of the major community hospitals that treat county residents with targeted cancers.
(ii)
In Baltimore, Montgomery, and Prince George’s counties, the local health officer, in consultation with the Department, shall determine whether a hospital is a major community hospital based on the following factors:
(1)
The number of county residents with targeted cancers who are served by the hospital;
(2)
Whether the hospital has special expertise in treating targeted cancers;
(3)
Whether the hospital has demonstrated a commitment to treating uninsured individuals; and
(4)
The number of research activities conducted by the hospital that relate to targeted cancers and the amount of funding for these activities.
(iii)
In Baltimore City, the University of Maryland Medical Group and the Johns Hopkins Institutions, acting jointly in collaboration with the Baltimore City Health Department, in consultation with the Department, shall determine whether a hospital is a major community hospital based on the factors listed under subparagraph (ii) of this paragraph.
(b)
The membership of a Community Health Coalition established under § 13–1109(c) of this subtitle may include:
(1)
Representatives of:
(i)
A local management board established under Title 8, Subtitle 3 of the Human Services Article;
(ii)
Local hospitals, clinics, physicians, and other health care providers;
(iii)
Local religious organizations;
(iv)
Institutions of higher education; and
(v)
Hospitals and other entities located outside the county that could enhance the county’s cancer prevention, education, screening, and treatment efforts; and
(2)
Any other person that the local health officer believes would help the county meet the cancer prevention, education, screening, and treatment goals and requirements established for the county under § 13–1108 of this subtitle.
Md. Code Ann., Health-Gen. § 13-1112 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1112LinkCopy Citation
(a)
Except as provided in § 13-1115(f) of this subtitle, this section does not apply in Baltimore City.
(b)
(1)
Before receiving a Local Public Health Cancer Grant, a local health officer shall submit to the Department an inventory of all existing publicly funded cancer prevention, education, screening, and treatment programs that relate to targeted cancers in the county that were identified under § 13-1109(c) of this subtitle.
(2)
The inventory shall specify the amount of county funds that are being spent on each of the programs included in the inventory.
(c)
The level of funding specified under subsection (b)(2) of this section shall be the county’s base-year funding for cancer prevention, education, screening, and treatment programs that relate to targeted cancers.
(d)
A Local Public Health Cancer Grant may not be used to supplant a county’s base-year funding for cancer prevention, education, screening, and treatment programs that relate to targeted cancers.
(e)
The Department may not distribute a Local Public Health Cancer Grant to a county unless the Department determines that the county will spend, in the applicable fiscal year, at least its base-year funding for cancer prevention, education, screening, and treatment programs that relate to targeted cancers.
Md. Code Ann., Health-Gen. § 13-1113 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1113LinkCopy Citation
(a)
The Department shall review a Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment submitted under § 13-1109(e) of this subtitle and determine whether:
(1)
The Plan addresses the goals and requirements established for the county under § 13-1108 of this subtitle; and
(2)
All other requirements of §§ 13-1107 through 13-1112 of this subtitle have been met.
(b)
The Department may not distribute a county’s share of money for a Local Public Health Cancer Grant, as provided under § 13-1108 of this subtitle, if the Department determines that the requirements of subsection (a) of this section have not been met.
Md. Code Ann., Health-Gen. § 13-1114 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1114LinkCopy Citation
(a)
There is a Statewide Academic Health Center Component in the Program.
(b)
The purpose of the Statewide Academic Health Center Component is to maximize the effectiveness of the Program by involving the University of Maryland Medical Group and the Johns Hopkins Institutions in the implementation of the Program.
(c)
Subject to §§ 13–1115 and 13–1116 of this subtitle, the Department may implement the Statewide Academic Health Center Component by distributing:
(1)
Statewide Academic Health Center Public Health Grants, as provided under § 13–1115 of this subtitle; and
(2)
Statewide Academic Health Center Cancer Research Grants, as provided under § 13–1116 of this subtitle.
(d)
The University of Maryland Medical Group and the Johns Hopkins Institutions shall coordinate their efforts with regard to initiatives that are funded with grants that are distributed under the Statewide Academic Health Center Component to maximize the benefits received from the use of these grant funds and to eliminate unnecessary duplication of efforts.
Md. Code Ann., Health-Gen. § 13-1115 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1115LinkCopy Citation
(a)
(1)
Subject to the other provisions of this section, the University of Maryland Medical Group and the Johns Hopkins Institutions may each apply for a Statewide Academic Health Center Public Health Grant.
(2)
For fiscal year 2007 and any subsequent fiscal year, the amount of each Statewide Academic Health Center Public Health Grant that is distributed to the University of Maryland Medical Group or the Johns Hopkins Institutions, respectively, shall be equal to the sum of:
(i)
At least 9.5% of the total local public health component money distributed under § 13–1108(b) of this subtitle; and
(ii)
One–half of any money that is transferred from the Local Public Health Component to the Statewide Academic Health Center Component under § 13–1108(c) of this subtitle.
(b)
Before applying for a Statewide Academic Health Center Public Health Grant, the University of Maryland Medical Group and the Johns Hopkins Institutions, acting jointly in collaboration with the Baltimore City Health Department, shall:
(1)
Establish a Baltimore City Community Health Coalition, as provided under § 13–1111 of this subtitle, or identify another coalition approved by the Department that reflects the demographics of Baltimore City and includes representatives of community–based groups, including minority and medically underserved populations, that, taken together, are familiar with all of the different communities and cultures in Baltimore City; and
(2)
With the assistance of the coalition established or identified under item (1) of this subsection:
(i)
Identify all existing cancer prevention, education, screening, and treatment programs that relate to targeted cancers in Baltimore City that are publicly funded;
(ii)
Evaluate the effectiveness of the publicly funded programs identified under item (i) of this paragraph; and
(iii)
Develop a Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment that outlines a strategy for meeting the cancer prevention, education, screening, and treatment goals and requirements established for Baltimore City under § 13–1108 of this subtitle.
(c)
The Baltimore City Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment shall:
(1)
Include a list of the members of the coalition established or identified under subsection (b)(1) of this section and their organizational affiliations;
(2)
Include the evaluation of any program funded with a Statewide Academic Health Center Public Health Grant in the prior year;
(3)
Each year, after the first year of funding, demonstrate that progress has been made toward meeting the cancer prevention, education, screening, and treatment goals established for Baltimore City under § 13–1108 of this subtitle;
(4)
Include a budget plan that provides specific levels of funding for each initiative described in the Plan and an explanation as to how each initiative is expected to help meet the cancer prevention, education, screening, and treatment goals and requirements established for Baltimore City under § 13–1108 of this subtitle;
(5)
Demonstrate that Baltimore City has met the base–year funding requirement established under subsection (h) of this section;
(6)
Demonstrate that any early detection or screening program that is or will be funded under a Statewide Academic Health Center Public Health Grant provides necessary treatment or linkages to necessary treatment for uninsured individuals who are diagnosed with a targeted and non–targeted cancer as a result of the screening process;
(7)
State that the Statewide Academic Health Center Public Health Grant will not be used to supplant any existing funding at the University of Maryland Medical Group or the Johns Hopkins Institutions for any cancer prevention, education, screening, or treatment programs that relate to targeted cancers;
(8)
Each year, after the first year of funding, identify all persons who received money under the Statewide Academic Health Center Public Health Grant in the prior year and state the amount of money that was received by each person under the Grant;
(9)
Each year, after the first year of funding, state the amount of money that was received by the University of Maryland Medical Group and the Johns Hopkins Institutions under a Statewide Academic Health Center Public Health Grant in the prior fiscal year that remained unspent and unobligated at the end of that year;
(10)
Describe how the Plan will help to eliminate the greater incidence of and higher morbidity rates for cancer in minority populations, with particular emphasis on how the Plan seeks to address the relevant findings and recommendations of the Task Force Report;
(11)
Describe how the Plan will help to increase availability of and access to health care services for uninsured and underinsured individuals and medically underserved populations, with particular emphasis on how the Plan seeks to address the relevant findings and recommendations of the Task Force Report;
(12)
Demonstrate that priority consideration was given to persons, including federally qualified health centers, that have a demonstrated commitment to providing cancer prevention, education, screening, and treatment services to uninsured and underinsured individuals in the city and a proven ability to do so; and
(13)
Contain any data or other information required by the Department.
(d)
To apply for a Statewide Academic Health Center Public Health Grant, the University of Maryland Medical Group and the Johns Hopkins Institutions shall submit to the Department a copy of Baltimore City’s Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment for approval.
(e)
Each year, the University of Maryland Medical Group and the Johns Hopkins Institutions, acting jointly in collaboration with the Baltimore City Health Department, in consultation with the coalition established or identified under subsection (b)(1) of this section, shall update the Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment.
(f)
(1)
Rather than distributing a Statewide Academic Health Center Public Health Grant to the University of Maryland Medical Group or the Johns Hopkins Institutions under this section, the Department may distribute to the Baltimore City Health Department or another person designated by the Department a Local Public Health Cancer Grant for the purpose of coordinating Baltimore City’s cancer prevention, education, screening, and treatment efforts if:
(i)
The University of Maryland Medical Group or the Johns Hopkins Institutions are unwilling to coordinate these efforts;
(ii)
The University of Maryland Medical Group or the Johns Hopkins Institutions have been unsuccessful in implementing cancer prevention, education, screening, and treatment initiatives that satisfy performance standards established by the Department; or
(iii)
The University of Maryland Medical Group or the Johns Hopkins Institutions lack sufficient staff or resources to coordinate these efforts.
(2)
If the Department distributes a Local Public Health Cancer Grant to the Baltimore City Health Department or another person designated by the Department under this subsection rather than distributing a Statewide Academic Health Center Public Health Grant to the University of Maryland Medical Group, the amount of the Grant shall equal the sum of:
(i)
$2,000,000; and
(ii)
One–half of any money that is transferred from the Local Public Health Component to the Statewide Academic Health Center Component under § 13–1108(c) of this subtitle.
(3)
If the Department distributes a Local Public Health Cancer Grant to the Baltimore City Health Department or another person designated by the Department under this subsection rather than distributing a Statewide Academic Health Center Public Health Grant to the Johns Hopkins Institutions, the amount of the Grant shall equal the sum of:
(i)
$2,000,000; and
(ii)
One–half of any money that is transferred from the Local Public Health Component to the Statewide Academic Health Center Component under § 13–1108(c) of this subtitle.
(4)
The Department shall use money that is allocated to the Statewide Academic Health Center Component in the State budget or transferred to the Statewide Academic Health Center Component under § 13–1108(c) of this subtitle to fund a Local Public Health Cancer Grant that is distributed to the Baltimore City Health Department or another person designated by the Department under this subsection.
(5)
If the Baltimore City Health Department or another person designated by the Department applies for a Local Public Health Cancer Grant as authorized under this subsection, the Baltimore City Health Department or other person shall comply with the requirements of §§ 13–1107 through 13–1113 of this subtitle.
(6)
Subject to paragraph (7) of this subsection, the Department shall establish procedures for making a designation under this subsection.
(7)
If the Department determines that it is necessary to designate a person other than the Baltimore City Health Department to coordinate the city’s cancer prevention, education, screening, and treatment efforts as authorized under this subsection, the Department may designate the Department as the entity that will coordinate the city’s efforts.
(g)
(1)
(i)
Before the University of Maryland Medical Group or the Johns Hopkins Institutions may receive a Statewide Academic Health Center Public Health Grant, the Baltimore City Health Department shall submit to the Department an inventory of all existing publicly funded cancer prevention, education, screening, and treatment programs that relate to targeted cancers in Baltimore City that are identified under subsection (b) of this section.
(ii)
The inventory prepared under subparagraph (i) of this paragraph shall specify the amount of funds that are being spent by Baltimore City on each of the programs included in the inventory.
(2)
The level of funding specified under paragraph (1)(ii) of this subsection shall be Baltimore City’s base–year funding for cancer prevention, education, screening, and treatment programs that relate to targeted cancers.
(3)
A Statewide Academic Health Center Public Health Grant may not be used to supplant:
(i)
Baltimore City’s base–year funding for cancer prevention, education, screening, and treatment programs that relate to targeted cancers; or
(ii)
Any existing funding at the University of Maryland Medical Group or the Johns Hopkins Institutions for cancer prevention, education, screening, and treatment programs that relate to targeted cancers.
(h)
(1)
Subject to paragraph (2) of this subsection, the Department may not distribute a Statewide Academic Health Center Public Health Grant under this section until after the Baseline Cancer Study has been completed.
(2)
Before the Baseline Cancer Study is completed, the Department may use money that is allocated to the Statewide Academic Health Center Component in the State budget to fund a planning grant of not more than $10,000 that may be distributed to and used collectively by the University of Maryland Medical Group, the Johns Hopkins Institutions, and the Baltimore City Health Department.
(i)
(1)
The Department shall review a Comprehensive Plan for Cancer Prevention, Education, Screening, and Treatment submitted under this section and determine whether:
(i)
The Plan addresses the goals and requirements established for Baltimore City under § 13–1108 of this subtitle; and
(ii)
All other requirements of this section have been met.
(2)
If the Department determines that the requirements of this section have not been met, the Department may not distribute:
(i)
A Statewide Academic Health Center Public Health Grant to the University of Maryland Medical Group or the Johns Hopkins Institutions; or
(ii)
A Local Public Health Cancer Grant to the Baltimore City Health Department or another person designated by the Department under subsection (f) of this section.
Md. Code Ann., Health-Gen. § 13-1116 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1116LinkCopy Citation
(a)
(1)
(i)
For each of fiscal years 2011 and 2012:
(1)
The Governor shall include at least $2,400,000 in the annual budget in appropriations for the Statewide Academic Health Center Cancer Research Grants under this section; and
(2)
The Grants shall be distributed between the Statewide Academic Health Centers as follows:
(A)
$2,007,300 to the University of Maryland Medical Group; and
(B)
$392,700 to the Johns Hopkins Institutions.
(ii)
For fiscal year 2013 and each fiscal year thereafter:
(1)
The Governor shall include at least $13,000,000 in the annual budget in appropriations for the Statewide Academic Health Center Cancer Research Grants under this section; and
(2)
The Grants shall be distributed according to historical allocations between the Academic Health Centers.
(2)
Subject to the other provisions of this section, the Department may distribute Statewide Academic Health Center Cancer Research Grants to the University of Maryland Medical Group and the Johns Hopkins Institutions for the purpose of enhancing cancer research activities that may lead to a cure for a targeted cancer and increasing the rate at which cancer research activities are translated into treatment protocols in the State.
(b)
Before receiving a Statewide Academic Health Center Cancer Research Grant, an institution shall:
(1)
Submit a Cancer Research Plan that:
(i)
Provides a detailed plan as to how the Statewide Academic Health Center Cancer Research Grant will be spent and how it will be used to meet the goals established by the Department;
(ii)
Provides a complete inventory of all cancer research activities relating to targeted cancers that are currently being conducted by the institution, including a breakdown of the types of cancer to which the research relates;
(iii)
Specifies the source and amount of funding for all of the cancer research activities identified under item (ii) of this paragraph;
(iv)
Certifies that the cancer research activities that will be funded by the Statewide Academic Health Center Cancer Research Grant have been endorsed by an independent peer review group that is comprised of experts in the field from outside the institution who will not be involved in the research;
(v)
Identifies the individuals who make up the independent peer review group; and
(vi)
Includes any other information that is requested by the Department; and
(2)
Enter into a memorandum of understanding with the Maryland Department of Health, the Department of Commerce, and the Maryland Technology Development Corporation that:
(i)
Establishes the scope of the State’s ownership or other financial interest in the commercialization and other benefits of the results, products, inventions, and discoveries of cancer research activities funded by a Statewide Academic Health Center Cancer Research Grant;
(ii)
Establishes a plan for expediting the translation of cancer research activities into treatment protocols and clinical trials; and
(iii)
To the extent consistent with federal and State law, reflects the intellectual property policies of the Statewide Academic Health Center.
(c)
A memorandum of understanding established under subsection (b)(2) of this section may allow for the selection of a higher education institution or private entity to expedite the translation of cancer research activities into treatment protocols and clinical trials.
(d)
The Department may not distribute a Statewide Academic Health Center Cancer Research Grant unless the Department first determines that:
(1)
A Cancer Research Plan will help achieve the purpose of the Program;
(2)
The institution that receives the Grant will not use any part of the Grant to supplant existing cancer research activities or any other type of current expenditure by the institution;
(3)
The Grant will be used to fund cancer research activities that relate to targeted cancers;
(4)
The institution has executed a memorandum of understanding as required by subsection (b)(2) of this section; and
(5)
The institution satisfies any other requirement established by the Department as a condition of receiving the Grant.
Md. Code Ann., Health-Gen. § 13-1119 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11. Cancer Prevention, Education, Screening, and Treatment Program
§ 13–1119LinkCopy Citation
(a)
There is an Administrative Component in the Program.
(b)
The purpose of the Administrative Component is to provide the necessary administrative structure in the Department for effective management of the Program.
(c)
Funds that are allocated to the Administrative Component in the State budget shall be used to cover administrative costs incurred by the Department in administering the Program.
(d)
Unless otherwise specified in the annual budget bill as enacted, the amount of funds that are allocated to the Administrative Component in the State budget may not exceed 7% of the total amount that is allocated to the Program in the State budget.
(e)
A county that receives funds under a Local Public Health Cancer Grant, a person who receives funds under a Local Public Health Cancer Grant, a Statewide Academic Health Center that receives money under any of the grants distributed under the Statewide Academic Health Component, and any other person who receives funds under the Program may not use more than 7% of the funds to cover administrative costs.
Subtitle 11A. Public Education Campaign on Prostate, Lung, and Breast Cancer Prevention
Md. Code Ann., Health-Gen. § 13-11A-01 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 11A. Public Education Campaign on Prostate, Lung, and Breast Cancer Prevention
§ 13–11A-01LinkCopy Citation
(a)
The Department shall develop and implement a 3–year public education campaign on prostate, lung, and breast cancer prevention that targets communities disproportionately impacted by prostate, lung, and breast cancer.
(b)
In developing the public education campaign, the Department shall work with:
(1)
Health care providers, including licensed physicians, who treat individuals impacted by prostate, lung, and breast cancer;
(2)
Hospitals; and
(3)
Health care associations that focus on prostate, lung, and breast cancer.
(c)
The public education campaign shall:
(1)
Provide educational information on prostate, lung, and breast cancer, including information regarding:
(i)
The risks and warning signs of prostate, lung, and breast cancer; and
(ii)
Guidelines and best practices to prevent prostate, lung, and breast cancer;
(2)
Promote screenings for prostate, lung, and breast cancer; and
(3)
Provide information on legislation that reduces cost barriers to prevention services for prostate, lung, and breast cancer.
(d)
To implement the public education campaign, the Department shall:
(1)
Use communications tools and messaging;
(2)
Post all materials on the Department’s website in a conspicuous manner and an accessible format; and
(3)
Develop partnerships with health agencies, nonprofit organizations, and private entities that work with communities disproportionately impacted by prostate, lung, and breast cancer.
(e)
The Department shall:
(1)
Develop the public education campaign on or before December 1, 2026;
(2)
Implement the public education campaign on or before January 1, 2027; and
(3)
Set measurable goals for the public education campaign.
(f)
(1)
For each of fiscal years 2026, 2027, 2028, 2029, and 2030, the Governor shall include in the annual budget bill an appropriation to the Department for the public education campaign from the Cigarette Restitution Fund established under § 7–317 of the State Finance and Procurement Article.
(2)
The total appropriation for fiscal years 2026 through 2030 shall be not more than $750,000.
Subtitle 12. Maternal Mortality Review Program
Md. Code Ann., Health-Gen. § 13-1201 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1201LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Data use agreement” means an agreement between the Department and a national, State, or local agency or program that establishes the terms and conditions for the confidential submission, collection, storage, analysis, reporting, aggregation, and dissemination of de–identified data obtained from the Maternal Mortality Review Program.
(c)
“Local team” means the multidisciplinary and multiagency maternal mortality review team established for a county.
(d)
“Maternal death” means the death of a woman during pregnancy or within 1 year after the woman ceases to be pregnant.
(e)
“Maternal mortality review committee” means the maternal mortality review committee of MedChi that is a medical review committee, as defined under § 1–401 of the Health Occupations Article.
(f)
“MedChi” means the Maryland State Medical Society.
Md. Code Ann., Health-Gen. § 13-1202 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1202LinkCopy Citation
The General Assembly finds that:
(1)
Maternal deaths are a serious public health concern and have a tremendous family and societal impact;
(2)
Maternal deaths are significantly underestimated and inadequately documented, preventing efforts to identify and reduce or eliminate the causes of death;
(3)
No processes exist in the State for the confidential identification, investigation, or dissemination of findings regarding maternal deaths; and
(4)
There is a need to establish a Maternal Mortality Review Program to review maternal deaths and to develop strategies for the prevention of maternal deaths.
Md. Code Ann., Health-Gen. § 13-1203 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1203LinkCopy Citation
The Secretary shall establish a Maternal Mortality Review Program to review maternal deaths and to develop strategies for the prevention of maternal deaths.
Md. Code Ann., Health-Gen. § 13-1204 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1204LinkCopy Citation
(a)
The Secretary may contract with MedChi to administer the Maternal Mortality Review Program.
(b)
In consultation with the maternal mortality review committee of MedChi, the Secretary shall develop a system to:
(1)
Identify maternal death cases;
(2)
Review medical records and other relevant data;
(3)
Contact family members and other affected or involved persons to collect additional relevant data;
(4)
Consult with relevant experts to evaluate the records and data collected;
(5)
Make determinations regarding the preventability of maternal deaths;
(6)
Develop recommendations for the prevention of maternal deaths; and
(7)
Disseminate findings and recommendations to policy makers, health care providers, health care facilities, and the general public.
(c)
On the approval of the Secretary and with a signed data use agreement, the Department may release de–identified data and findings to the Centers for Disease Control and Prevention, local maternal mortality review teams, and other entities at the discretion of the Secretary.
(d)
In accordance with § 4–221 of this article and notwithstanding § 4–224 of this article, the Secretary shall provide the Program with:
(1)
Information on maternal death cases when the records become available, including a copy of the death certificate; and
(2)
Medical information from the birth or fetal death record for any pregnancy that occurred within 1 year before the death of the woman, excluding Social Security numbers, addresses, and names of the infants.
(e)
On the request of the Secretary, the Program shall be provided access, to the extent allowed by law, to all information and records maintained by a State or local government agency, law enforcement investigative information, medical examiner investigative information, parole and probation information and records, and information and records of a social services agency that provided services to a woman whose death is being reviewed by the Program.
(f)
The Maternal Mortality Review Program, in consultation with the Office of Minority Health and Health Disparities, shall make recommendations to reduce any disparities in the maternal mortality rate including recommendations related to social determinants of health.
Md. Code Ann., Health-Gen. § 13-1205 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1205LinkCopy Citation
(a)
A health care provider or health care facility, as defined under Title 19, Subtitles 3, 3A, and 3B of this article, shall provide the Maternal Mortality Review Program reasonable access to all relevant medical records associated with a case under review by the Maternal Mortality Review Program.
(b)
A health care provider or health care facility, as defined under Title 19, Subtitles 3, 3A, and 3B of this article, shall provide to the local team, on request of the chair, prompt access to all relevant medical records associated with a case under review by the Maternal Mortality Review Program without undue delay.
(c)
The provisions of Title 4, Subtitle 3 of this article do not apply to a disclosure made to the Program or to a local team under this subtitle.
Md. Code Ann., Health-Gen. § 13-1206 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1206LinkCopy Citation
(a)
Notwithstanding the provisions of Title 4, Subtitle 3 of this article, if a patient of a health care provider or a health care facility dies of a maternal death and the health care provider or the health care facility has knowledge of the circumstances of the death, the health care provider or the health care facility shall report the death to the Maternal Mortality Review Program.
(b)
Any health care provider and health care facility report required under this section shall be:
(1)
Confidential;
(2)
Not open to public inspection; and
(3)
Except under a court order sealing the court record, not subject to subpoena or discovery in any criminal or civil proceeding.
(c)
A health care provider or health care facility may not be held liable for civil damages or subject to any criminal or disciplinary action for good faith efforts made to comply with the provisions of this subtitle.
Md. Code Ann., Health-Gen. § 13-1207 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1207LinkCopy Citation
(a)
(1)
Subject to paragraph (2) of this subsection, there may be a multidisciplinary and multiagency maternal mortality review team in each county.
(2)
(i)
Two or more counties may agree to establish a single multicounty local team.
(ii)
A multicounty local team shall execute a memorandum of understanding on membership, staffing, and operation.
(b)
If a local team is established in a county, the local team:
(1)
Shall be convened by the local health officer; and
(2)
May include representatives from other local agencies and local organizations, licensed health care providers with expertise in maternal child health, and other individuals necessary to the work of the local team, recommended by the local team, and designated by the local health officer.
(c)
From among its members, each local team shall elect a chair by majority vote.
Md. Code Ann., Health-Gen. § 13-1208 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1208LinkCopy Citation
(a)
The purpose of a local team is to prevent maternal deaths by:
(1)
Promoting cooperation and coordination among agencies involved in preventing and responding to maternal deaths or in providing services to surviving family members;
(2)
Developing an understanding of the causes and incidence of maternal deaths in the county;
(3)
Developing plans for and recommending changes within the community, local institutions, and agencies the members represent to prevent maternal deaths; and
(4)
Advising the Maternal Mortality Review Program on changes to law, policy, or practice to prevent maternal deaths.
(b)
To achieve its purpose, a local team shall:
(1)
In consultation with the Maternal Mortality Review Program, establish and implement a protocol for the local team;
(2)
Meet at least annually to review the status of maternal fatality cases, recommend actions to improve coordination of services in the community, and recommend actions within local institutions and member agencies to prevent maternal deaths;
(3)
Enter into a data use agreement with the Department for the receipt of information from the Maternal Mortality Review Program necessary to carry out the local team’s purpose and duties; and
(4)
Provide reports to the Maternal Mortality Review Program, including:
(i)
Information on, and local team discussions related to, individual cases;
(ii)
Any racial disparities observed during case review;
(iii)
Steps taken to improve coordination of services and investigations;
(iv)
Steps taken to implement changes recommended by the local team within member agencies; and
(v)
Recommendations on necessary changes to State and local law, policy, and practice to prevent maternal deaths.
Md. Code Ann., Health-Gen. § 13-1209 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1209LinkCopy Citation
On request of the chair of the local team and as necessary to carry out the local team’s purpose and duties, the local team shall be provided:
(1)
Access to all relevant information and records in accordance with the local team’s data use agreement with the Department; and
(2)
Access, to the extent allowed by law, to all information and records maintained by any State or local government agency, law enforcement investigative information, medical examiner investigative information, parole and probation information and records, and information and records of a social services agency that provided services to a woman whose death is being reviewed by the local team.
Md. Code Ann., Health-Gen. § 13-1210 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1210LinkCopy Citation
(a)
A meeting of a local team shall be closed to the public and not subject to Title 3 of the General Provisions Article when a local team is discussing individual cases of maternal deaths.
(b)
Subject to subsection (c) of this section, a meeting of a local team shall be open to the public and subject to Title 3 of the General Provisions Article when the local team is not discussing individual cases of maternal deaths.
(c)
(1)
During a public meeting, information may not be disclosed that identifies:
(i)
A deceased woman; or
(ii)
A family member, guardian, or caretaker of a deceased woman.
(2)
During a public meeting, information may not be disclosed regarding the involvement of any agency with:
(i)
A deceased woman; or
(ii)
A family member, guardian, or caretaker of a deceased woman.
(d)
This section does not prohibit a local team from requesting the attendance at a team meeting of an individual who has information relevant to the team’s performance of its purpose and duties.
(e)
A violation of this section is a misdemeanor and is punishable by a fine not exceeding $500 or imprisonment not exceeding 90 days or both.
Md. Code Ann., Health-Gen. § 13-1211 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1211LinkCopy Citation
(a)
Except as otherwise provided in this section, the proceedings, records, and files of a local team are confidential and privileged, and are not discoverable or admissible as evidence in any civil or criminal proceeding.
(b)
Statistical compilations of data that do not contain any information that would cause the identification of any person to be ascertained are public records.
(c)
Reports of a local team that do not contain any information that would cause the identification of any person to be ascertained are public information.
(d)
A member of a team and an individual attending a team meeting may not disclose what transpired at a meeting that is not public under § 13–1210 of this subtitle or any information the disclosure of which is prohibited by this section.
(e)
(1)
Subject to paragraph (2) of this subsection, a member of a team, an individual attending a team meeting, and an individual who presents information to a team may not be questioned in any civil or criminal proceeding regarding information presented in or opinions formed as a result of a meeting.
(2)
Paragraph (1) of this subsection does not prohibit an individual from testifying to information obtained independently of the team or that is public information.
Md. Code Ann., Health-Gen. § 13-1212 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1212LinkCopy Citation
(a)
On or before December 1 of each year, the Secretary shall submit a report on findings, recommendations, and Program actions to the Governor and, subject to § 2–1257 of the State Government Article, to the General Assembly.
(b)
The Secretary shall include in the report required under subsection (a) of this section:
(1)
A summary of any stakeholder meetings held under § 13–1213 of this subtitle during the immediately preceding 12–month period that includes:
(i)
Stakeholder responses to existing recommendations; and
(ii)
Recommendations from stakeholders that address factors contributing to maternal mortality; and
(2)
A section on racial disparities that includes:
(i)
A comparison of the maternal mortality rates of non–Hispanic black and non–Hispanic white women;
(ii)
Data on changes in the maternal mortality rate by race and ethnicity;
(iii)
The number of live births by race;
(iv)
The percentage of women who gave birth by race;
(v)
The percentage of maternal deaths by race and ethnicity;
(vi)
The maternal mortality rate by race;
(vii)
A comparison of the leading causes of maternal death by race; and
(viii)
Any other information that the Secretary determines necessary to carry out the purposes of this subtitle.
Md. Code Ann., Health-Gen. § 13-1213 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 12. Maternal Mortality Review Program
§ 13–1213LinkCopy Citation
(a)
(1)
Subject to paragraph (2) of this subsection, at least twice a year, the Secretary shall convene a meeting of stakeholders, including:
(i)
Representatives of:
(1)
The Maryland Office of Minority Health and Health Disparities;
(2)
The Maryland Patient Safety Center;
(3)
The Maryland Healthy Start Program;
(4)
Women’s health advocacy organizations;
(5)
Community organizations engaged in maternal health and family support issues;
(6)
Local health departments; and
(7)
Health care providers that provide maternal health services; and
(ii)
(1)
Families of women who have experienced a near maternal death, a high–risk pregnancy, other challenges during pregnancy, or a maternal death; or
(2)
Women who have experienced a near maternal death, a high–risk pregnancy, or other challenges during pregnancy.
(2)
To the extent practicable, the stakeholders convened in accordance with paragraph (1) of this subsection shall reflect the racial and ethnic diversity of women most impacted by maternal deaths in the State.
(b)
Of the two meetings required under subsection (a) of this section:
(1)
One meeting shall be held within 90 days after submission of the report required under § 13–1212 of this subtitle to:
(i)
Review the findings and recommendations in the report;
(ii)
Examine issues resulting in disparities in maternal deaths;
(iii)
Review the status of implementation of previous recommendations; and
(iv)
Identify new recommendations with a focus on initiatives to address issues resulting in disparities in maternal deaths; and
(2)
One meeting shall be held within 6 months after the meeting held under item (1) of this subsection to review the status of implementation of previous recommendations and consider any new information that may be relevant for the identification of additional recommendations.
Subtitle 13. Governor's Wellmobile Program
Md. Code Ann., Health-Gen. § 13-1301 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 13. Governor's Wellmobile Program
§ 13–1301LinkCopy Citation
(a)
There is a Governor’s Wellmobile Program within the University of Maryland School of Nursing.
(b)
The purpose of the Program is to:
(1)
Deliver primary and preventive health care services to geographically underserved communities and uninsured individuals around the State; and
(2)
Provide principal training sites for the University of Maryland School of Nursing that will expand student learning opportunities in the care of underserved populations.
(c)
The Program shall be operated, managed, and administered by the University of Maryland School of Nursing.
(d)
The operation, management, and administration of the Program shall be funded as provided for in the State budget.
Md. Code Ann., Health-Gen. § 13-1302 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 13. Governor's Wellmobile Program
§ 13–1302LinkCopy Citation
(a)
(1)
There is a Governor’s Wellmobile Program Advisory Board.
(2)
The purpose of the Advisory Board is to assist the University of Maryland School of Nursing in overseeing and raising funds for the Program.
(b)
The Advisory Board consists of nine individuals, of whom:
(1)
One shall be the Dean of the University of Maryland School of Nursing;
(2)
One shall be a member of the House of Delegates appointed by the Speaker;
(3)
One shall be a member of the Senate appointed by the President;
(4)
Two shall have business expertise;
(5)
Two shall have health expertise; and
(6)
Two shall have media or marketing expertise.
(c)
Except for the ex officio and legislative members, the members of the Advisory Board shall be appointed by the Governor with the advice and consent of the Senate.
(d)
The Dean of the University of Maryland School of Nursing shall serve as the chairman of the Advisory Board.
(e)
(1)
Except for the ex officio and legislative members, the term of a member is 3 years.
(2)
Except for the ex officio and legislative members, the terms of members are staggered as required by the terms provided for members of the Board on October 1, 2000.
(3)
At the end of a term, a member continues to serve until a successor is appointed.
(4)
A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed.
(f)
The Board shall meet at least four times each year, at the times and places that it determines.
Md. Code Ann., Health-Gen. § 13-1303 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 13. Governor's Wellmobile Program
§ 13–1303LinkCopy Citation
(a)
The University of Maryland School of Nursing and the Advisory Board shall ensure that the following geographic areas are served by the Program:
(1)
Western Maryland;
(2)
The Washington metropolitan area;
(3)
The Baltimore metropolitan area;
(4)
Southern/Central Maryland;
(5)
The upper Eastern Shore; and
(6)
The lower Eastern Shore.
(b)
The University of Maryland School of Nursing and the Advisory Board shall:
(1)
Develop partnerships with local health departments, hospitals, schools, community associations, businesses, and other entities that can facilitate the provision of primary and preventive health care services through the Program;
(2)
Solicit public and private grants and donations on behalf of the Program; and
(3)
Develop a mechanism for receiving third party reimbursement.
(c)
The University of Maryland, Baltimore Campus may establish a nonprofit corporation to accept any public and private grants or donations made to the Program.
(d)
The accounts and transactions of the Governor’s Wellmobile Program shall be subject to audit by the Legislative Auditor in accordance with §§ 2–1220 through 2–1227 of the State Government Article.
Subtitle 15. Children's Environmental Health
Md. Code Ann., Health-Gen. § 13-1501 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 15. Children's Environmental Health
§ 13–1501LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Advisory Council” means the Children’s Environmental Health and Protection Advisory Council.
(c)
“Environmental hazard” means one or a group of toxic chemical, biological, or physical agents in the environment, resulting from human activities or natural processes, that may impact the health of exposed children, including such pollutants as lead, pesticides, air pollutants, contaminated drinking water, polluted waters, toxic waste, polychlorinated biphenyls, secondhand tobacco smoke, and industrial and home chemicals.
Md. Code Ann., Health-Gen. § 13-1502 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 15. Children's Environmental Health
§ 13–1502LinkCopy Citation
(a)
The General Assembly finds that:
(1)
Children in the State face an array of preventable exposures to environmental hazards in their schools, homes, and communities;
(2)
In certain cases children are at greater risk than adults for exposure to and possible illness from environmental hazards because children:
(i)
Have a decreased ability to detoxify certain substances;
(ii)
Have a greater sensitivity to environmental hazards during the stages of development and growth as a result of their immature body organs and tissues and immature immune systems;
(iii)
Have different exposure behavior patterns, such as hand-to-mouth behavior, spending a greater amount of time outdoors near hazards, and spending more time on the floor and on the ground where contaminants can concentrate; and
(iv)
Take in a greater amount of contaminants due to their eating proportionately more food, breathing proportionately more air, and drinking proportionately more fluids than adults;
(3)
Higher rates of poverty are one of the factors that place children of ethnic and minority communities at disproportionate risk for environmental exposures, due to inadequate housing, poor nutrition, and limited access to health care;
(4)
Solutions to complex environmental health problems require the ongoing communication, collaboration, and cooperation of affected communities and many disciplines including science, medicine, public health, economics, planning, law, and policy; and
(5)
As recommended by the Advisory Council on Environmental Justice in its report pursuant to Chapter 741 of the Acts of the General Assembly of 1997, as amended, it is necessary to assess the impacts of State policies, programs, and activities on affected communities and, in this instance, children are the affected community.
(b)
(1)
The General Assembly recognizes its responsibilities:
(i)
To enable all children to grow up in a safe and healthy environment; and
(ii)
To use its resources to ensure that every child is provided with an environmentally safe and healthy learning environment in which to grow, develop, and mature into a productive and healthy adult.
(2)
The General Assembly seeks to meet these responsibilities by creating an Advisory Council to:
(i)
Identify environmental hazards that may affect children’s health; and
(ii)
Recommend solutions to those hazards through interdisciplinary problem solving and coalition building.
Md. Code Ann., Health-Gen. § 13-1503 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 15. Children's Environmental Health
§ 13–1503LinkCopy Citation
There is a State Children’s Environmental Health and Protection Advisory Council.
Md. Code Ann., Health-Gen. § 13-1504 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 15. Children's Environmental Health
§ 13–1504LinkCopy Citation
(a)
(1)
The Advisory Council shall be composed of 19 members as follows:
(i)
One member of the Senate of Maryland, appointed by the President of the Senate;
(ii)
One member of the House of Delegates, appointed by the Speaker of the House;
(iii)
The Secretary of Health, or the Secretary’s designee;
(iv)
The Secretary of the Environment, or the Secretary’s designee;
(v)
The Secretary of Agriculture, or the Secretary’s designee;
(vi)
The Secretary of Education, or the Secretary’s designee;
(vii)
The Secretary of Human Services, or the Secretary’s designee;
(viii)
The Secretary of Housing and Community Development, or the Secretary’s designee;
(ix)
The Special Secretary of the Governor’s Office for Children, or the Special Secretary’s designee;
(x)
Two licensed health care providers with expertise in the field of children’s environmental health, appointed by the Governor;
(xi)
One representative from an academic institution who has expertise in studying the impact of environmental exposures on childhood disease, appointed by the Governor;
(xii)
One parent or guardian whose child has been clinically diagnosed as having been exposed to environmental health hazards including lead paint or pesticides, appointed by the Governor;
(xiii)
One epidemiologist with expertise in children’s environmental health, appointed by the Governor;
(xiv)
One economist skilled in measuring the economic costs of illness and the benefits of prevention, appointed by the Governor;
(xv)
One environmental toxicologist with expertise in issues of importance to children’s environmental health, appointed by the Governor;
(xvi)
One representative from the Maryland Association of Counties, appointed by the Governor;
(xvii)
One individual from private industry representing the regulated community, appointed by the Governor; and
(xviii)
One representative from the Maryland Commission on Environmental Justice and Sustainable Communities, appointed by the Governor.
(2)
The Secretary of Health or the Secretary’s designee shall serve as the chairman.
(3)
The Secretary of the Environment or the Secretary’s designee shall serve as the vice chairman.
(b)
(1)
The term of a member is 4 years.
(2)
The terms of the members are staggered as required by the terms provided for members of the Advisory Council on October 1, 2000.
(3)
At the end of a term, a member continues to serve until a successor is appointed and qualifies.
(4)
A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
Md. Code Ann., Health-Gen. § 13-1505 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 15. Children's Environmental Health
§ 13–1505LinkCopy Citation
(a)
A majority of the full authorized membership of the Advisory Council is a quorum.
(b)
The Advisory Council shall meet at least six times a year, at the times and places that it determines.
(c)
Each member of the Advisory Council is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(d)
(1)
The Maryland Department of Health shall coordinate with the Department of the Environment and other State agencies to provide for staffing of the Advisory Council.
(2)
The Advisory Council may employ consultants subject to the State budget.
(e)
(1)
The Advisory Council may contract for an analysis of the current State organizational structure regarding children’s environmental health and protection.
(2)
An analysis under this subsection shall be performed in a manner consistent with the recommendation of the Advisory Council on Environmental Justice contained in the Council’s report dated November 1999.
Md. Code Ann., Health-Gen. § 13-1506 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 15. Children's Environmental Health
§ 13–1506LinkCopy Citation
The Advisory Council shall:
(1)
Review and comment on existing rules, regulations, and standards to ensure that the rules, regulations, and standards adequately protect the health of children from environmental hazards by taking into account the special vulnerability of children because of their developing physiology, and because their exposures, behaviors, and diets can differ greatly from those of adults;
(2)
(i)
Review proposed regulations submitted to the Advisory Council in accordance with § 10–110 of the State Government Article to determine if the proposed regulation:
(1)
Adequately protects the health of children from environmental hazards by taking into account the special vulnerability of children because of their developing physiology, and because their exposures, behaviors, and diets can differ greatly from those of adults; and
(2)
Is consistent and uniform with the children’s environmental health policies, rules, regulations, and standards of other State agencies; and
(ii)
Recommend to the promulgating unit measures that would avoid or minimize any negative impact that the proposed regulation may have on the health of children;
(3)
Comment on any proposed regulations that may be submitted by any other principal department of the Executive Branch, as enumerated in § 8–201 of the State Government Article, during the public comment period required under § 10–112(a)(3)(v) of the State Government Article if the Advisory Council determines that the proposed regulation will have an adverse impact on children’s health;
(4)
Gather and disseminate information to the public, including the research and medical communities, community–based organizations, schools, and State agencies, on how to reduce, treat, and eliminate children’s exposures to environmental hazards to further the public’s understanding of the environmental hazards that may potentially affect children;
(5)
Recommend uniform guidelines for State agencies to follow to help reduce and eliminate children’s exposure to environmental hazards, especially in areas reasonably accessible to children;
(6)
Create and promote education programs, in partnership with health and environmental professionals, for parents, guardians, and caregivers of children that include information on:
(i)
The potential health effects of environmental hazards;
(ii)
Practical suggestions on how to reduce children’s exposure to environmental hazards; and
(iii)
Any other relevant information to assist parents, guardians, and caregivers in protecting children from environmental hazards;
(7)
Provide input to the General Assembly on legislation that may impact environmental hazards that affect the health of children; and
(8)
Report to the Governor and, in accordance with § 2–1257 of the State Government Article, to the General Assembly on or before December 1, 2001 and each December 1 thereafter describing the activities of the Children’s Environmental Health and Protection Advisory Council.
Subtitle 16. State Advisory Council on Serious Illness Care
Md. Code Ann., Health-Gen. § 13-1601 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 16. State Advisory Council on Serious Illness Care
§ 13–1601LinkCopy Citation
There is a State Advisory Council on Serious Illness Care.
Md. Code Ann., Health-Gen. § 13-1602 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 16. State Advisory Council on Serious Illness Care
§ 13–1602LinkCopy Citation
(a)
The Advisory Council consists of the following 23 members:
(1)
The Attorney General or the Attorney General’s designee;
(2)
One member of the Senate of Maryland, appointed by the President of the Senate of Maryland;
(3)
One member of the House of Delegates, appointed by the Speaker of the House;
(4)
The Secretary of Aging or the Secretary’s designee;
(5)
The Secretary of Health or the Secretary’s designee;
(6)
The Secretary of Disabilities or the Secretary’s designee; and
(7)
17 members appointed by the Governor:
(i)
One physician with experience in end–of–life care;
(ii)
One nurse with experience in end–of–life care;
(iii)
One pharmacist with experience in end–of–life care;
(iv)
One physician with experience managing long–term care;
(v)
One nurse with experience managing long–term care;
(vi)
One representative of the health insurance industry;
(vii)
One representative from a managed care organization;
(viii)
One representative of the legal community;
(ix)
One representative from the hospice care community;
(x)
Two representatives from advocacy groups for end–of–life care;
(xi)
Two representatives from religious groups;
(xii)
Two representatives of the general public with experience with end–of–life or long–term care issues;
(xiii)
One representative of the hospital industry; and
(xiv)
One representative of the nursing home industry.
(b)
(1)
The term of a member appointed by the Governor is 4 years.
(2)
At the end of a term, a member continues to serve until a successor is appointed and qualifies.
(3)
A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
(4)
A member who serves two consecutive 4–year terms may not be reappointed for 4 years after the completion of those terms.
(5)
If a vacancy occurs among the members appointed by the Governor, the Governor shall promptly appoint a successor.
Md. Code Ann., Health-Gen. § 13-1603 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 16. State Advisory Council on Serious Illness Care
§ 13–1603LinkCopy Citation
(a)
The Governor shall appoint the chair of the Advisory Council.
(b)
The members present at a meeting are a quorum to do business.
(c)
The Advisory Council shall meet at least twice a year, at the times and places that it determines.
(d)
A member of the Advisory Council may not receive compensation but is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(e)
The Department of Aging and the Office of the Attorney General shall jointly provide staff support and technical assistance for the Advisory Council.
Md. Code Ann., Health-Gen. § 13-1604 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 16. State Advisory Council on Serious Illness Care
§ 13–1604LinkCopy Citation
The Advisory Council shall:
(1)
Monitor trends in the provision of care to Marylanders with life–limiting illnesses;
(2)
Study the impact of State statutes, regulations, policies, and other aspects of public policy on the provision of care at the end of life;
(3)
Provide recommendations to the Office of the Attorney General, the Department, the Department of Aging, and other agencies of State government with respect to their activities affecting the provision of care at the end of life;
(4)
Advise the General Assembly on legislative proposals affecting the provision of care at the end of life;
(5)
Participate in or otherwise promote public and professional educational efforts concerning care at the end of life; and
(6)
Carry out other duties as may be requested by the Governor or the General Assembly.
Subtitle 17. Asthma Control Program
Md. Code Ann., Health-Gen. § 13-1701 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 17. Asthma Control Program
§ 13–1701LinkCopy Citation
In this subtitle, “Program” means the Asthma Control Program.
Md. Code Ann., Health-Gen. § 13-1702 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 17. Asthma Control Program
§ 13–1702LinkCopy Citation
There is an Asthma Control Program in the Department.
Md. Code Ann., Health-Gen. § 13-1703 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 17. Asthma Control Program
§ 13–1703LinkCopy Citation
(a)
The Secretary shall appoint a director for the Program.
(b)
The director may establish advisory councils, task forces, committees, and work groups to the extent necessary to implement the Program.
Md. Code Ann., Health-Gen. § 13-1704 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 17. Asthma Control Program
§ 13–1704LinkCopy Citation
(a)
The director shall:
(1)
Establish a statewide asthma coalition composed of individuals and organizations with an interest in asthma;
(2)
Develop and finalize a comprehensive statewide asthma plan;
(3)
After finalization of the development of the statewide asthma plan, implement a statewide asthma intervention program;
(4)
Develop and organize collaborative relationships with asthma control and stakeholders within other State and local agencies and in the private sector;
(5)
Develop and implement an asthma surveillance system;
(6)
Upon completion of the asthma surveillance system in paragraph (5) of this subsection, identify mechanisms for the utilization of surveillance data in identifying interventions to control asthma;
(7)
Identify and promote educational programs for providers, parents, guardians, caregivers, and asthma patients that include information on identifying symptoms of asthma, effective treatment for asthma, and methods of preventing asthma; and
(8)
Identify sources of grant funding for the Asthma Control Program.
(b)
The Program may:
(1)
Provide funding for local asthma intervention initiatives; and
(2)
Provide training for school personnel, or other appropriate personnel, on asthma education in conjunction with the Department of Education and local health departments.
Md. Code Ann., Health-Gen. § 13-1705 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 17. Asthma Control Program
§ 13–1705LinkCopy Citation
(a)
The Program shall be funded as provided in the State budget.
(b)
The funding provided in the State budget for the Program is intended to complement funding received:
(1)
By the Department from the Centers for Disease Control and Prevention for the Program for enhancing the State’s capacity to address asthma from a public health perspective; and
(2)
From any other lawful source.
Md. Code Ann., Health-Gen. § 13-1706 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 17. Asthma Control Program
§ 13–1706LinkCopy Citation
The Secretary shall, in consultation with the director, adopt rules and regulations necessary to implement the Program.
Subtitle 17A. Breathe Easy East Baltimore Pilot Program
Md. Code Ann., Health-Gen. § 13-17A-01 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 17A. Breathe Easy East Baltimore Pilot Program
§ 13–17A-01LinkCopy Citation
(a)
(1)
In this section the following words have the meanings indicated.
(2)
“Eligible household” means a household located in East Baltimore City that:
(i)
Has a household income of not more than 150% of the federal poverty level; and
(ii)
Includes an individual who is under the age of 14 years.
(3)
“Pilot Program” means the Breathe Easy East Baltimore Pilot Program.
(b)
(1)
There is a Breathe Easy East Baltimore Pilot Program in the Baltimore City Health Department.
(2)
The purpose of the Pilot Program is to provide and study the effects of asthma remediation services on eligible households.
(3)
Asthma remediation services provided by the Pilot Program may include cleaning, education, structural interventions, and any other services the Baltimore City Health Department, in consultation with the Green and Healthy Homes Initiative, determines to be necessary.
(c)
The Baltimore City Health Department, in consultation with the Green and Healthy Homes Initiative, shall:
(1)
On or before July 1, 2020, select eligible households to participate in the Pilot Program;
(2)
Provide participating eligible households with asthma remediation services; and
(3)
Study the effect that asthma remediation services have on the well–being of members of participating eligible households by measuring, relative to individuals who do not receive asthma remediation services:
(i)
Health outcomes;
(ii)
Economic outcomes; and
(iii)
Educational outcomes for children.
(d)
In addition to the items listed in subsection (c) of this section, the Baltimore City Health Department may include in the Pilot Program, at the discretion of the Baltimore City Health Department:
(1)
Implementation of policies and procedures to encourage participation in the Pilot Program; and
(2)
Development of a referral process or integrated partnerships with other local or State agencies through which eligible households may access programs and services that target improved health.
(e)
In addition to any other funds available for the Pilot Program, the Baltimore City Health Department shall attempt to access any federal funds related to asthma remediation services for households.
(f)
(1)
On or before December 1, 2024, the Baltimore City Health Department shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on the Pilot Program.
(2)
The report required under paragraph (1) of this subsection shall include:
(i)
The number of eligible households participating in the Pilot Program;
(ii)
Information regarding how the Pilot Program has affected the health, economic, and educational well–being of the members of participating eligible households; and
(iii)
A recommendation on whether the Pilot Program should be extended or expanded.
Subtitle 20. Human Subject Research
Md. Code Ann., Health-Gen. § 13-2001 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 20. Human Subject Research
§ 13–2001LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Federal regulations on the protection of human subjects” means:
(1)
Title 45, Part 46 of the Code of Federal Regulations, and any subsequent revision of those regulations; and
(2)
With respect to research that is subject to the jurisdiction of the federal Food and Drug Administration, Title 21, Parts 50 and 56 of the Code of Federal Regulations, and any subsequent revision of those regulations.
(c)
“Human subject” has the meaning stated in the federal regulations on the protection of human subjects.
(d)
“Institutional review board” has the meaning stated in the federal regulations on the protection of human subjects.
(e)
“Research” has the meaning stated in the federal regulations on the protection of human subjects.
Md. Code Ann., Health-Gen. § 13-2002 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 20. Human Subject Research
§ 13–2002LinkCopy Citation
(a)
A person may not conduct research using a human subject unless the person conducts the research in accordance with the federal regulations on the protection of human subjects.
(b)
Notwithstanding any provision in the federal regulations on the protection of human subjects that limits the applicability of the federal regulations to certain research, subsection (a) of this section applies to all research using a human subject.
Md. Code Ann., Health-Gen. § 13-2003 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 20. Human Subject Research
§ 13–2003LinkCopy Citation
(a)
An institutional review board shall make the final minutes of a meeting available for inspection within 30 days of receipt of a request for the minutes from any person.
(b)
Prior to making the minutes of a meeting available for inspection under subsection (a) of this section, an institutional review board may redact confidential or privileged information.
(c)
The minutes of a meeting of an institutional review board are not public records under Title 4 of the General Provisions Article.
Md. Code Ann., Health-Gen. § 13-2004 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 20. Human Subject Research
§ 13–2004LinkCopy Citation
(a)
The Office of the Attorney General may seek appropriate injunctive or other relief to prevent the conduct of human subject research in violation of the federal regulations on the protection of human subjects or this subtitle.
(b)
In exercising the authority granted under subsection (a) of this section, the Office of the Attorney General may not:
(1)
Duplicate the investigatory, compliance, or enforcement action undertaken by an agency of the federal government; or
(2)
Bring an action under subsection (a) of this section if an agency of the federal government has determined that an investigation is not warranted.
Subtitle 21. State Traumatic Brain Injury Advisory Board
Md. Code Ann., Health-Gen. § 13-2101 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 21. State Traumatic Brain Injury Advisory Board
§ 13–2101LinkCopy Citation
In this subtitle, “Advisory Board” means the State Traumatic Brain Injury Advisory Board.
Md. Code Ann., Health-Gen. § 13-2102 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 21. State Traumatic Brain Injury Advisory Board
§ 13–2102LinkCopy Citation
There is a State Traumatic Brain Injury Advisory Board.
Md. Code Ann., Health-Gen. § 13-2103 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 21. State Traumatic Brain Injury Advisory Board
§ 13–2103LinkCopy Citation
The Advisory Board consists of the following 36 voting members:
(1)
The following two members, who shall serve ex officio:
(i)
One member of the Senate, to be appointed by the President of the Senate; and
(ii)
One member of the House of Delegates, to be appointed by the Speaker of the House;
(2)
The Secretary of Disabilities, or the Secretary’s designee;
(3)
The Secretary of Health, or the Secretary’s designee;
(4)
The Secretary of Education, or the Secretary’s designee;
(5)
One representative of the State Department of Education, Division of Rehabilitation Services, appointed by the Director of the Division;
(6)
One representative of the Maryland Department of Health, Developmental Disabilities Administration, appointed by the Director of the Administration;
(7)
One representative of the Maryland Department of Health, Behavioral Health Administration, appointed by the Director of the Administration;
(8)
One representative of the Maryland Department of Health, Prevention and Health Promotion Administration, Center for Chronic Disease Prevention and Control, appointed by the Director of the Center;
(9)
One representative of the Maryland Department of Health, Prevention and Health Promotion Administration, Office for Genetics and People with Special Health Care Needs, appointed by the Director of the Office;
(10)
One representative of the Maryland Institute of Emergency Medical Services Systems, appointed by the Director of the Institute;
(11)
One representative of the Maryland Department of Health, Office of Health Services, appointed by the Director of the Office;
(12)
One representative of the Maryland Department of Health, Alcohol and Drug Abuse Administration, appointed by the Director of the Administration;
(13)
Four representatives of the Brain Injury Association of Maryland, appointed by the Executive Director of the Association;
(14)
One representative of the Maryland Statewide Independent Living Council, appointed by the Executive Director of the Council;
(15)
One representative of the Maryland Disability Law Center, Maryland’s Protection Advocacy System, appointed by the Director of the Office;
(16)
One representative of the National Institutes of Health, appointed by the Director of the Institutes; and
(17)
The following 16 members, appointed by the Governor:
(i)
One representative of State or local law enforcement;
(ii)
Six Maryland citizens who have experienced a traumatic brain injury;
(iii)
Five Maryland citizens who are currently caring for, or are family members of, individuals who have experienced a traumatic brain injury; and
(iv)
Four professionals with specialized experience in providing services to individuals with traumatic brain injuries or traumatic brain injury prevention activities.
Md. Code Ann., Health-Gen. § 13-2104 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 21. State Traumatic Brain Injury Advisory Board
§ 13–2104LinkCopy Citation
(a)
(1)
The term of a member is 3 years.
(2)
At the end of a term, a member continues to serve until a successor is appointed and qualifies.
(3)
A member appointed to fill a vacancy in an unexpired term serves only for the remainder of the term and until a successor is appointed and qualifies.
(4)
A member of the Advisory Board may not serve more than two consecutive terms.
(5)
The terms of the members of the Advisory Board are staggered as required by the terms provided for members on October 1, 2005.
(b)
The members of the Advisory Board shall elect a chair of the Advisory Board each year.
(c)
A majority of the members present at a meeting shall constitute a quorum for transacting business or performing any duties.
(d)
The Advisory Board shall meet at least once every other month.
(e)
A member of the Advisory Board:
(1)
May not receive compensation; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(f)
The Maryland Department of Health and the Department of Disabilities shall jointly provide staff support and technical assistance for the Advisory Board.
Md. Code Ann., Health-Gen. § 13-2105 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 21. State Traumatic Brain Injury Advisory Board
§ 13–2105LinkCopy Citation
The Advisory Board shall:
(1)
Investigate the needs of citizens with traumatic brain injuries;
(2)
Identify gaps in services to citizens with traumatic brain injuries;
(3)
Facilitate collaboration among State agencies that provide services to individuals with traumatic brain injuries;
(4)
Facilitate collaboration among organizations and entities that provide services to individuals with traumatic brain injuries;
(5)
Encourage and facilitate community participation in program implementation;
(6)
Issue an annual report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on or before November 30, 2005, and each November 30 thereafter:
(i)
Summarizing the actions of the Advisory Board and containing recommendations for:
(1)
Providing oversight in acquiring and utilizing State and federal funding dedicated to services for individuals with traumatic brain injuries;
(2)
Building provider–capacity and provider–training that address the needs of individuals with traumatic brain injuries; and
(3)
Improving the coordination of services for individuals with traumatic brain injuries; and
(ii)
Including information concerning the number of individuals served and the services provided in the preceding fiscal year to individuals with traumatic brain injury; and
(7)
Disseminate copies of the annual report to the President of the Senate, Speaker of the House, and the secretary of each department represented on the Advisory Board.
Subtitle 21A. State Brain Injury Trust Fund
Md. Code Ann., Health-Gen. § 13-21A-01 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 21A. State Brain Injury Trust Fund
§ 13–21A-01LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Fund” means the State Brain Injury Trust Fund.
(c)
“Secretary” means the Secretary of Health.
(d)
“Traumatic brain injury” has the meaning established in the policies and procedures adopted by the State Traumatic Brain Injury Advisory Board under § 13–2105 of this title.
Md. Code Ann., Health-Gen. § 13-21A-02 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 21A. State Brain Injury Trust Fund
§ 13–21A-02LinkCopy Citation
(a)
There is a State Brain Injury Trust Fund.
(b)
(1)
The purpose of the Fund is to assist in the provision of the following services to eligible individuals who have sustained brain injuries:
(i)
Individual case management services; and
(ii)
Neuropsychological evaluation.
(2)
The Fund may be used to support:
(i)
Prevention, education, and awareness programs;
(ii)
Rehabilitation services;
(iii)
Medical services;
(iv)
Durable medical equipment;
(v)
Assistive technology assessment and equipment;
(vi)
Services to assist in the return to driving;
(vii)
Evaluation and training related to the brain injury;
(viii)
Neurobehavioral health services;
(ix)
Nursing home transition services;
(x)
Community reentry services;
(xi)
Educational needs;
(xii)
Housing and residential services; and
(xiii)
Transportation services.
(c)
The Secretary or the Secretary’s designee shall administer the Fund.
(d)
(1)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(2)
The State Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(e)
The Fund consists of:
(1)
Money appropriated in the State budget to the Fund;
(2)
Investment earnings of the Fund; and
(3)
Any other money from any other source accepted for the benefit of the Fund.
(f)
The Fund may be used only to provide funding for the purpose described in subsection (b) of this section.
(g)
(1)
The State Treasurer shall invest the money of the Fund in the same manner as other State money may be invested.
(2)
Any investment earnings of the Fund shall be credited to the Fund.
(h)
Money expended from the Fund to support services to individuals with brain injuries is supplemental to and is not intended to take the place of funding that would otherwise be appropriated for those services.
Md. Code Ann., Health-Gen. § 13-21A-03 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 21A. State Brain Injury Trust Fund
§ 13–21A-03LinkCopy Citation
(a)
To be eligible for assistance from the Fund, an individual shall:
(1)
Be a United States citizen and a resident of the State at the time of the brain injury;
(2)
Have a brain injury that has been documented in the medical records of the individual;
(3)
Have income at or below 300% of the federal poverty level; and
(4)
Have exhausted all other health, rehabilitation, and disability benefit funding sources that cover the services provided by the Fund.
(b)
An individual may not receive services from the Fund costing more than:
(1)
The annual amount established by policies and procedures adopted by the Secretary or the Secretary’s designee; and
(2)
The lifetime of the individual amount established by policies and procedures adopted by the Secretary or the Secretary’s designee.
Subtitle 22. Child Abuse Medical Providers (Maryland Champ)
Md. Code Ann., Health-Gen. § 13-2201 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 22. Child Abuse Medical Providers (Maryland Champ)
§ 13–2201LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Child Abuse Medical Providers (Maryland CHAMP)” means a network of Maryland health care professionals with the expertise to address the prevention, diagnosis and treatment of child abuse and neglect while working closely with other disciplines and organizations addressing these issues, including child advocacy centers.
(c)
“Child Abuse Medical Providers (Maryland CHAMP) faculty” means a core group of clinical experts, as designated by the Department, who provide training, consultation, and support for the diagnosis and treatment of child abuse and neglect to health care professionals.
(d)
“Child advocacy center” means a child–focused entity within or outside a health care facility that investigates, diagnoses, and treats children who may have been abused or neglected that:
(1)
Includes local law enforcement officers, local criminal prosecutors, and the local department of social services; and
(2)
May include child mental health service providers and other children and family service providers.
(e)
“Initiative” means the Child Abuse Medical Providers (Maryland CHAMP) Initiative.
(f)
“Multidisciplinary team” means a group of professionals with expertise in various health care and social service professional disciplines who provide consultation, treatment, and planning in cases of child abuse and neglect.
Md. Code Ann., Health-Gen. § 13-2202 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 22. Child Abuse Medical Providers (Maryland Champ)
§ 13–2202LinkCopy Citation
(a)
There is a Child Abuse Medical Providers (Maryland CHAMP) Initiative in the Department.
(b)
The purposes of the Initiative are:
(1)
To improve the protection of children in the State;
(2)
To recruit local physicians to gain clinical expertise in the diagnosis and treatment of child abuse and neglect;
(3)
To develop and guide the practice of local or regional multidisciplinary teams to improve the medical assessment and treatment of children who are the subject of a child abuse or neglect investigation or a child in need of assistance;
(4)
To facilitate the appropriate prosecution of criminal child abuse and neglect; and
(5)
To provide expert consultation and training to local or regional multidisciplinary teams in the diagnosis and treatment of physical child abuse and neglect and sexual abuse through teleconferencing and on–site services.
Md. Code Ann., Health-Gen. § 13-2203 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 22. Child Abuse Medical Providers (Maryland Champ)
§ 13–2203LinkCopy Citation
The Child Abuse Medical Providers (Maryland CHAMP) faculty shall:
(1)
Assist local and regional jurisdictions to develop standards and protocols for the composition and operation of local or regional Child Abuse Medical Providers (Maryland CHAMP);
(2)
Provide training and consultation to local or regional Child Abuse Medical Providers (Maryland CHAMP) in the diagnosis and treatment of child abuse and neglect;
(3)
Provide financial support to part–time local and regional expert clinic staff for the diagnosis and treatment of child abuse and neglect;
(4)
Collaborate with local or regional child advocacy centers and forensic nurse examiner programs; and
(5)
Help assure that medical professionals have access to information on how to cooperate with local departments of social services, child advocacy centers, and local law enforcement officers to:
(i)
Protect children from trauma during the process of child abuse and neglect investigations and prosecution;
(ii)
Minimize the number of times each child is interviewed and examined; and
(iii)
Minimize the potential for influencing a child’s statement.
Md. Code Ann., Health-Gen. § 13-2204 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 22. Child Abuse Medical Providers (Maryland Champ)
§ 13–2204LinkCopy Citation
A Child Abuse Medical Provider (Maryland CHAMP) may receive information from the Department and may consult with the Department on any case:
(1)
Referred from the Children in Need of Assistance program;
(2)
Concerning a child committed to the Department or a local department of social services; or
(3)
Concerning a child who is the subject of a child abuse or neglect investigation.
Md. Code Ann., Health-Gen. § 13-2206 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 22. Child Abuse Medical Providers (Maryland Champ)
§ 13–2206LinkCopy Citation
(a)
In fiscal year 2007, the Governor shall include in the State budget an appropriation in the amount of $225,000 for the Child Abuse Medical Providers (Maryland CHAMP) Initiative.
(b)
In each fiscal year beginning with fiscal 2008, the Governor shall include in the annual budget bill submitted to the General Assembly a General Fund appropriation for the Child Abuse Medical Providers (Maryland CHAMP) Initiative in an amount not less than the amount of the General Fund appropriation for the Initiative as approved in the State budget as enacted by the General Assembly for the prior fiscal year, increased by not less than the percentage by which the projected total General Fund revenues for the upcoming fiscal year exceed the revised estimate of total General Fund revenues for the current fiscal year, as contained in the report of the estimated State revenues submitted by the Board of Revenue Estimates to the Governor under § 6–106(b) of the State Finance and Procurement Article.
(c)
The accounts and transactions of the Child Abuse Medical Providers (Maryland CHAMP) Initiative shall be subject to audit by the Legislative Auditor in accordance with §§ 2–1220 through 2–1227 of the State Government Article.
Md. Code Ann., Health-Gen. § 13-2207 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 22. Child Abuse Medical Providers (Maryland Champ)
§ 13–2207LinkCopy Citation
(a)
In this section, “Fund” means the Children’s Trust Fund.
(b)
There is a Children’s Trust Fund.
(c)
The purpose of the Fund is to provide funding for the Child Abuse Medical Providers (Maryland CHAMP) Initiative.
(d)
The Department shall administer the Fund.
(e)
The Fund is a special, nonlapsing fund that is not subject to § 7-302 of the State Finance and Procurement Article.
(f)
The Fund consists of:
(1)
Fees distributed to the Fund from the issuance of commemorative birth certificates under § 4-217(a)(3) of this article;
(2)
Money appropriated in the State budget to the Fund; and
(3)
Any other money from any other source accepted for the benefit of the Fund.
(g)
The Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(h)
The Treasurer shall invest and reinvest the money of the Fund in the same manner as other State money may be invested.
(i)
(1)
The Comptroller shall pay out money from the Fund as directed by the Secretary.
(2)
No part of the Fund may revert or be credited to:
(i)
The General Fund of the State; or
(ii)
Any other special fund of the State.
(j)
Expenditures from the Fund may be made only in accordance with the State budget.
Subtitle 23. Folic Acid Supplement Distribution Program
Md. Code Ann., Health-Gen. § 13-2301 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 23. Folic Acid Supplement Distribution Program
§ 13–2301LinkCopy Citation
In this subtitle, “women of childbearing age” means women between the ages of 15 and 45 years old who have family incomes at or below 185% of the federal poverty level.
Md. Code Ann., Health-Gen. § 13-2302 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 23. Folic Acid Supplement Distribution Program
§ 13–2302LinkCopy Citation
(a)
The Department shall establish a program to distribute a folic acid supplement to women of childbearing age.
(b)
The purpose of the program is to reduce the number of cases of neural tube defects in the State.
(c)
The program shall provide the following to women of childbearing age as appropriate, based on an assessment of their individual need:
(1)
An appropriate folic acid supplement that contains the recommended level of folic acid for women of childbearing age;
(2)
Counseling and written information regarding the proper use of the supplement; and
(3)
Any other health information that the Department determines necessary to carry out the purposes of this subtitle.
Md. Code Ann., Health-Gen. § 13-2303 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 23. Folic Acid Supplement Distribution Program
§ 13–2303LinkCopy Citation
Subject to the availability of funding, the program shall be funded as provided in the State budget.
Subtitle 25. Oral Health Safety Net Program
Md. Code Ann., Health-Gen. § 13-2501 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 25. Oral Health Safety Net Program
§ 13–2501LinkCopy Citation
(a)
In this subtitle, “Program” means the Oral Health Safety Net Program.
(b)
There is an Oral Health Safety Net Program in the Office of Oral Health in the Department.
(c)
The purpose of the Program is to provide start–up funding to expand oral health capacity for underserved low–income and disabled individuals, including individuals enrolled in the Maryland Medical Assistance Program and in the Maryland Children’s Health Program.
Md. Code Ann., Health-Gen. § 13-2502 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 25. Oral Health Safety Net Program
§ 13–2502LinkCopy Citation
(a)
The Office of Oral Health shall solicit proposals from local health departments, federally qualified health centers, and entities providing dental services within State facilities, for the purpose of issuing grants to support collaborative and innovative ways to increase dental provider capacity for the underserved.
(b)
Subject to the limitations of the State budget, the Office of Oral Health shall:
(1)
Award grants; and
(2)
Oversee the operation of the Program.
(c)
The Office of Oral Health shall place priority on awarding grants to proposals that:
(1)
Are targeted to regions of the State where oral health services are most scarce for low–income, disabled, and Medicaid populations; and
(2)
Outline how the potential grantee will maximize limited resources, including:
(i)
Sharing of resources with other persons;
(ii)
Case management to eliminate barriers to dental services;
(iii)
Public–private purchasing agreements;
(iv)
Obtaining matching funds to increase resources;
(v)
Incentives to increase provider participation;
(vi)
Quantifiable outcome measures of success;
(vii)
School–based screenings; and
(viii)
Plans to ensure sustainability of services after termination of grants awarded under this subtitle.
Md. Code Ann., Health-Gen. § 13-2503 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 25. Oral Health Safety Net Program
§ 13–2503LinkCopy Citation
Subject to the limitations of the State budget, the Office of Oral Health shall:
(1)
Contract with a licensed dentist to provide expertise in dental public health issues for the Office; and
(2)
Provide for appropriate continuing education courses for providers that offer oral health treatment to underserved populations.
Md. Code Ann., Health-Gen. § 13-2504 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 25. Oral Health Safety Net Program
§ 13–2504LinkCopy Citation
(a)
(1)
The Office of Oral Health shall conduct an annual evaluation of the Program.
(2)
The evaluation required under this subsection shall include:
(i)
Data on any progress resulting from each grant awarded under this subtitle;
(ii)
Data on any progress of the overall Program;
(iii)
Data demonstrating any increase in the use of restorative dental care among underserved populations; and
(iv)
Data from any statewide survey conducted by the Department that demonstrates any progress of the Program.
(b)
The Department, in conjunction with the Office of Oral Health, shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on or before November 1 of each year on:
(1)
The results of the Program;
(2)
Findings and recommendations for the Oral Health Program and any other oral health programs established under Title 18, Subtitle 8 of this article;
(3)
The availability and accessibility of dentists throughout the State participating in the Maryland Medical Assistance Program;
(4)
The outcomes that managed care organizations and dental managed care organizations under the Maryland Medical Assistance Program achieve concerning the utilization of targets required by the Five Year Oral Health Care Plan, including:
(i)
Loss ratios that the managed care organizations and dental managed care organizations experience for providing dental services; and
(ii)
Corrective action by managed care organizations and dental managed care organizations to achieve the utilization targets; and
(5)
The allocation and use of funds authorized for dental services under the Maryland Medical Assistance Program.
Md. Code Ann., Health-Gen. § 13-2505 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 25. Oral Health Safety Net Program
§ 13–2505LinkCopy Citation
It is the intent of the General Assembly:
(1)
That grants shall be awarded through the Program from July 1, 2008 through June 30, 2009, for fiscal year 2009; and
(2)
That full funding for grants shall continue in the subsequent two fiscal years unless the Office of Oral Health determines that a grantee is not fulfilling the conditions of the award.
Md. Code Ann., Health-Gen. § 13-2506 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 25. Oral Health Safety Net Program
§ 13–2506LinkCopy Citation
The Department shall conduct a statewide follow–up survey on or before June 1, 2011, concerning the oral health status of school children in the State.
Subtitle 27. Behavioral Health Services for Maryland Veterans
Md. Code Ann., Health-Gen. § 13-2701 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 27. Behavioral Health Services for Maryland Veterans
§ 13–2701LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Behavioral health services” means mental health services or alcohol and substance abuse services.
(c)
(1)
“Crisis services” means temporary services designed to address and stabilize a severe behavioral health problem and to avoid an emergency situation.
(2)
“Crisis services” includes hotlines, in–home support, and residential crisis services.
(d)
“Eligible veteran” means a veteran who is a Maryland resident.
(e)
“Maryland Defense Force” means the military force established under § 13–501 of the Public Safety Article.
(f)
“Maryland National Guard” means the Maryland Army National Guard and Maryland Air National Guard.
(g)
“Service coordination” means a service designed to coordinate and provide assistance in obtaining access to behavioral health services.
(h)
“Web–based resource program” means an interactive web–based communication medium that:
(1)
Allows individuals to access comprehensive information, advocacy, and other resources regarding public and private behavioral health services, crisis and emergency services, and early intervention and prevention programs; and
(2)
Enables the public and private health care communities to work together to address the problems related to providing and obtaining access to behavioral health services.
Md. Code Ann., Health-Gen. § 13-2702 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 27. Behavioral Health Services for Maryland Veterans
§ 13–2702LinkCopy Citation
(a)
Subject to the limitations of its budget, the Department:
(1)
In collaboration with the United States Department of Veterans Affairs, the Maryland Department of Veterans and Military Families, the Maryland National Guard, and the Maryland Defense Force, shall provide behavioral health service coordination for eligible veterans in all geographic regions of the State to connect them to behavioral health services, including mental health first aid described under § 13–2703(b) of this subtitle, which may be available through the United States Department of Veterans Affairs;
(2)
(i)
Where behavioral health services are not yet available or accessible through the United States Department of Veterans Affairs, shall provide service coordination for eligible veterans in all geographic regions of the State to connect them to behavioral health services, including mental health first aid described under § 13–2703(b) of this subtitle, which may be available through the Behavioral Health Administration, until such federal services can be accessed and obtained; and
(ii)
Shall provide behavioral health services through the Behavioral Health Administration based on eligibility and medical necessity criteria established by these administrations; and
(3)
Shall provide eligible veterans up–to–date information about behavioral health services and resources through a web–based resource program.
(b)
Subject to the limitations of its budget and in addition to the service coordination provided under subsection (a) of this section, the Department shall provide or fund certain behavioral health services for eligible veterans who:
(1)
Meet the eligibility and medical necessity criteria of the Behavioral Health Administration; and
(2)
Cannot obtain immediate access to behavioral health services through the United States Department of Veterans Affairs.
(c)
(1)
The behavioral health services provided under subsection (b) of this section may include:
(i)
Crisis services in all geographic regions of the State; and
(ii)
Short–term behavioral health services, where existing federal and State behavioral health services are determined by the Department to be inadequate or inaccessible.
(2)
The short–term behavioral health services provided under paragraph (1)(ii) of this subsection:
(i)
Shall be available only until an eligible veteran is able to access and obtain adequate behavioral health services through the United States Department of Veterans Affairs; and
(ii)
May include:
(1)
Screening assessments;
(2)
Individual, family, and group therapy;
(3)
Substance abuse early intervention and detoxification services; and
(4)
Substance abuse medication–assisted treatment.
(3)
The Department shall seek reimbursement from the United States Department of Veterans Affairs or other responsible public or private payer for any behavioral health services provided under subsection (b) of this section.
(d)
The Department shall account separately for funds used to provide behavioral health services to eligible veterans under subsection (b) of this section.
Md. Code Ann., Health-Gen. § 13-2703 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 27. Behavioral Health Services for Maryland Veterans
§ 13–2703LinkCopy Citation
(a)
The behavioral health services for which the Department provides service coordination for eligible veterans under this subtitle shall include mental health first aid.
(b)
Mental health first aid shall consist of training for eligible veterans and the immediate family members of eligible veterans on how to identify and respond to signs of mental illness and substance use disorders.
(c)
Each entity teaching a mental health first aid course shall report to the Department:
(1)
The number of eligible veterans who took the mental health first aid course; and
(2)
The number of family members of eligible veterans who took the mental health first aid course.
(d)
On or before June 1 each year, beginning in 2023, if the Department received a report under subsection (c) of this section in the immediately preceding year, the Department shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly the following information for the immediately preceding year:
(1)
The total number of eligible veterans in the State who took a mental health first aid course;
(2)
The total number of family members of eligible veterans in the State who took a mental health first aid course; and
(3)
The total number of mental health first aid courses taught in the State, reported by the entity that taught the mental health first aid course.
Subtitle 30. Cord Blood Transplant Program
Md. Code Ann., Health-Gen. § 13-3001 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 30. Cord Blood Transplant Program
§ 13–3001LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Cord blood transplant center” means a medical facility that uses cells obtained from a human umbilical cord or placenta to treat pediatric or adult patients afflicted with a disease or injury.
(c)
“Fund” means the Cord Blood Transplant Center Support Fund.
(d)
“Qualified medical institution” means a medical institution accredited by the Joint Commission on Accreditation of Health Care Organizations that:
(1)
Is located in the State; and
(2)
Has an established hematologic malignancies research program.
Md. Code Ann., Health-Gen. § 13-3002 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 30. Cord Blood Transplant Program
§ 13–3002LinkCopy Citation
(a)
There is a Cord Blood Transplant Program in the Department.
(b)
The purpose of the Cord Blood Transplant Program is to provide funding, subject to the limitations of the State budget, to qualified medical institutions to establish or maintain a cord blood transplant center.
Md. Code Ann., Health-Gen. § 13-3003 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 30. Cord Blood Transplant Program
§ 13–3003LinkCopy Citation
(a)
There is a Cord Blood Transplant Center Support Fund.
(b)
The purpose of the Fund is to promote economic development by supporting cord blood transplant centers at qualified medical institutions with a goal of being recognized as a regional center of excellence in the area of cord blood transplantation.
(c)
The Department shall administer the Fund.
(d)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(e)
The State Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(f)
The Fund consists of:
(1)
Beginning in 2013, any money appropriated in the State budget to the Fund; and
(2)
Any other money from any other source accepted for the benefit of the Fund.
(g)
The Fund may be used only for the establishment of or support for a cord blood transplant center at a qualified medical institution.
(h)
(1)
The State Treasurer shall invest and reinvest the money of the Fund in the same manner as other State money may be invested.
(2)
Any investment earnings of the Fund shall be paid into the Fund.
(i)
(1)
The Comptroller shall pay out money from the Fund as directed by the Secretary.
(2)
No part of the Fund may revert or be credited to:
(i)
The General Fund of the State; or
(ii)
Any other special fund of the State.
(j)
Expenditures from the Fund may be made only in accordance with the State budget.
Md. Code Ann., Health-Gen. § 13-3004 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 30. Cord Blood Transplant Program
§ 13–3004LinkCopy Citation
(a)
A qualified medical institution may apply for a grant from the Fund each year.
(b)
The Department shall adopt regulations to administer the Fund in accordance with the purposes of this subtitle.
Subtitle 31. Overdose Response Program
Md. Code Ann., Health-Gen. § 13-3101 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3101LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Pharmacist” has the meaning stated in § 12–101 of the Health Occupations Article.
(c)
“Private or public entity” means a health care provider, local health department, community–based organization, substance abuse treatment organization, or other person that addresses medical or social issues related to drug addiction.
(d)
“Program” means the Overdose Response Program.
(e)
“Standing order” means a written instruction for the prescribing and dispensing of an opioid overdose reversal drug approved by the federal Food and Drug Administration in accordance with § 13–3106 of this subtitle.
Md. Code Ann., Health-Gen. § 13-3102 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3102LinkCopy Citation
The Overdose Response Program is a program administered by the Department for the purpose of providing a means of authorizing certain individuals to administer an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual experiencing, or believed to be experiencing, opioid overdose to help prevent a fatality when medical services are not immediately available.
Md. Code Ann., Health-Gen. § 13-3103 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3103LinkCopy Citation
(a)
The Department shall adopt regulations necessary for the administration of the Program.
(b)
The Department may:
(1)
Collect fees necessary for the administration of the Program;
(2)
Authorize private or public entities to conduct education and training on opioid overdose recognition and response that include:
(i)
Education on recognizing the signs and symptoms of an opioid overdose;
(ii)
Training on responding to an opioid overdose, including the administration of opioid overdose reversal drugs approved by the federal Food and Drug Administration, emphasizing the restoration of breathing, avoiding withdrawal, and compassionate postoverdose support and care; and
(iii)
Access to opioid overdose reversal drugs approved by the federal Food and Drug Administration and the necessary supplies for the administration of the opioid overdose reversal drugs;
(3)
Develop guidance regarding the content of educational training programs conducted by private or public entities; and
(4)
Collect and report data on the operation and results of the programs.
(c)
An individual is not required to obtain training and education on opioid overdose recognition and response from a private or public entity under subsection (b) of this section in order for a pharmacist to dispense an opioid overdose reversal drug approved by the federal Food and Drug Administration to the individual.
(d)
(1)
Subject to the limitations of the State budget, the Department shall purchase and provide opioid overdose reversal drugs approved by the federal Food and Drug Administration, at no cost, to the providers who are required to offer opioid overdose reversal drugs approved by the federal Food and Drug Administration under § 8–408 or § 19–310.3 of this article.
(2)
An entity required to offer an opioid overdose reversal drug approved by the federal Food and Drug Administration under § 8–408 or § 19–310.3 of this article may provide an opioid overdose reversal drug approved by the federal Food and Drug Administration only if the opioid overdose reversal drug approved by the federal Food and Drug Administration is provided by the Department.
(3)
The Department shall, subject to the limitations of the State budget, allow an entity that is provided with opioid overdose reversal drugs by the Department under this subsection to choose the formulation or dosage of opioid overdose reversal drugs approved by the federal Food and Drug Administration with which the entity is to be provided.
Md. Code Ann., Health-Gen. § 13-3104 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3104LinkCopy Citation
An authorized private or public entity shall enter into a written agreement with a licensed health care provider with prescribing authority to establish protocols for the prescribing and dispensing of an opioid overdose reversal drug approved by the federal Food and Drug Administration to any individual in accordance with this subtitle.
Md. Code Ann., Health-Gen. § 13-3105 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3105LinkCopy Citation
(a)
An individual may receive from any licensed health care provider with prescribing authority a prescription for an opioid overdose reversal drug approved by the federal Food and Drug Administration and the necessary supplies for the administration of the opioid overdose reversal drug.
(b)
An individual for whom an opioid overdose reversal drug approved by the federal Food and Drug Administration is prescribed and dispensed in accordance with this subtitle may:
(1)
Possess the prescribed opioid overdose reversal drug and the necessary supplies for the administration of the opioid overdose reversal drug; and
(2)
In an emergency situation when medical services are not immediately available, administer the opioid overdose reversal drug to an individual experiencing or believed by the individual to be experiencing an opioid overdose.
Md. Code Ann., Health-Gen. § 13-3106 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3106LinkCopy Citation
(a)
A licensed health care provider with prescribing authority may prescribe and dispense an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual who:
(1)
Is believed by the licensed health care provider to be at risk of experiencing an opioid overdose; or
(2)
Is in a position to assist an individual at risk of experiencing an opioid overdose.
(b)
(1)
A licensed health care provider with prescribing authority may prescribe and dispense opioid overdose reversal drugs approved by the federal Food and Drug Administration by issuing a standing order if the licensed health care provider:
(i)
Is employed by the Department or a local health department; or
(ii)
Has a written agreement with an authorized private or public entity under § 13–3104 of this subtitle.
(2)
A licensed health care provider with prescribing authority who issues a standing order under paragraph (1) of this subsection may delegate the dispensing of opioid overdose reversal drugs approved by the federal Food and Drug Administration to an employee or a volunteer of an authorized private or public entity in accordance with a written agreement under § 13–3104 of this subtitle.
(3)
Any licensed health care provider who has dispensing authority also may dispense an opioid overdose reversal drug approved by the federal Food and Drug Administration to any individual in accordance with a standing order issued by a licensed health care provider with prescribing authority in accordance with this subsection.
(c)
A pharmacist may dispense opioid overdose reversal drugs approved by the federal Food and Drug Administration in accordance with a therapy management contract under Title 12, Subtitle 6A of the Health Occupations Article.
Md. Code Ann., Health-Gen. § 13-3107 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3107LinkCopy Citation
(a)
An individual who, in accordance with this subtitle, is administering an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual experiencing or believed by the individual to be experiencing an opioid overdose may not be considered to be practicing:
(1)
Medicine for the purposes of Title 14 of the Health Occupations Article; or
(2)
Registered nursing for the purposes of Title 8 of the Health Occupations Article.
(b)
An employee or volunteer of a private or public entity who, in accordance with this subtitle, provides an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual who has received education and training in opioid overdose recognition and response in accordance with a standing order may not be considered to be practicing:
(1)
Medicine for the purposes of Title 14 of the Health Occupations Article;
(2)
Registered nursing for the purposes of Title 8 of the Health Occupations Article; or
(3)
Pharmacy for the purposes of Title 12 of the Health Occupations Article.
(c)
A licensed health care provider who prescribes or dispenses opioid overdose reversal drugs approved by the federal Food and Drug Administration in accordance with this subtitle may not be subject to any disciplinary action by the appropriate licensing health occupations board under the Health Occupations Article solely for the act of prescribing or dispensing opioid overdose reversal drugs approved by the federal Food and Drug Administration.
Md. Code Ann., Health-Gen. § 13-3108 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3108LinkCopy Citation
(a)
An individual who administers an opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual who is or in good faith is believed to be experiencing an opioid overdose shall have immunity from liability under §§ 5–603 and 5–629 of the Courts Article.
(b)
A cause of action may not arise against any licensed health care provider with prescribing authority or pharmacist for any act or omission when the health care provider with prescribing authority or pharmacist in good faith prescribes or dispenses an opioid overdose reversal drug approved by the federal Food and Drug Administration and the necessary paraphernalia for the administration of the opioid overdose reversal drug approved by the federal Food and Drug Administration to an individual under § 13–3106 of this subtitle.
(c)
A cause of action may not arise against any business or business owner for any act or omission when the business or business owner in good faith makes opioid overdose reversal drugs approved by the federal Food and Drug Administration available to the employees or patrons of the business along with the necessary paraphernalia for administration of the opioid overdose reversal drugs approved by the federal Food and Drug Administration to an individual under § 13–3104 or § 13–3106 of this subtitle.
(d)
This subtitle may not be construed to create a duty on any individual to:
(1)
Obtain education and training from an authorized private or public entity under this subtitle, and an individual may not be held civilly liable for failing to obtain education and training from an authorized private or public entity under this subtitle; or
(2)
Administer opioid overdose reversal drugs approved by the federal Food and Drug Administration to an individual who is experiencing or believed by the individual to be experiencing an opioid overdose.
Md. Code Ann., Health-Gen. § 13-3109 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 31. Overdose Response Program
§ 13–3109LinkCopy Citation
A person who dispenses an opioid overdose reversal drug approved by the federal Food and Drug Administration in accordance with this subtitle is exempt from any laws that require a person to maintain a permit to dispense prescription drugs.
Subtitle 32. Virginia I. Jones Alzheimer's Disease and Related Dementias Council
Md. Code Ann., Health-Gen. § 13-3201 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32. Virginia I. Jones Alzheimer's Disease and Related Dementias Council
§ 13–3201LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Council” means the Virginia I. Jones Alzheimer’s Disease and Related Dementias Council.
(c)
“Director” means the Director of Dementia Services and Brain Health established under Subtitle 32A of this title.
Md. Code Ann., Health-Gen. § 13-3202 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32. Virginia I. Jones Alzheimer's Disease and Related Dementias Council
§ 13–3202LinkCopy Citation
There is a Virginia I. Jones Alzheimer’s Disease and Related Dementias Council.
Md. Code Ann., Health-Gen. § 13-3203 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32. Virginia I. Jones Alzheimer's Disease and Related Dementias Council
§ 13–3203LinkCopy Citation
(a)
The Council consists of the following members:
(1)
One member of the Senate of Maryland, appointed by the President of the Senate;
(2)
One member of the House of Delegates, appointed by the Speaker of the House;
(3)
The Secretary of Health, or the Secretary’s designee;
(4)
The Secretary of Aging, or the Secretary’s designee;
(5)
The Executive Director of the Alzheimer’s Association, Greater Maryland Chapter, or the Executive Director’s designee;
(6)
The President of the Alzheimer’s Association, National Capital Area Chapter, or the President’s designee; and
(7)
The following members, appointed by the Governor:
(i)
Seven health care professionals with relevant professional experience;
(ii)
Three human service professionals with relevant professional experience;
(iii)
One elder law attorney with relevant professional experience;
(iv)
Two research professionals with relevant professional experience;
(v)
Two family caregivers of individuals with Alzheimer’s disease or a related disorder; and
(vi)
At the recommendation of the Council, any other member necessary to fulfill the duties of the Council.
(b)
To the extent practicable, the members appointed to the Council shall reflect the geographic, racial, ethnic, cultural, and gender diversity of the State.
Md. Code Ann., Health-Gen. § 13-3204 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32. Virginia I. Jones Alzheimer's Disease and Related Dementias Council
§ 13–3204LinkCopy Citation
(a)
The members of the Council shall select the chair of the Council.
(b)
A member of the Council:
(1)
May not receive compensation as a member of the Council; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(c)
(1)
The term of an appointed member of the Council is 3 years.
(2)
The terms of the appointed members of the Council are staggered as required by the terms provided for the appointed members of the Council on October 1, 2022.
(3)
At the end of a term, an appointed member continues to serve until a successor is appointed and qualifies.
(4)
A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
Md. Code Ann., Health-Gen. § 13-3205 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32. Virginia I. Jones Alzheimer's Disease and Related Dementias Council
§ 13–3205LinkCopy Citation
(a)
The Dementia Services and Brain Health Program, with assistance from the Department of Aging, shall provide staff support for the Council.
(b)
The Director may request staffing assistance from public health entities with an interest in the duties of the Council.
Md. Code Ann., Health-Gen. § 13-3206 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32. Virginia I. Jones Alzheimer's Disease and Related Dementias Council
§ 13–3206LinkCopy Citation
The Council shall:
(1)
Update the State Plan on Alzheimer’s Disease and Related Dementias and advocate for the State Plan;
(2)
(i)
Examine the needs of individuals with Alzheimer’s disease and related dementias and their caregivers; and
(ii)
Identify methods through which the State can most effectively and efficiently assist in meeting those needs;
(3)
(i)
Examine the readiness and capacity of health care providers to deliver care to individuals with or at risk for Alzheimer’s disease and related dementias; and
(ii)
Identify methods through which the State can assist health care providers in delivering care to individuals with or at risk for Alzheimer’s disease and related dementias in the most effective and efficient manner;
(4)
Advise the Governor and the General Assembly on policy, funding, regulatory, and other issues related to individuals with Alzheimer’s disease and related dementias and their caregivers; and
(5)
Develop and promote strategies to encourage brain health and reduce cognitive decline.
Md. Code Ann., Health-Gen. § 13-3207 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32. Virginia I. Jones Alzheimer's Disease and Related Dementias Council
§ 13–3207LinkCopy Citation
On or before September 1, 2022, and on or before September 1 every 5 years thereafter, the Council shall issue and publish an update to the State Plan on Alzheimer’s Disease and Related Dementias.
Subtitle 32A. Director of Dementia Services and Brain Health
Md. Code Ann., Health-Gen. § 13-32A-01 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32A. Director of Dementia Services and Brain Health
§ 13–32A-01LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Council” means the Virginia I. Jones Alzheimer’s Disease and Related Dementias Council.
(c)
“Director” means the Director of Dementia Services and Brain Health.
(d)
“Program” means the Dementia Services and Brain Health Program.
Md. Code Ann., Health-Gen. § 13-32A-02 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32A. Director of Dementia Services and Brain Health
§ 13–32A-02LinkCopy Citation
There is a Director of Dementia Services and Brain Health in the Department.
Md. Code Ann., Health-Gen. § 13-32A-03 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32A. Director of Dementia Services and Brain Health
§ 13–32A-03LinkCopy Citation
The position of Director shall be a full–time and permanent position.
Md. Code Ann., Health-Gen. § 13-32A-04 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32A. Director of Dementia Services and Brain Health
§ 13–32A-04LinkCopy Citation
(a)
There is a Dementia Services and Brain Health Program in the Department.
(b)
The Director shall administer the Program.
(c)
The purpose of the Program is to lead the State’s public health efforts relating to brain health and dementia.
(d)
The Program shall:
(1)
Coordinate the Department’s approach to addressing Alzheimer’s disease and other forms of dementia and brain health, including through public awareness, prevention, and early detection and diagnosis;
(2)
Staff the Council and update the Council each quarter on the Program’s activities;
(3)
Oversee implementation of the State Plan on Alzheimer’s Disease and Related Dementias;
(4)
Assess, analyze, and conduct outreach to share cognitive health and dementia–related data;
(5)
Develop and monitor implementation milestones and measurable outcomes to assess progress in achieving the goals laid out in the State Plan on Alzheimer’s Disease and Related Dementias;
(6)
Identify efficiencies across State agencies that aid individuals with dementia and their caregivers, and coordinate public and private stakeholder partnerships;
(7)
Support and promote the delivery of dementia–capable care across health care settings through various methods, including:
(i)
Establishing and maintaining a provider resource toolkit for dementia care, as defined in § 13–32A–07 of this subtitle, to support health care providers in delivering evidence–based, person–centered care;
(ii)
Coordinating with academic institutions, health occupations boards, and continuing education providers to promote participation in dementia–specific education, training, and certification for health care professionals; and
(iii)
Collaborating with State–led care transformation initiatives to identify opportunities to incorporate dementia–capable care practices into health care models;
(8)
Apply for grants to enable the implementation of the State Plan on Alzheimer’s Disease and Related Dementias goals to reduce the risk of dementia, and to improve the quality of care for individuals with dementia and their caregivers; and
(9)
Carry out other duties relevant to the support of individuals with dementia as may be assigned by the Department.
Md. Code Ann., Health-Gen. § 13-32A-05 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32A. Director of Dementia Services and Brain Health
§ 13–32A-05LinkCopy Citation
On or before September 1, 2023, and on or before September 1 every 5 years thereafter, the Director shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the Senate Finance Committee and the House Health and Government Operations Committee on the activities and recommendations of the Program.
Md. Code Ann., Health-Gen. § 13-32A-06 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32A. Director of Dementia Services and Brain Health
§ 13–32A-06LinkCopy Citation
The Governor shall include in the annual budget bill an appropriation to fund the position of Director and the Council, as follows:
(1)
For fiscal year 2023, at least $71,400;
(2)
For fiscal year 2024, at least $83,000;
(3)
For fiscal year 2025, at least $85,300;
(4)
For fiscal year 2026, at least $87,600; and
(5)
For fiscal year 2027 and each fiscal year thereafter, at least $89,900.
Md. Code Ann., Health-Gen. § 13-32A-07 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 32A. Director of Dementia Services and Brain Health
§ 13–32A-07LinkCopy Citation
(a)
In this section, “toolkit” means the provider resource toolkit for dementia care for health care providers developed under subsection (b) of this section.
(b)
On or before October 1, 2027, the Department, in partnership with the Department of Aging, the Council, and other public or private organizations with expertise in Alzheimer’s disease or related dementias shall establish and maintain a provider resource toolkit for dementia care for health care providers.
(c)
The purpose of the toolkit is to provide a centralized, up–to–date resource to support health care providers in caring for patients who are at risk for or who may have dementia.
(d)
The toolkit developed under subsection (b) of this section shall:
(1)
Be composed of materials that can be developed using existing resources and expertise within the Department or obtained through partnerships with public or private entities as determined necessary by the Department; and
(2)
Include information on:
(i)
Risk factors for Alzheimer’s disease and related dementias, including chronic diseases and the co–occurrence of Down syndrome (Trisomy–21);
(ii)
Risk reduction strategies, including information on lifestyle interventions to reduce dementia risk;
(iii)
The importance of early detection and diagnosis of Alzheimer’s disease and related dementias;
(iv)
Validated assessment tools for the detection and diagnosis of cognitive impairment;
(v)
The racial and ethnic disparities in detecting, diagnosing, and accessing treatment and services;
(vi)
Person–centered care delivery and relevant sources of clinical practice guidelines and tools;
(vii)
Effective care planning tools, including:
(1)
Available reimbursement tools, including relevant billing codes, for individuals with cognitive impairment;
(2)
Referral pathways to community–based services and care planning resources; and
(3)
Information on treatment options and relevant sources for guidelines; and
(viii)
Continuing education opportunities related to dementia care best practices.
(e)
The Department shall promote the use of the toolkit across health care sectors, including:
(1)
Managed care programs;
(2)
Academic research institutions;
(3)
Hospitals and health systems;
(4)
Federally qualified health centers;
(5)
Hospital and health system associations;
(6)
Physician and medical student organizations;
(7)
Organizations representing the advancement of nurses, health care professionals, and health care organizations; and
(8)
Any other public or private organization, entity, or part of an organization or entity the Department deems necessary.
(f)
On or before January 1 each year, beginning in 2028, the Department shall review and update the information in the toolkit to reflect the most recent and accurate available information.
Subtitle 34. Family Planning Program
Md. Code Ann., Health-Gen. § 13-3401 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 34. Family Planning Program
§ 13–3401LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Family planning providers” means providers of services:
(1)
Funded under Title X of the federal Public Health Service Act as of December 31, 2024; and
(2)
That lost eligibility for Title X funding as a result of the termination of federal funding for providers because of:
(i)
The scope of services offered by the providers; or
(ii)
The scope of services for which the providers offer referrals.
(c)
“Family planning services” means services provided under Title X of the federal Public Health Service Act as of December 31, 2024.
(d)
“Program” means the Family Planning Program established under § 13–3402 of this subtitle.
Md. Code Ann., Health-Gen. § 13-3402 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 34. Family Planning Program
§ 13–3402LinkCopy Citation
(a)
There is a Family Planning Program in the Department.
(b)
The purpose of the Program is to ensure the continuity of family planning services in the State.
(c)
The Program shall provide family planning services to individuals who are eligible for family planning services through family planning providers that meet Program requirements.
(d)
The Department may adopt regulations to implement this subtitle, including regulations establishing a sliding scale fee for services provided under the Program.
(e)
Funding used to support family planning services under the Program shall be in addition to any funding applied by the Department before December 31, 2024, to the maintenance of effort requirement for federal funding under Title X of the federal Public Health Service Act.
(f)
(1)
The Department may not accept any federal funding under Title X of the federal Public Health Service Act if the Title X program:
(i)
Excludes family planning providers; and
(ii)
Does not require family planning providers to provide a broad range of acceptable and effective medically approved family planning methods and services.
(2)
If the Department does not accept Title X program funds in accordance with paragraph (1) of this subsection, the Governor shall fund the Program with State funds at the same level of total funds provided to the Program in the immediately preceding fiscal year.
Subtitle 35. Co-Prescribing of Opioid Overdose Reversal Drugs
Md. Code Ann., Health-Gen. § 13-3501 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 35. Co-Prescribing of Opioid Overdose Reversal Drugs
§ 13–3501LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Co–prescribing” means, with respect to an opioid overdose reversal drug, the practice of prescribing the drug in conjunction with an opioid prescription for a patient at an elevated risk of overdose.
(c)
“Opioid overdose reversal drug” means naloxone or a similarly acting and equally safe drug that is approved by the federal Food and Drug Administration for the treatment of a known or suspected opioid overdose.
Md. Code Ann., Health-Gen. § 13-3502 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 35. Co-Prescribing of Opioid Overdose Reversal Drugs
§ 13–3502LinkCopy Citation
(a)
The Secretary shall establish guidelines for the co–prescribing of opioid overdose reversal drugs that are applicable to all licensed health care providers in the State who are authorized by law to prescribe a monitored prescription drug, as defined in § 21–2A–01 of this article.
(b)
The guidelines established under subsection (a) of this section shall address the co–prescribing of opioid overdose reversal drugs for patients who are:
(1)
At an elevated risk of overdose; and
(2)
(i)
Receiving opioid therapy for chronic pain;
(ii)
Receiving a prescription for benzodiazepines; or
(iii)
Being treated for opioid use disorders.
Subtitle 36. Reporting of Overdoses
Md. Code Ann., Health-Gen. § 13-3601 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 36. Reporting of Overdoses
§ 13–3601LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Emergency medical services provider” has the meaning stated in § 13–516 of the Education Article.
(c)
“Law enforcement officer” has the meaning stated in § 1–101 of the Public Safety Article.
(d)
“Overdose” means a condition, including extreme physical illness, decreased level of consciousness, respiratory depression, coma, or death, resulting from the consumption or use of any controlled dangerous substance that requires medical attention, assistance, or treatment, and clinical suspicion for drug overdose, including respiratory depression, unconsciousness, or altered mental state, without other conditions to explain the clinical condition.
Md. Code Ann., Health-Gen. § 13-3602 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 36. Reporting of Overdoses
§ 13–3602LinkCopy Citation
(a)
An emergency medical services provider or a law enforcement officer who treats and releases or transports to a medical facility an individual experiencing a suspected or an actual overdose may report the incident using an appropriate information technology platform with secure access, including the Washington/Baltimore High Intensity Drug Trafficking Area overdose detection mapping application program, or any other program operated by the federal government or a unit of State or local government.
(b)
A report of an overdose made under this section shall include:
(1)
The date and time of the overdose;
(2)
The approximate address where the overdose victim was initially encountered or where the overdose occurred;
(3)
Whether an opioid overdose reversal drug was administered; and
(4)
Whether the overdose was fatal or nonfatal.
(c)
If an emergency medical services provider or a law enforcement officer reports an overdose under this section, the emergency medical services provider or law enforcement officer making the report shall make best efforts to make the report within 24 hours after responding to the incident.
(d)
On receipt of a patient care report that indicates an overdose, the Maryland Institute for Emergency Medical Services Systems shall report the information listed under subsection (b) of this section to an appropriate information technology platform with secure access, including the Washington/Baltimore High Intensity Drug Trafficking Area overdose detection mapping application, or any other program operated by the federal government or a unit of State or local government.
(e)
Overdose information reported by an emergency medical services provider under subsection (a) of this section or by the Maryland Institute for Emergency Medical Services Systems under subsection (d) of this section may not be:
(1)
Used for a criminal investigation or prosecution; or
(2)
Obtained by a law enforcement officer as part of a criminal investigation or prosecution.
(f)
An emergency medical services provider or a law enforcement officer who in good faith makes a report under this section shall be immune from criminal liability for making the report.
Md. Code Ann., Health-Gen. § 13-3603 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 36. Reporting of Overdoses
§ 13–3603LinkCopy Citation
A law enforcement agency may not publicly publish the exact address of an overdose location unless there is a valid public safety concern.
Subtitle 37. Community Health Workers
Md. Code Ann., Health-Gen. § 13-3701 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3701LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Advisory Committee” means the State Community Health Worker Advisory Committee.
(c)
“Community health worker” means a frontline public health worker who:
(1)
Is a trusted member of, or has an unusually close understanding of, the community being served;
(2)
Serves as a liaison to, link to, or intermediary between health and social services and the community to:
(i)
Facilitate access to services; and
(ii)
Improve the quality and cultural competence of service delivery; and
(3)
Builds individual and community capacity by increasing health knowledge and self–sufficiency through a range of activities, including:
(i)
Outreach;
(ii)
Community education;
(iii)
The provision of information to support individuals in the community;
(iv)
Social support; and
(v)
Advocacy.
(d)
“Fund” means the State Community Health Workers Fund established under § 13–3707 of this subtitle.
Md. Code Ann., Health-Gen. § 13-3702 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3702LinkCopy Citation
(a)
There is a State Community Health Worker Advisory Committee.
(b)
The Advisory Committee consists of the following members:
(1)
The Secretary of Health, or the Secretary’s designee; and
(2)
The following members appointed by the Governor, with the advice and consent of the Senate:
(i)
Nine community health workers;
(ii)
One registered nurse with experience in community health;
(iii)
One licensed social worker with experience in community health;
(iv)
One representative of a community health worker training organization;
(v)
One representative of the Maryland Public Health Association;
(vi)
One representative of a community–based employer of community health workers;
(vii)
One member of the public who is familiar with the services of community health workers;
(viii)
One representative of the Maryland Association of County Health Officers;
(ix)
One representative of the Maryland Hospital Association; and
(x)
One representative of the Community Behavioral Health Association of Maryland.
(c)
Each Advisory Committee member must be a resident of the State.
(d)
(1)
The term of an appointed member is 4 years.
(2)
The terms of the appointed members are staggered as required by the terms provided for the appointed members of the Advisory Committee on October 1, 2018.
(3)
At the end of a term, an appointed member continues to serve until a successor is appointed and qualifies.
(4)
A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
(5)
An appointed member may not serve more than two consecutive full terms.
(6)
To the extent practicable, the Governor shall fill any vacancy on the Advisory Committee within 60 days after the date of the vacancy.
(e)
(1)
The Governor may remove an appointed member for incompetence, misconduct, incapacity, or neglect of duty.
(2)
On the recommendation of the Secretary, the Governor may remove an appointed member whom the Secretary finds to have been absent from two successive Advisory Committee meetings without adequate reason.
Md. Code Ann., Health-Gen. § 13-3703 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3703LinkCopy Citation
(a)
(1)
The Secretary of Health, or the Secretary’s designee, shall serve as the chair of the Advisory Committee.
(2)
(i)
From among its appointed members, the Advisory Committee annually shall elect a vice chair and a secretary.
(ii)
The Advisory Committee shall determine:
(1)
The manner of election of the vice chair and the secretary; and
(2)
The duties of each officer.
(b)
A majority of the members then serving on the Advisory Committee is a quorum.
(c)
The Advisory Committee shall meet at least two times each year, at the times and places that the Advisory Committee determines, to make recommendations regarding the items listed under § 13–3704 of this subtitle.
(d)
A member of the Advisory Committee is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(e)
The Department shall provide staff support and technical assistance for the Advisory Committee.
(f)
Written materials used to conduct the business of the Advisory Committee shall be provided in the preferred language of the Advisory Committee members, as necessary.
(g)
Training or educational opportunities shall be made available to Advisory Committee members on the formal and informal processes that will be used to conduct the business of the Advisory Committee.
Md. Code Ann., Health-Gen. § 13-3704 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3704LinkCopy Citation
After seeking input from the Maryland Department of Labor, the Maryland Higher Education Commission, the Maryland Rural Health Association, the Maryland Academy of Nutrition and Dietetics, the Maryland State Dental Association, community and hospital employers of community health workers, and institutions of postsecondary education with programs in nursing, social work, and dietetics, the Advisory Committee shall advise the Department on:
(1)
Community health worker training programs, including tiers of training;
(2)
Fees for the issuance and renewal of certificates and other services;
(3)
Grandfathering provisions;
(4)
Criteria for the denial of a certification application, reprimand of a certificate holder, placing a certificate holder on probation, or suspension or revocation of a certificate;
(5)
Hearing procedures before the Department takes any disciplinary action listed under item (4) of this section;
(6)
Appeal procedures for a person aggrieved by a decision of the Department;
(7)
Criteria for the reinstatement of a suspended or revoked certificate;
(8)
Penalties for violations of this subtitle; and
(9)
The appropriate term of a certificate and renewal procedures.
Md. Code Ann., Health-Gen. § 13-3705 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3705LinkCopy Citation
(a)
(1)
(i)
Subject to subparagraph (ii) of this paragraph, a certified community health worker training program must be accredited by the Department before operating in the State.
(ii)
A certified community health worker training program in operation on October 1, 2018, may continue to operate until the deadline established by the Department under paragraph (3)(i)2 of this subsection.
(iii)
An apprenticeship program registered with the Maryland Department of Labor may be accredited by the Department as a certified community health worker training program.
(2)
The Department, working in collaboration with the Advisory Committee, shall adopt regulations establishing a procedure for accrediting community health worker training programs.
(3)
(i)
The regulations adopted under this subsection shall include:
(1)
A deadline before which certified community health worker training programs in operation on October 1, 2018, must apply for accreditation; and
(2)
A deadline before which the Department will make a decision regarding accreditation applications.
(ii)
The Department shall consult with community health worker training programs in establishing the time frames required under this paragraph.
(4)
The regulations adopted under this subsection shall include:
(i)
A procedure for reviewing a certified community health worker training program’s application;
(ii)
Curriculum requirements;
(iii)
A process through which an individual working as a community health worker on October 1, 2018, and who already possesses the knowledge taught in a community health worker training program accredited by the Department under this section, may be exempted from the training required under § 13–3706(b)(1) of this subtitle;
(iv)
Requirements for periodic review of an accredited certified community health worker training program;
(v)
A process by which the Department shall notify a certified community health worker training program in operation on October 1, 2018, of any changes needed to comply with the Department’s accreditation requirements;
(vi)
A reasonable deadline before which a certified community health worker training program in operation on October 1, 2018, is required to comply with the Department’s accreditation requirements; and
(vii)
A process by which the Department may revoke a certified community health worker training program’s accreditation that allows for an adequate hearing and chance for appeal.
(b)
The Department, working in collaboration with the Advisory Committee, shall:
(1)
Adopt initial regulations for the certification of community health workers that establish:
(i)
That any individual who completes a community health worker training program accredited by the Department under subsection (a) of this section is a qualified community health worker applicant; and
(ii)
An initial fee for the certification of community health workers, not to exceed $75, which shall be adjusted as advised by the Advisory Committee;
(2)
Keep a current record of all certified community health workers;
(3)
Collect and account for fees provided for under this subtitle;
(4)
Pay all necessary expenses associated with certifying community health workers in accordance with the State budget;
(5)
Keep a complete record of proceedings relating to certified community health workers; and
(6)
Maintain a list of certified community health workers on its website to allow employers and consumers to verify the certification status of community health workers.
(c)
The Department may adopt regulations on the procedures for:
(1)
Denying a certification application;
(2)
Suspending and revoking certificates;
(3)
Renewing certificates; and
(4)
Otherwise regulating the certification of community health workers.
(d)
The Department may adopt any additional regulations recommended by the Advisory Committee for the certification of community health workers.
Md. Code Ann., Health-Gen. § 13-3706 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3706LinkCopy Citation
(a)
The Department may certify an individual to practice as a community health worker in the State.
(b)
To qualify for certification, an applicant shall:
(1)
(i)
Have completed a community health worker training program accredited by the Department under § 13–3705 of this subtitle; or
(ii)
Be exempted by the Department from the training required under item (i) of this item; and
(2)
Meet any other requirements established by the Department.
(c)
To apply for certification as a community health worker, an applicant shall:
(1)
Submit an application to the Department on the form that the Department requires; and
(2)
Pay any fee and submit any additional materials required by the Department.
(d)
The Department shall issue a certificate to any applicant who meets the requirements of subsection (b) of this section.
(e)
The Department shall include on each certificate that the Department issues:
(1)
The full name of the certificate holder;
(2)
The dates of issuance and expiration;
(3)
A serial number; and
(4)
The signature of the Department’s representative.
(f)
(1)
The Department shall establish a deadline after which an individual must be certified under this subtitle to make representations to the public that the individual is a certified community health worker.
(2)
On or after the date set under paragraph (1) of this subsection, unless certified as a community health worker under this subtitle, an individual may not represent to the public by title that the individual is certified as a community health worker.
(3)
An individual who violates paragraph (2) of this subsection is subject to a penalty determined and collected by the Department.
Md. Code Ann., Health-Gen. § 13-3707 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3707LinkCopy Citation
(a)
There is a State Community Health Workers Fund.
(b)
(1)
The Department may set fees as advised by the Advisory Committee.
(2)
Funds to cover the expenses of the Department relating to the certification of community health workers shall be generated by fees set under this subtitle.
(c)
(1)
The Department shall remit all fees collected under this subtitle to the Comptroller.
(2)
The Comptroller shall distribute the fees to the Fund.
(d)
(1)
The Fund shall be used to cover the actual documented direct and indirect costs of fulfilling the statutory and regulatory duties of the Department as provided under this subtitle.
(2)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(3)
Any unspent portion of the Fund may not be transferred or revert to the General Fund but shall remain in the Fund to be used for the purposes specified in this subtitle.
(4)
No other State money may be used to support the Fund.
(e)
(1)
A designee of the Department shall administer the Fund.
(2)
Money in the Fund may be expended only for any lawful purpose authorized under this subtitle.
Md. Code Ann., Health-Gen. § 13-3708 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3708LinkCopy Citation
A person shall have the immunity from liability described in § 5–702 of the Courts Article for giving information to the Department or the Advisory Committee or otherwise participating in activities of the Department or the Advisory Committee relating to community health workers.
Md. Code Ann., Health-Gen. § 13-3709 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 37. Community Health Workers
§ 13–3709LinkCopy Citation
This subtitle may be cited as the Maryland Community Health Workers Act.
Subtitle 39. Veteran Suicide Prevention
Md. Code Ann., Health-Gen. § 13-3901 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 39. Veteran Suicide Prevention
§ 13–3901LinkCopy Citation
(a)
The Department shall develop a comprehensive action plan to increase access to and availability of professional veteran health services to prevent veteran suicides that includes:
(1)
Short–term initiatives and reforms and a plan for State implementation beginning on or before July 1, 2021; and
(2)
Long–term initiatives and reforms and a plan for State implementation beginning on or before July 1, 2023.
(b)
The action plan developed under subsection (a) of this section shall:
(1)
Identify opportunities for raising awareness of and providing resources for veteran suicide prevention;
(2)
Identify opportunities to increase access to veteran mental health services;
(3)
Identify funding resources to provide accessible and affordable veteran mental health services;
(4)
Provide measures to expand public–private partnerships to ensure access to quality and timely mental health services;
(5)
Provide for proactive outreach measures to reach veterans needing care;
(6)
Provide for peer–to–peer service coordination, including training, certification, recertification, and continuing education for peer coordinators; and
(7)
Address suicide prevention awareness, measures, and training regarding veterans who are involved in the justice system.
(c)
The Department shall collaborate with interested parties in developing the plan required under subsection (a) of this section, including:
(1)
The Maryland Department of Veterans and Military Families;
(2)
The United States Department of Veterans Affairs;
(3)
The Service Members, Veterans, and their Families Technical Assistance Center Implementation Academy of the Substance Abuse and Mental Health Services Administration of the United States Department of Health and Human Services;
(4)
Veteran advocacy groups;
(5)
Medical providers; and
(6)
Any other interested party the Department considers appropriate.
(d)
(1)
The Department shall implement the short–term initiatives and reforms in the plan developed under subsection (a)(1) of this section on or before June 30, 2023.
(2)
The Department shall implement the long–term initiatives and reforms in the plan required under subsection (a)(2) of this section on or before June 30, 2029.
Subtitle 39A. Youth Suicide Prevention and Firearm Safe Storage
Md. Code Ann., Health-Gen. § 13-39A-01 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 39A. Youth Suicide Prevention and Firearm Safe Storage
§ 13–39A-01LinkCopy Citation
(a)
In this subtitle, “guide” means the youth suicide prevention and firearm safe storage guide developed under subsection (b) of this section.
(b)
On or before January 1, 2024, the Deputy Secretary for Public Health Services shall develop a youth suicide prevention and firearm safe storage guide.
(c)
The guide developed under subsection (b) of this section shall:
(1)
Provide a description of the firearm and ammunition requirements for safely storing firearms under State law;
(2)
Identify the risks associated with unsafe firearm storage for minors, including:
(i)
Suicide;
(ii)
Death or serious bodily injury from accidental discharge; and
(iii)
Shooting incidents involving minors; and
(3)
Incorporate best practices for firearm and ammunition safe storage.
(d)
The Department shall:
(1)
Post the guide on its website;
(2)
Make an electronic version of the guide available to families, health and social services providers, and any other entities that have an interest in youth suicide prevention or firearms storage, including:
(i)
Behavioral health programs;
(ii)
The Department of Juvenile Services;
(iii)
Firearms dealers licensed by the federal government;
(iv)
Local health departments;
(v)
Local school systems;
(vi)
The Maryland Association of Nonpublic Special Education Facilities;
(vii)
The Maryland Association of Youth Service Bureaus;
(viii)
State and local law enforcement agencies;
(ix)
The State Department of Education; and
(x)
Instructors who have been licensed or certified by the Department of State Police to teach firearm safety training courses; and
(3)
Provide grants to local school systems, local health departments, and nonprofit agencies to support the education of families on the safe storage practices recommended in the guide.
Subtitle 40. Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program
Md. Code Ann., Health-Gen. § 13-4001 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 40. Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program
§ 13–4001LinkCopy Citation
In this subtitle, “Program” means the Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program.
Md. Code Ann., Health-Gen. § 13-4002 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 40. Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program
§ 13–4002LinkCopy Citation
(a)
There is a Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program in the Department.
(b)
The Department shall administer the Program.
(c)
The Department may adopt regulations to implement this subtitle.
Md. Code Ann., Health-Gen. § 13-4003 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 40. Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program
§ 13–4003LinkCopy Citation
(a)
The purpose of the Program is to provide grants to local fire departments and volunteer fire companies and departments to procure innovative cancer screening tests that are not otherwise conducted during routine physical examinations or covered by insurance to professional firefighters employed by a local fire department and volunteer firefighters who serve in a volunteer fire company or department.
(b)
The goal of the Program is to reduce cancer mortality among professional and volunteer firefighters while advancing the adoption of novel technologies that may also benefit the health of Marylanders and the economy of the State.
Md. Code Ann., Health-Gen. § 13-4004 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 40. Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program
§ 13–4004LinkCopy Citation
(a)
(1)
A local fire department or a volunteer fire company or department may apply to the Department for a grant under the Program.
(2)
The county in which a volunteer fire company or department is located shall assist volunteer fire companies or departments in filing applications under paragraph (1) of this subsection.
(b)
Each year, the Department shall issue a request for applications from local fire departments and volunteer fire companies or departments for grants offered under the Program.
(c)
An application submitted in accordance with subsection (b) of this section shall include, at minimum:
(1)
The names and qualifications of competent health care providers that are advising the applicant on the selection and administration of cancer screening tests;
(2)
The number of firefighters proposed to be screened and the criteria for selecting those firefighters that the applicant has determined to be at the highest cancer risk based on the latest scientific and medical research reports; and
(3)
A description of each test proposed to be procured by the applicant, including:
(i)
The claimed accuracy and reliability of the test;
(ii)
The scientific and clinical evidence supporting the claimed accuracy and reliability;
(iii)
Whether the test employs innovative or novel technologies, such as DNA sequencing, genomics, proteomics, metabolomics, machine learning, artificial intelligence, big data analytics, or other state–of–the–art technology;
(iv)
Whether the test has the ability to simultaneously screen for two or more cancer types for which firefighters have a higher incidence or death rate;
(v)
The cost of the test; and
(vi)
Whether the test is developed, manufactured, or commercialized by a business entity located in the State.
Md. Code Ann., Health-Gen. § 13-4005 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 40. Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program
§ 13–4005LinkCopy Citation
(a)
The Department shall develop a weighting formula by which to rate each application received under § 13–4004 of this subtitle.
(b)
Subject to subsection (c) of this section, the Department shall prioritize awarding grants to applicants based on the quality of the application and the degree to which the tests proposed to be procured by the applicant meet the following criteria:
(1)
The scientific and clinical evidence supporting the claimed accuracy and reliability of the test;
(2)
Whether the test employs innovative or novel technologies;
(3)
The ability of the test to simultaneously screen for two or more cancer types;
(4)
The cost–effectiveness of the test; and
(5)
Whether the test is developed, manufactured, or commercialized by a business entity located in the State.
(c)
If the Department receives applications for grants totaling more than the amount of funds appropriated for the Program for a fiscal year, the Department shall award the grants on a pro rata basis.
Md. Code Ann., Health-Gen. § 13-4006 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 40. Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program
§ 13–4006LinkCopy Citation
(a)
(1)
For fiscal years 2021 through 2024, the Governor shall include at least $100,000 in the annual budget for the Program.
(2)
For fiscal year 2025 and each fiscal year thereafter, the Governor may include at least $1,000,000 in the annual budget for the Program.
(b)
Appropriations and expenditures made for the purpose of implementing the Program, including the use of any funds received by a person under any component of the Program, are subject to audit by the Office of Legislative Audits as provided in § 2–1220 of the State Government Article.
(c)
The Secretary may use up to 20% of Program funds to support research centers, including the University of Maryland Institute for Health Computing, in the collection, analysis, and processing of Program outcome data for the purposes of assessing, maximizing, and improving the effectiveness and clinical utility of the cancer screening funded by the Program.
Md. Code Ann., Health-Gen. § 13-4007 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 40. Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Program
§ 13–4007LinkCopy Citation
On or before December 1, 2020, and each December 1 thereafter, the Department shall report, in accordance with § 2–1257 of the State Government Article, to the Senate Finance Committee and the House Health and Government Operations Committee on:
(1)
The number of individuals who have been screened through the Program;
(2)
The types of tests used to screen those individuals;
(3)
The costs of the tests; and
(4)
The types of cancers detected by the tests.
Subtitle 41. Maryland Children's Service Animal Program
Md. Code Ann., Health-Gen. § 13-4101 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 41. Maryland Children's Service Animal Program
§ 13–4101LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Direct threat” has the meaning stated in the federal Americans with Disabilities Act.
(c)
“Eligible child” means a child who has a history of trauma, has been diagnosed with post–traumatic stress disorder, or has been diagnosed with a developmental disability and special health care need under Title V of the Social Security Act.
(d)
“Fund” means the Maryland Children’s Service Animal Program Fund established under § 13–4105 of this subtitle.
(e)
“Nonprofit training entity” means a corporation, a foundation, or any other legal entity that:
(1)
Is qualified under § 501(c)(3) of the Internal Revenue Code;
(2)
(i)
Engages in the training of service dogs or support dogs for use by children; or
(ii)
Uses trained therapy horses for interaction with children; and
(3)
Has been selected by the Department to provide services under this subtitle.
(f)
“Program” means the Maryland Children’s Service Animal Program established under § 13–4102 of this subtitle.
(g)
“Program participant” means an eligible child who participates in the Program.
(h)
“Successful Program participant” means a Program participant who successfully completes the training or therapy protocol specified by a nonprofit training entity.
Md. Code Ann., Health-Gen. § 13-4102 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 41. Maryland Children's Service Animal Program
§ 13–4102LinkCopy Citation
(a)
There is a Maryland Children’s Service Animal Program in the Department.
(b)
The purposes of the Program are to:
(1)
Refer eligible children who may benefit from participation in the Program to one or more nonprofit training entities;
(2)
Provide additional funding mechanisms to assist children participating in the Program; and
(3)
Expand treatment of children with a history of trauma or post–traumatic stress disorder or with a developmental disability and special health care need under Title V of the Social Security Act.
Md. Code Ann., Health-Gen. § 13-4103 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 41. Maryland Children's Service Animal Program
§ 13–4103LinkCopy Citation
(a)
The Department shall select at least one nonprofit training entity to:
(1)
Implement a training or therapy protocol for the purposes of the Program that will teach each Program participant methodologies, strategies, and techniques for:
(i)
Partnering with a service dog or support dog; or
(ii)
Interacting with therapy horses;
(2)
Select qualified Program participants from those eligible children referred to the nonprofit entity under the Program;
(3)
Select an appropriate service dog, support dog, or therapy horse, as applicable, for each Program participant;
(4)
Facilitate each Program participant’s training or therapy using the nonprofit training entity’s training or therapy protocol; and
(5)
Unless the nonprofit training entity uses trained therapy horses, partner each successful Program participant with the service dog or support dog on the Program participant’s successful completion of the nonprofit training entity’s training protocol.
(b)
To be eligible for selection under subsection (a) of this section, a nonprofit entity must:
(1)
Be based in the State;
(2)
Serve the needs of children with a history of trauma or post–traumatic stress disorder or with a developmental disability and special health care need under Title V of the Social Security Act; and
(3)
Generate its own revenue and reinvest the proceeds of that revenue in the growth and development of its programs.
Md. Code Ann., Health-Gen. § 13-4104 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 41. Maryland Children's Service Animal Program
§ 13–4104LinkCopy Citation
(a)
A nonprofit training entity may disqualify a Program participant from participation in the Program if the nonprofit training entity determines that the Program participant’s involvement in the Program:
(1)
Presents a danger to the Program participant’s mental or physical well–being;
(2)
Presents a direct threat to others;
(3)
Presents a direct threat to the mental or physical well–being of the service dog, support dog, or therapy horse; or
(4)
Does not meet the training requirements of the nonprofit training entity.
(b)
A Program participant may discontinue involvement in the Program for any reason.
Md. Code Ann., Health-Gen. § 13-4105 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 41. Maryland Children's Service Animal Program
§ 13–4105LinkCopy Citation
(a)
There is a Maryland Children’s Service Animal Program Fund.
(b)
The Department shall use revenue from the Fund to pay a nonprofit training entity.
(c)
Revenue from the Fund may be used only to pay:
(1)
A nonprofit training entity; and
(2)
Administrative costs of the Program.
(d)
The Secretary shall administer the Fund.
(e)
(1)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(2)
The State Treasurer shall hold the fund separately, and the Comptroller shall account for the Fund.
(f)
The Fund consists of:
(1)
Revenue collected by the Department in the form of donations to the Program;
(2)
Money appropriated in the State budget to the Fund; and
(3)
Any other money from any other source accepted for the benefit of the Fund.
(g)
The State Treasurer shall invest the money of the Fund in the same manner as other State money may be invested.
(h)
Any interest earnings of the Fund shall be credited to the General Fund of the State.
(i)
Money expended from the Fund is supplemental to and is not intended to take the place of funding that otherwise would be appropriated for the Program.
Md. Code Ann., Health-Gen. § 13-4106 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 41. Maryland Children's Service Animal Program
§ 13–4106LinkCopy Citation
The Department shall adopt regulations to carry out this subtitle.
Subtitle 42. Maryland Behavioral Health and Public Safety Center of Excellence
Md. Code Ann., Health-Gen. § 13-4201 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 42. Maryland Behavioral Health and Public Safety Center of Excellence
§ 13–4201LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Center” means the Maryland Behavioral Health and Public Safety Center of Excellence established under § 13–4202 of this subtitle.
(c)
“Maryland HBCU” means the following historically black colleges and universities:
(1)
Bowie State University;
(2)
Coppin State University;
(3)
Morgan State University; and
(4)
University of Maryland Eastern Shore.
(d)
“Racial impact analysis” means a systematic examination of how racial minorities are or will be impacted by existing or proposed models, plans, policies, strategies, programs, processes, or recommendations.
(e)
“Racial minority” means:
(1)
Black or African American;
(2)
Hispanic or Latino;
(3)
Indigenous, American Indian, or Alaska Native;
(4)
Asian; or
(5)
Native Hawaiian or Pacific Islander.
(f)
“Sequential Intercept Model” means a systems–level framework for criminal justice and behavioral health stakeholders to prevent entrance into the criminal justice system, minimize penetration into the criminal justice system, and engage individuals with behavioral health services and recovery supports as they transition into the community from the criminal justice system.
Md. Code Ann., Health-Gen. § 13-4202 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 42. Maryland Behavioral Health and Public Safety Center of Excellence
§ 13–4202LinkCopy Citation
(a)
There is a Maryland Behavioral Health and Public Safety Center of Excellence in the Governor’s Office of Crime Prevention and Policy.
(b)
The purposes of the Center are to:
(1)
Act as the statewide information repository for behavioral health treatment and diversion programs related to the criminal justice system;
(2)
Lead the development of a strategic plan to increase treatment and reduce the detention of individuals with behavioral health disorders involved in the criminal justice system;
(3)
Provide technical assistance to local governments for developing effective behavioral health systems of care that prevent and minimize involvement with the criminal justice system for individuals with behavioral health disorders;
(4)
Facilitate local or regional planning workshops using the Sequential Intercept Model;
(5)
Coordinate with the Department and the Behavioral Health Administration to implement and track the progress of creating an effective behavioral health system of care in the State relating to individuals involved in the criminal justice system; and
(6)
Identify and inform any relevant stakeholders of any federal funding available to the Center to carry out the mission of the Center, including through the provision of grants, scholarships, and other funding to recipients engaged in training, the provision of services, or the study of matters relating to behavioral health, public safety, and criminal justice.
(c)
In carrying out its duties, the Center shall continuously monitor and analyze its models, plans, policies, strategies, programs, technical assistance, and training for their validity and for opportunities to reduce and eliminate disparities in the criminalization of racial minorities with behavioral health disorders and increase access to culturally competent care.
(d)
(1)
The Governor’s Office of Crime Prevention and Policy shall appoint the following individuals to jointly oversee the Center:
(i)
A crisis intervention law enforcement coordinator;
(ii)
A mental health coordinator; and
(iii)
Any other individuals determined necessary by the Office.
(2)
The individuals appointed under paragraph (1) of this subsection may be associated with the Crisis Intervention Team Center of Excellence within the Governor’s Office of Crime Prevention and Policy.
(e)
The Center may designate points of contact throughout the State who specialize in behavioral health treatment within the criminal justice system to brief the Center on the progress of statewide implementation of diversion programs.
(f)
The Center may coordinate with the Justice Reinvestment Oversight Board and other State entities working to reduce State and local detention facility populations and recidivism.
(g)
(1)
The Center may enter into contracts with the University of Maryland System, Maryland HBCUs, or other entities or organizations for the purposes of carrying out its mission.
(2)
For fiscal year 2024 and each fiscal year thereafter, the Governor shall include in the annual budget bill an appropriation of $500,000 for the Center to enter into contracts for the purposes of carrying out its mission, including:
(i)
Facilitating the gathering of information from all counties in the State;
(ii)
Supporting local or regional planning workshops; and
(iii)
Supporting the purposes of the Center established under subsection (b) of this section.
(h)
The operation of the Center is subject to the limitations of the State budget.
Md. Code Ann., Health-Gen. § 13-4203 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 42. Maryland Behavioral Health and Public Safety Center of Excellence
§ 13–4203LinkCopy Citation
(a)
The activities of the Center shall include:
(1)
Strategic planning;
(2)
Technical assistance;
(3)
State and local government coordination; and
(4)
Facilitating the provision of train–the–trainer courses for the Sequential Intercept Model for completion in 2021 in partnership with the federal Substance Abuse and Mental Health Services Administration, with the goal of training 50 individuals in the State as facilitators.
(b)
The Center shall provide technical assistance to local governments for the purposes of:
(1)
Sharing best practices across jurisdictions;
(2)
Applying for grants to support work related to behavioral health, public safety, or criminal justice;
(3)
Facilitating the distribution of resources, technical assistance, and training in best practices related to behavioral health, public safety, or criminal justice; and
(4)
Facilitating local and regional Sequential Intercept Model Summits.
(c)
The Center shall develop the following:
(1)
A statewide model for law enforcement–assisted diversion;
(2)
Recommendations for pretrial services;
(3)
Procedures for sharing deflection and diversion statistics between relevant State agencies;
(4)
Recommendations for statewide implementation of law enforcement–assisted diversion programs; and
(5)
A statewide model for community crisis intervention services other than law enforcement.
(d)
(1)
The Center shall host one State Sequential Intercept Model Summit each year for the purpose of sharing best practices across jurisdictions and tracking the progression of Maryland’s community health and public safety system.
(2)
It is the intent of the General Assembly that the Center apply to the federal Substance Abuse and Mental Health Services Administration for grant funding to hold subsequent State Sequential Intercept Model Summits annually.
(e)
The Center shall support county or regional Sequential Intercept Model mapping workshops and summarize results in reports that inform cross–agency planning and program development.
(f)
The Center shall implement systems and policies that establish a regional approach to community health and public safety, including by:
(1)
Facilitating multijurisdictional applications for federal behavioral health and criminal justice grants;
(2)
Coordinating and connecting similar programs across multiple jurisdictions; and
(3)
Assisting localities in broadening and formalizing county–level collaboration in behavioral health, public safety, and criminal justice.
Md. Code Ann., Health-Gen. § 13-4204 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 42. Maryland Behavioral Health and Public Safety Center of Excellence
§ 13–4204LinkCopy Citation
(a)
On or before December 1 each year, beginning in 2022, the Center shall produce and update a multiyear strategic plan to implement the recommendations of the report of the annual State Sequential Intercept Model Summit.
(b)
The strategic plan shall include:
(1)
A plan for formal, consistent, appropriate, and coordinated behavioral health screening processes that are properly applied at jail booking, including expanded behavioral health screening for veterans;
(2)
Recommendations for the coordination of behavioral health and criminal justice initiatives with related State health initiatives;
(3)
Recommendations for investment in preventive services systems including:
(i)
Assertive community treatment;
(ii)
Crisis response services;
(iii)
Harm reduction strategies; and
(iv)
Other preventive services for individuals with behavioral health disorders;
(4)
An expansion of the use of technology and data analysis across the behavioral health, public safety, and criminal justice systems in accordance with the purposes of the Center;
(5)
A plan for expanding the use of peer support services across intercepts; and
(6)
A racial impact analysis.
(c)
In developing the strategic plan, the Center shall consider:
(1)
Opportunities for the provision of pre–crisis–to–recovery services to individuals with behavioral health disorders who are involved in the criminal justice system;
(2)
The availability of housing options for individuals with behavioral health disorders who are involved with the criminal justice system; and
(3)
The availability of transportation for individuals with behavioral health disorders who are involved with the criminal justice system.
Md. Code Ann., Health-Gen. § 13-4205 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 42. Maryland Behavioral Health and Public Safety Center of Excellence
§ 13–4205LinkCopy Citation
(a)
Each local jurisdiction in the State shall develop a 2–year community health and public safety plan in collaboration with:
(1)
The Center;
(2)
The local health department;
(3)
The local department of human services;
(4)
Behavioral health coordinators for the local school system;
(5)
The local health improvement council;
(6)
Community–based behavioral health providers;
(7)
A representative of the NAACP;
(8)
A representative of public defenders; and
(9)
Other key stakeholders.
(b)
The plan shall include:
(1)
An assessment of the capacity of the local behavioral system;
(2)
Recommendations for the enhancement of the local crisis response system;
(3)
Recommendations for the enhancement of the local behavioral health care system, including culturally competent care;
(4)
An analysis of available federal grant funds available to the county or jurisdiction; and
(5)
A racial impact analysis.
(c)
A local jurisdiction is encouraged to use an existing local planning and coordinating committee or local management board to satisfy the requirements of this section.
Md. Code Ann., Health-Gen. § 13-4206 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 42. Maryland Behavioral Health and Public Safety Center of Excellence
§ 13–4206LinkCopy Citation
It is the intent of the General Assembly that the Center, to the extent practicable, identify opportunities to fund:
(1)
Behavioral health crisis grants;
(2)
Training for 9–1–1 operators;
(3)
Peer support services;
(4)
Behavioral health screenings;
(5)
Scholarships for students who attend a Maryland HBCU to study behavioral health–, public safety–, or criminal justice–related issues; and
(6)
Behavioral health initiatives in rural communities.
Subtitle 43. Maryland Commission on Health Equity
Md. Code Ann., Health-Gen. § 13-4301 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 43. Maryland Commission on Health Equity
§ 13–4301LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Commission” means the Maryland Commission on Health Equity.
(c)
“Health equity framework” means a public health framework through which policymakers and stakeholders in the public and private sectors use a collaborative approach to improve health outcomes and reduce health inequities in the State by incorporating health considerations into decision making across sectors and policy areas.
(d)
“Statewide health equity plan” means the equity plan required under a cooperative grant funding agreement with the Center for Medicare and Medicaid Innovation.
Md. Code Ann., Health-Gen. § 13-4302 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 43. Maryland Commission on Health Equity
§ 13–4302LinkCopy Citation
There is a Maryland Commission on Health Equity.
Md. Code Ann., Health-Gen. § 13-4303 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 43. Maryland Commission on Health Equity
§ 13–4303LinkCopy Citation
(a)
The Commission consists of the following members:
(1)
One member of the Senate, appointed by the President of the Senate;
(2)
One member of the House of Delegates, appointed by the Speaker of the House;
(3)
The Secretary, or the Secretary’s designee;
(4)
The Secretary of Aging, or the Secretary’s designee;
(5)
The Secretary of Budget and Management, or the Secretary’s designee;
(6)
The Secretary of Disabilities, or the Secretary’s designee;
(7)
The State Superintendent of Schools, or the State Superintendent’s designee;
(8)
The Secretary of Housing and Community Development, or the Secretary’s designee;
(9)
The Secretary of Human Services, or the Secretary’s designee;
(10)
The Secretary of Planning, or the Secretary’s designee;
(11)
The Deputy Secretary for Behavioral Health, or the Deputy Secretary’s designee;
(12)
The Deputy Secretary for Public Health Services, or the Deputy Secretary’s designee;
(13)
The Deputy Secretary for Health Care Financing, or the Deputy Secretary’s designee;
(14)
The Maryland Insurance Commissioner, or the Insurance Commissioner’s designee;
(15)
The Executive Director of the Health Services Cost Review Commission, or the Executive Director’s designee;
(16)
The Executive Director of the Office of Minority Health and Health Disparities, or the Executive Director’s designee;
(17)
The Executive Director of the Maryland Health Care Commission, or the Executive Director’s designee;
(18)
The Executive Director of the Maryland Community Health Resources Commission, or the Executive Director’s designee;
(19)
One representative of a local health department, designated by the Maryland Association of County Health Officers; and
(20)
The following members, appointed by the Secretary with the advice of the Health Services Cost Review Commission:
(i)
At least one representative of hospitals in the State;
(ii)
At least two individuals with experience in hospital–based population health;
(iii)
At least one representative of a federally qualified health center in the State;
(iv)
At least two representatives of community–based organizations;
(v)
At least two patients from underserved communities;
(vi)
At least one representative of a managed care organization;
(vii)
At least one representative of a commercial health insurer;
(viii)
At least two representatives of clinicians and providers who are not affiliated with a hospital or a federally qualified health center;
(ix)
At least one representative from the State Rural Health Office; and
(x)
At least one representative of a tribal community in the State.
(b)
To the extent practicable, the members appointed to the Commission shall reflect the geographic, racial, ethnic, cultural, and gender diversity of the State.
(c)
A majority of the members present at a meeting shall constitute a quorum.
(d)
(1)
Subject to paragraph (2) of this subsection, the Commission shall determine the times, places, and frequency of its meetings.
(2)
The Commission shall meet at least four times each year.
Md. Code Ann., Health-Gen. § 13-4304 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 43. Maryland Commission on Health Equity
§ 13–4304LinkCopy Citation
(a)
The Secretary, or the Secretary’s designee, and the Executive Director of the Health Services Cost Review Commission, or the Executive Director’s designee, shall cochair the Commission.
(b)
A member of the Commission:
(1)
May not receive compensation as a member of the Commission; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(c)
The Department shall provide staff support for the Commission.
Md. Code Ann., Health-Gen. § 13-4305 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 43. Maryland Commission on Health Equity
§ 13–4305LinkCopy Citation
(a)
The purpose of the Commission is to:
(1)
Employ a health equity framework to:
(i)
Develop a statewide health equity plan; and
(ii)
Examine:
(1)
The health of residents of the State to the extent necessary to carry out the requirements of this section;
(2)
Ways for units of State and local government to collaborate to implement policies that will positively impact the health of residents of the State; and
(3)
The impact of the following factors on the health of residents of the State:
(A)
Access to safe and affordable housing;
(B)
Educational attainment;
(C)
Opportunities for employment;
(D)
Economic stability;
(E)
Environmental factors;
(F)
Public safety, including the impact of crime, citizen unrest, the criminal justice system, and governmental policies that affect individuals who are in prison or released from prison; and
(G)
Food insecurity;
(2)
Provide direct advice to the Secretary and the State’s independent health regulatory commissions, and indirect advice to the Department’s senior administrators and planners through the Secretary, regarding issues of racial, ethnic, cultural, or socioeconomic health disparities;
(3)
Facilitate coordination of the expertise and experience of the State’s health and human services, housing, transportation, education, environment, community development, and labor systems in developing a comprehensive health equity plan addressing the social determinants of health; and
(4)
Set goals for health equity and prepare a plan for the State to achieve health equity in alignment with any other statewide planning activities.
(b)
The Commission, using a health equity framework, shall:
(1)
Examine and make recommendations regarding:
(i)
Health considerations that may be incorporated into the decision–making processes of government agencies and private sector stakeholders who interact with government agencies;
(ii)
Requirements for implicit bias training for clinicians engaged in patient care and whether the State should provide the training;
(iii)
Training for health care providers on consistent and proper collection of patient self–identified race, ethnicity, and language data to identify disparities accurately; and
(iv)
Requirements to comply with, and for enforcement of, National Standards for Culturally and Linguistically Appropriate Services in Health and Health Care (CLAS Standards);
(2)
Foster collaboration between units of the State and local government and develop policies to improve health and reduce health inequities;
(3)
Identify measures for monitoring and advancing health equity in the State;
(4)
Establish a State plan for achieving health equity in alignment with other statewide planning activities in coordination with the State’s health and human services, housing, transportation, education, environment, community development, and labor systems;
(5)
Make recommendations and provide advice, including direct advice to the Secretary, on implementing laws and policies to improve health and reduce health inequities; and
(6)
Develop and monitor a statewide health equity plan as required by the Center for Medicare and Medicaid Innovation under any agreement entered into between the State and the Centers for Medicare and Medicaid Services.
(c)
(1)
The Commission may establish advisory committees to assist the Commission in the performance of its duties under this section.
(2)
An advisory committee established under this subsection may include individuals who are not members of the Commission.
Md. Code Ann., Health-Gen. § 13-4306 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 43. Maryland Commission on Health Equity
§ 13–4306LinkCopy Citation
(a)
(1)
The Commission shall, in coordination with the Department, the Health Services Cost Review Commission, and the State designated health information exchange, establish an advisory committee to make recommendations on data collection, needs, quality, reporting, evaluation, and visualization for the Commission to carry out the purposes of this subtitle.
(2)
The advisory committee shall include representatives from the State designated health information exchange.
(3)
The advisory committee shall define the parameters of a health equity data set to be maintained by the State designated health information exchange, including indicators for:
(i)
Social and economic conditions;
(ii)
Environmental conditions;
(iii)
Health status;
(iv)
Behaviors;
(v)
Health care; and
(vi)
Priority health outcomes for monitoring health equity for racial and ethnic minority populations in the State.
(4)
The data set for which parameters are defined under paragraph (3) of this subsection shall include data from:
(i)
Health care facilities that report to the Health Services Cost Review Commission;
(ii)
Health care payers that report to the Maryland Health Care Commission; and
(iii)
Any other data source the advisory committee determines necessary.
(5)
Data shall be reported in the aggregate if it is reported:
(i)
To the public; or
(ii)
From the State designated health information exchange to the Commission.
(6)
If the advisory committee makes a recommendation that data be made available to the public, the recommendation shall comply with applicable federal and State privacy law.
(b)
(1)
The Commission may request data consistent with the recommendations of the advisory committee.
(2)
Data requested by the Commission under paragraph (1) of this subsection shall be provided, to the extent authorized by federal and State privacy law, to:
(i)
The Commission; or
(ii)
The State designated exchange.
(c)
The Commission may publish or provide to the public any data collected under this section consistent with the recommendations of the advisory committee established under subsection (a) of this section.
Md. Code Ann., Health-Gen. § 13-4307 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 43. Maryland Commission on Health Equity
§ 13–4307LinkCopy Citation
On or before December 1 each year, the Commission shall submit a report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on the activities of the Commission.
Subtitle 44. Cannabis Use Baseline Study
Md. Code Ann., Health-Gen. § 13-4401 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 44. Cannabis Use Baseline Study
§ 13–4401LinkCopy Citation
(a)
The Natalie M. LaPrade Medical Cannabis Commission, in consultation with the Department, the Behavioral Health Administration, the Governor’s Office of Crime Prevention and Policy, the Maryland Poison Center, the State’s designated Health Information Exchange, and the Maryland Hospital Association, shall conduct, or contract with an institution of higher education or a private research entity to conduct, a comprehensive baseline study of cannabis use in the State that includes a survey of:
(1)
Patterns of use, including frequency of use and dosing, methods of consumption, and general perceptions of cannabis among:
(i)
Individuals under the age of 18 years;
(ii)
Individuals at least 18 years old and under the age of 21 years;
(iii)
Individuals at least 21 years old and under the age of 55 years;
(iv)
Individuals at least 55 years old;
(v)
Pregnant women; and
(vi)
Breastfeeding women;
(2)
Incidents of impaired driving, including arrests, accidents, and fatalities, related to cannabis use;
(3)
Hospitalizations related to cannabis use;
(4)
Calls to poison control centers related to cannabis use, including data on calls related to individuals under the age of 21 years; and
(5)
Diagnoses of cannabis use disorder and problem cannabis use.
(b)
On or before March 1, 2023, the Natalie M. LaPrade Medical Cannabis Commission shall submit a report of the findings of the baseline study conducted under subsection (a) of this section to the Governor and, in accordance with § 2–1257 of the State Government Article, the Senate Finance Committee, the Senate Judicial Proceedings Committee, the House Judiciary Committee, and the House Health and Government Operations Committee.
(c)
On or before March 1, 2025, and every other year thereafter, the Natalie M. LaPrade Medical Cannabis Commission shall:
(1)
Survey the same factors that are set forth in subsection (a) of this section;
(2)
Use the same methodology or model that is used to conduct the survey required under subsection (a) of this section; and
(3)
Submit a report of the findings of the survey required under this subsection to the Governor and, in accordance with § 2–1257 of the State Government Article, the Senate Finance Committee, the Senate Judicial Proceedings Committee, the House Judiciary Committee, and the House Health and Government Operations Committee.
Subtitle 45. Cannabis Public Health Advisory Council
Md. Code Ann., Health-Gen. § 13-4501 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 45. Cannabis Public Health Advisory Council
§ 13–4501LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Advisory Council” means the Cannabis Public Health Advisory Council.
(c)
“Fund” means the Cannabis Public Health Fund.
Md. Code Ann., Health-Gen. § 13-4502 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 45. Cannabis Public Health Advisory Council
§ 13–4502LinkCopy Citation
(a)
There is a Cannabis Public Health Advisory Council.
(b)
The Advisory Council consists of the following members:
(1)
One member from the Senate of Maryland, appointed by the President of the Senate;
(2)
One member from the House of Delegates, appointed by the Speaker of the House;
(3)
The Secretary, or the Secretary’s designee;
(4)
The Deputy Secretary for Behavioral Health, or the Deputy Secretary’s designee;
(5)
The Director of the Maryland Cannabis Administration, or the Director’s designee;
(6)
The State Superintendent of Schools, or the State Superintendent’s designee;
(7)
The Executive Director of the Governor’s Office of Crime Prevention and Policy, or the Executive Director’s designee;
(8)
The Administrator of the Motor Vehicle Administration, or the Administrator’s designee;
(9)
The Executive Director of the Office of Social Equity in the Department of Social and Economic Mobility, or the Executive Director’s designee; and
(10)
The following members appointed by the Governor:
(i)
One representative from a historically black college or university;
(ii)
One health care provider with experience in cannabis;
(iii)
One pharmacist licensed in the State;
(iv)
One health care provider with expertise in substance use disorder treatment and recovery;
(v)
One individual with expertise in cannabis use disorder;
(vi)
One academic researcher with expertise in cannabis law and policy;
(vii)
One individual with at least 5 years of experience in health or social equity;
(viii)
One public health professional with cannabis experience; and
(ix)
One representative of a laboratory that tests cannabis.
(c)
(1)
To the extent practicable and consistent with federal and State law, the membership of the Advisory Council shall reflect the gender, ethnic, and racial diversity of the State.
(2)
The membership of the Advisory Council shall include residents of rural and urban regions of the State.
(d)
A member of the Advisory Council shall file a financial disclosure statement with the State Ethics Commission in accordance with Title 5, Subtitle 6 of the General Provisions Article.
(e)
(1)
The term of an appointed member is 4 years.
(2)
The terms of the appointed members are staggered as required by the terms provided for the appointed members of the Advisory Council on January 1, 2023.
(3)
At the end of a term, an appointed member continues to serve until a successor is appointed and qualifies.
(4)
A member who is appointed after a term has begun serves only for the rest of the term and until a successor is appointed and qualifies.
(5)
An appointed member may not serve more than two consecutive full terms.
Md. Code Ann., Health-Gen. § 13-4503 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 45. Cannabis Public Health Advisory Council
§ 13–4503LinkCopy Citation
(a)
The chair of the Advisory Council shall be elected by the members of the Advisory Council.
(b)
A majority of the members then serving on the Advisory Council is a quorum.
(c)
The Advisory Council shall meet at least four times each year, at the times and places that the Advisory Council determines.
(d)
The Advisory Council may form workgroups to assist in the work of the Advisory Council.
(e)
A member of the Advisory Council:
(1)
May not receive compensation as a member of the Advisory Council; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(f)
The Department shall provide staff support and technical assistance for the Advisory Council.
Md. Code Ann., Health-Gen. § 13-4504 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 45. Cannabis Public Health Advisory Council
§ 13–4504LinkCopy Citation
(a)
The Advisory Council shall study and make recommendations regarding:
(1)
The promotion of public health and mitigation of youth use of, misuse of, and addiction to cannabis;
(2)
Data collection and reporting of data that measures the impact of cannabis consumption and legalization;
(3)
The impact of cannabis legalization on the education, behavioral health, and somatic health of individuals under the age of 21 years;
(4)
Initiatives to prevent cannabis use by individuals under the age of 21 years, including educational programs for use in schools;
(5)
Public health campaigns on cannabis;
(6)
Advertising, labeling, product testing, and quality control requirements;
(7)
Training for health care providers related to cannabis use;
(8)
Best practices regarding requirements to reduce the appeal of cannabis to minors, including advertising, potency, packaging, and labeling standards; and
(9)
Any other issues that advance public health related to cannabis use and legalization.
(b)
To the extent practicable, the Advisory Council shall consider any data collected by the State related to cannabis use when making recommendations, including data collected under § 13–4401 of this title.
Md. Code Ann., Health-Gen. § 13-4505 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 45. Cannabis Public Health Advisory Council
§ 13–4505LinkCopy Citation
(a)
There is a Cannabis Public Health Fund.
(b)
The purpose of the Fund is to provide funding to address the health effects associated with the legalization of adult–use cannabis.
(c)
The Department shall administer the Fund.
(d)
(1)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(2)
The State Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(e)
The Fund consists of:
(1)
Revenue distributed to the Fund based on revenues from adult–use cannabis;
(2)
Money appropriated in the State budget to the Fund;
(3)
Revenue distributed to the Fund in accordance with § 2–1302.2 of the Tax – General Article; and
(4)
Any other money from any other source accepted for the benefit of the Fund.
(f)
The Fund may be used only for:
(1)
Supporting the Advisory Council in performing its duties;
(2)
Supporting data collection and research on the effects of cannabis legalization in the State;
(3)
Providing funding for education and public awareness campaigns related to cannabis use, including funding for educational programs to be used in schools;
(4)
Supporting substance use disorder counseling and treatment for individuals;
(5)
Training and equipment for law enforcement to recognize impairments due to cannabis; and
(6)
Purchasing technology proven to be effective at measuring cannabis levels in drivers.
(g)
(1)
The State Treasurer shall invest the money of the Fund in the same manner as other State money may be invested.
(2)
Any interest earnings of the Fund shall be credited to the Fund.
(h)
Expenditures from the Fund may be made only in accordance with the State budget.
Md. Code Ann., Health-Gen. § 13-4506 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 45. Cannabis Public Health Advisory Council
§ 13–4506LinkCopy Citation
On or before December 1 each year, the Advisory Council shall report its findings and recommendations to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly.
Subtitle 47. Abortion Care Clinical Training Program
Md. Code Ann., Health-Gen. § 13-4701 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 47. Abortion Care Clinical Training Program
§ 13–4701LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Fund” means the Abortion Care Clinical Training Program Fund.
(c)
“Program” means the Abortion Care Clinical Training Program.
Md. Code Ann., Health-Gen. § 13-4702 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 47. Abortion Care Clinical Training Program
§ 13–4702LinkCopy Citation
There is an Abortion Care Clinical Training Program in the Department.
Md. Code Ann., Health-Gen. § 13-4703 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 47. Abortion Care Clinical Training Program
§ 13–4703LinkCopy Citation
The purpose of the Program is to protect access to abortion care by ensuring that there are a sufficient number of health professionals to provide abortion care.
Md. Code Ann., Health-Gen. § 13-4704 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 47. Abortion Care Clinical Training Program
§ 13–4704LinkCopy Citation
(a)
(1)
The Department shall contract with a coordinating organization to administer the Program.
(2)
The Department shall use funds appropriated in the budget for the Program to contract with the coordinating organization under paragraph (1) of this subsection.
(b)
The coordinating organization shall:
(1)
Have demonstrated experience in coordinating abortion care training programs at community–based and hospital–based provider sites;
(2)
Be a nonprofit entity;
(3)
Be in good standing in any state or jurisdiction in which the organization is registered or incorporated;
(4)
Submit an annual report to the Department on the performance of the Program;
(5)
Meet any other requirements established by the Department if the requirements are not inconsistent with Title 20, Subtitle 2 of this article; and
(6)
Perform the following functions:
(i)
Administer grants to develop and sustain abortion care training programs at a minimum of two community–based provider sites;
(ii)
Administer grants if funding is available to:
(1)
Other community–based sites;
(2)
Hospital–based provider sites;
(3)
Continuing education programs for qualified providers through professional associations or other clinical education programs; and
(4)
Establish training program requirements that:
(A)
Are consistent with evidence–based training standards;
(B)
Comply with any applicable State law and regulations; and
(C)
Focus on the provision of culturally congruent care and include implicit bias training;
(iii)
Support abortion care clinical training to qualified providers as defined in § 20–103 of this article and to the clinical care teams of the qualified providers to:
(1)
Expand the number of health care professionals with abortion care training; and
(2)
Increase the racial and ethnic diversity among health care professionals with abortion care training; and
(iv)
Support the identification, screening, and placement of qualified providers at training sites.
(c)
(1)
The Department shall release the name of the coordinating organization that the Department contracts with under subsection (a) of this section and any entity receiving funds through the coordinating organization.
(2)
The Department may not release the name of any individual or person administering services through or participating in the Program.
Md. Code Ann., Health-Gen. § 13-4705 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 47. Abortion Care Clinical Training Program
§ 13–4705LinkCopy Citation
For each fiscal year, the Governor shall include in the annual budget bill an appropriation of $3,500,000 to the Program.
Md. Code Ann., Health-Gen. § 13-4706 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 47. Abortion Care Clinical Training Program
§ 13–4706LinkCopy Citation
(a)
There is an Abortion Care Clinical Training Program Fund.
(b)
The purpose of the Fund is to support the Program.
(c)
The Department shall administer the Fund.
(d)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(e)
The State Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(f)
The Fund consists of:
(1)
Any money appropriated in the State budget to the Fund;
(2)
Interest earnings; and
(3)
Any other money from any other source accepted for the benefit of the Fund.
(g)
The Fund may be used only for the Program.
(h)
(1)
The State Treasurer shall invest and reinvest the money of the Fund in the same manner as other State money may be invested.
(2)
Any investment earnings of the Fund shall be paid into the Fund.
(i)
The Comptroller shall pay out money from the Fund as directed by the Secretary.
(j)
No part of the Fund may revert or be credited to:
(1)
The General Fund of the State; or
(2)
Any other special fund of the State.
(k)
Expenditures from the Fund may be made only in accordance with the State budget.
Md. Code Ann., Health-Gen. § 13-4707 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 47. Abortion Care Clinical Training Program
§ 13–4707LinkCopy Citation
On or before July 1 each year, the Department shall submit an annual report on the Program to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly.
Subtitle 48. Commission on Behavioral Health Care Treatment and Access
Md. Code Ann., Health-Gen. § 13-4801 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 48. Commission on Behavioral Health Care Treatment and Access
§ 13–4801LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Behavioral health” includes substance–related disorders, addictive disorders, mental disorders, life stressors and crises, and stress–related physical symptoms.
(c)
“Commission” means the Commission on Behavioral Health Care Treatment and Access.
Md. Code Ann., Health-Gen. § 13-4802 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 48. Commission on Behavioral Health Care Treatment and Access
§ 13–4802LinkCopy Citation
There is a Commission on Behavioral Health Care Treatment and Access, which shall meet jointly with the Behavioral Health Advisory Council.
Md. Code Ann., Health-Gen. § 13-4803 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 48. Commission on Behavioral Health Care Treatment and Access
§ 13–4803LinkCopy Citation
(a)
The Commission consists of the following members:
(1)
One member of the Senate of Maryland, appointed by the President of the Senate;
(2)
One member of the House of Delegates, appointed by the Speaker of the House;
(3)
One representative of Maryland’s Congressional Delegation;
(4)
The Secretary of Health, or the Secretary’s designee;
(5)
The Secretary of Human Services, or the Secretary’s designee;
(6)
The Secretary of Juvenile Services, or the Secretary’s designee;
(7)
The Deputy Secretary for Behavioral Health, or the Deputy Secretary’s designee;
(8)
The Maryland Insurance Commissioner, or the Commissioner’s designee;
(9)
The Executive Director of the Health Services Cost Review Commission, or the Executive Director’s designee;
(10)
The Executive Director of the Maryland Health Care Commission, or the Executive Director’s designee;
(11)
The Executive Director of the Maryland Community Health Resources Commission, or the Executive Director’s designee;
(12)
The Executive Director of the State–designated health information exchange, or the Executive Director’s designee;
(13)
The Executive Director of the Governor’s Office of Crime Prevention and Policy, or the Executive Director’s designee;
(14)
The Secretary of the Maryland Department of Disabilities, or the Secretary’s designee;
(15)
The Secretary of the Department of Public Safety and Correctional Services, or the Secretary’s designee;
(16)
The Special Secretary of the Governor’s Office for Children, or the Special Secretary’s designee;
(17)
The Special Secretary of Opioid Response, or the Special Secretary’s designee;
(18)
The Secretary of Aging, or the Secretary’s designee; and
(19)
The following members appointed by the Governor:
(i)
One representative of the Mental Health Association of Maryland;
(ii)
One representative of the National Alliance on Mental Illness;
(iii)
One representative of the Community Behavioral Health Association of Maryland;
(iv)
One representative of a provider of residential behavioral health services;
(v)
One representative of an acute care hospital;
(vi)
One representative of an inpatient psychiatric hospital;
(vii)
One individual with experience as a consumer of behavioral health services;
(viii)
One family member of an individual with experience as a consumer of behavioral health services;
(ix)
One representative of a provider of substance use treatment services;
(x)
One representative of a school–based health center;
(xi)
One individual with expertise in social determinants of health;
(xii)
One individual with expertise in health economics;
(xiii)
One representative of a health insurance carrier;
(xiv)
One representative of a managed care organization;
(xv)
One representative from the Office of the Public Defender;
(xvi)
One representative of the Developmental Disability Coalition;
(xvii)
One representative of the Maryland Chapter of the National Council on Alcoholism and Drug Dependence;
(xviii)
One representative of the Maryland Psychological Association;
(xix)
One representative of Disability Rights Maryland;
(xx)
One representative of a Federally Qualified Health Center;
(xxi)
One representative of a local behavioral health authority;
(xxii)
One individual with an intellectual disability who uses self–directed behavioral health services; and
(xxiii)
One representative of the Maryland State’s Attorneys’ Association.
(b)
To the extent practicable, the membership of the Commission shall reflect the geographic and ethnic diversity of the State.
(c)
The Governor, the President of the Senate, and the Speaker of the House jointly shall designate the chair of the Commission.
(d)
The Department shall provide staff for the Commission.
(e)
A member of the Commission:
(1)
May not receive compensation as a member of the Commission; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(f)
The Commission shall meet at least three times per year at the times and places determined jointly by the Commission and the Behavioral Health Advisory Council.
Md. Code Ann., Health-Gen. § 13-4804 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 48. Commission on Behavioral Health Care Treatment and Access
§ 13–4804LinkCopy Citation
The purpose of the Commission is to make recommendations to provide appropriate, accessible, and comprehensive behavioral health services that are available on demand to individuals in the State across the behavioral health continuum.
Md. Code Ann., Health-Gen. § 13-4805 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 48. Commission on Behavioral Health Care Treatment and Access
§ 13–4805LinkCopy Citation
The Commission shall:
(1)
Conduct an assessment of behavioral health services in the State to identify needs and gaps in services across the continuum, including community–based outpatient and support services, crisis response, and inpatient care;
(2)
Examine the methods for reimbursing behavioral health care services in the State and make recommendations on the most effective forms of reimbursement to maximize service delivery;
(3)
Compile findings of State–specific needs assessments related to behavioral health care services;
(4)
Review recommendations and reports of State commissions, workgroups, or task forces related to behavioral health care services;
(5)
Conduct a needs assessment on the State’s behavioral health care workforce to identify gaps and make recommendations to ensure an adequate, culturally competent, and diverse workforce across the behavioral health care continuum;
(6)
Review trends and best practices from other states regarding policy and reimbursement strategies that support access to a comprehensive array of services and ensure quality of care;
(7)
Examine and make recommendations related to the behavioral health of the geriatric and youth populations in the State;
(8)
Examine and make recommendations to provide appropriate and adequate behavioral health services to individuals with developmental disabilities and complex behavioral health needs, specifically youth;
(9)
Assess the health infrastructure, facilities, personnel, and services available for the State’s forensic population and identify deficiencies in resources and policies needed to prioritize health outcomes, increase public safety, and reduce recidivism;
(10)
Make recommendations on expanding behavioral health treatment access for the State’s court–ordered population;
(11)
Make recommendations on action plans regarding the behavioral health care system’s capacity to prepare for and respond to future challenges affecting the entire State or particular regions or populations in the State, including pandemics and extreme weather events;
(12)
Make recommendations to ensure that behavioral health treatment is provided in the appropriate setting, including methods to divert behavioral health patients from emergency departments by using the Maryland Mental Health and Substance Use Disorder Registry and Referral System established under § 7.5–802 of this article and 2–1–1;
(13)
Examine and review the use of harm reduction strategies to facilitate access to care;
(14)
Examine methods to assist consumers in accessing behavioral health services; and
(15)
Make, in coordination with the Behavioral Health Advisory Council, recommendations regarding the continuation of the State’s behavioral health carve–out and the financing structure and quality oversight necessary to integrate somatic and behavioral health services and ensure compliance with the Mental Health Parity and Addiction Equity Act in the Maryland Medical Assistance Program.
Md. Code Ann., Health-Gen. § 13-4806 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 48. Commission on Behavioral Health Care Treatment and Access
§ 13–4806LinkCopy Citation
(a)
The Commission shall establish the following workgroups:
(1)
Geriatric behavioral health;
(2)
Youth behavioral health, individuals with developmental disabilities, and individuals with complex behavioral health needs;
(3)
Criminal justice–involved behavioral health;
(4)
Behavioral health workforce development, infrastructure, coordination, and financing; and
(5)
Improvement of health, social, and economic outcomes related to substance use.
(b)
The workgroup required under subsection (a)(5) of this section shall:
(1)
Evaluate and review:
(i)
The availability, affordability, and accessibility of treatment for substance use disorder and recovery support services, including housing and employment services, in the State;
(ii)
The number and percentage of individuals who are directed to services described in item (i) of this item by the criminal justice system of the State;
(iii)
The health outcomes after receiving services described in item (i) of this item disaggregated by whether the services were sought voluntarily or mandated by the criminal justice system of the State;
(iv)
The impact of current criminal justice involvement related to substance use in the State on the health and well–being of individuals, families, and communities;
(v)
The cost to the State and local governments resulting from current criminal justice involvement related to substance use in the State;
(vi)
The equitable application of current criminal justice involvement related to substance use in the State;
(vii)
The current research on the efficacy of voluntary treatment for substance use disorder compared to treatment mandated by criminal justice systems, including criminal justice systems outside the State; and
(viii)
The availability and accessibility of data on the issues enumerated in this item;
(2)
Evaluate and review the Department’s regulations on the standards for the discharge of patients from substance use treatment programs to assess whether the standards adequately consider the patient’s mental health or substance use disorder diagnosis and the impact of the discharge standards on the patient; and
(3)
(i)
Make recommendations on changes to State laws, policies, and practices needed to mitigate the harms related to the criminalization of substance use with the goal of improving the public health and safety of residents of the State; and
(ii)
Make recommendations on changes to State laws, policies, and practices related to the discharge of patients from substance use treatment programs to consider the patient’s mental health or substance use disorder diagnosis in making an appropriate placement.
(c)
The workgroups established under subsection (a) of this section shall meet at least two times per year at the times and places determined by the workgroup.
(d)
The workgroups established under subsection (a) of this section shall include members of the Commission and may include individuals invited by the Commission or the Behavioral Health Advisory Council to serve on the workgroup.
(e)
On or before July 1 each year, beginning in 2024, the workgroups established under subsection (a) of this section shall report and make recommendations to the Commission and the Behavioral Health Advisory Council.
Md. Code Ann., Health-Gen. § 13-4807 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 48. Commission on Behavioral Health Care Treatment and Access
§ 13–4807LinkCopy Citation
(a)
(1)
On or before January 1 each year, beginning in 2024, the Commission, in coordination with the Behavioral Health Advisory Council, shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on the Commission’s findings and recommendations, including funding and legislative recommendations, that are consistent with providing appropriate, accessible, and comprehensive behavioral health services that are available on demand to individuals in the State across the behavioral health continuum.
(2)
Any legislative recommendations included in the report required under paragraph (1) of this subsection that require funding shall include an estimate of the funding required to implement the recommendation and information that supports the funding estimate.
(b)
The report required on or before January 1, 2024, shall include the findings of the needs assessments required under § 13–4805 of this subtitle.
(c)
On or before July 1, 2025, the Commission, in coordination with the Behavioral Health Advisory Council, shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on the Commission’s findings and recommendations regarding the continuation of the State’s behavioral health carve–out and the financing structure and quality oversight necessary to integrate somatic and behavioral health care services in the Maryland Medical Assistance Program.
Subtitle 49. Behavioral Health Care Coordination Value-Based Purchasing Pilot Program. [Effective Until December 1, 2027]
Md. Code Ann., Health-Gen. § 13-4901 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 49. Behavioral Health Care Coordination Value-Based Purchasing Pilot Program. [Effective Until December 1, 2027]
§ 13–4901LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Behavioral health care coordination” means a person–centered, team–based activity designed to:
(1)
Assess and meet the needs of an individual with a behavioral health condition; and
(2)
Help the individual navigate the health care system effectively and efficiently.
(c)
“Pilot Program” means the Behavioral Health Care Coordination Value–Based Purchasing Pilot Program.
(d)
“Value–based purchasing” means financially incentivizing providers to meet specified outcome measures.
Md. Code Ann., Health-Gen. § 13-4902 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 49. Behavioral Health Care Coordination Value-Based Purchasing Pilot Program. [Effective Until December 1, 2027]
§ 13–4902LinkCopy Citation
There is a Behavioral Health Care Coordination Value–Based Purchasing Pilot Program in the Department.
Md. Code Ann., Health-Gen. § 13-4903 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 49. Behavioral Health Care Coordination Value-Based Purchasing Pilot Program. [Effective Until December 1, 2027]
§ 13–4903LinkCopy Citation
The purpose of the Pilot Program is to establish and implement an intensive care coordination model using value–based purchasing in the specialty behavioral health system.
Md. Code Ann., Health-Gen. § 13-4904 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 49. Behavioral Health Care Coordination Value-Based Purchasing Pilot Program. [Effective Until December 1, 2027]
§ 13–4904LinkCopy Citation
(a)
The Department shall administer the Pilot Program.
(b)
The Department shall identify at least 500 adults whose behavioral health condition or functioning places them at risk of hospital emergency department utilization or inpatient psychiatric hospital admission.
(c)
The Pilot Program shall be operational for a 3–year period.
(d)
A provider or network of providers selected to participate in the Pilot Program shall:
(1)
Be licensed and in good standing with the Maryland Medical Assistance Program;
(2)
Have experience in providing community–based care coordination to specialty behavioral health program recipients;
(3)
Use an electronic medical record for documenting care coordination activities and outcomes collection; and
(4)
Have an automated data exchange with the State–designated health information exchange.
(e)
The Department shall:
(1)
Provide reimbursement on a per member per month basis for the behavioral health care coordination activities that are not otherwise covered by the Maryland Medical Assistance Program;
(2)
Collect outcomes data on recipients of health care services under the Pilot Program; and
(3)
Evaluate the effectiveness of the value–based purchasing model by analyzing the following outcome measures:
(i)
A comparison of the following data elements before and after enrollment of recipients of health care services under the Pilot Program:
(1)
Emergency department utilization for both behavioral and somatic health purposes;
(2)
Inpatient hospitalization for both behavioral and somatic health purposes; and
(3)
Total health care expenditures;
(ii)
Outcomes for recipients with and without primary care services coordinated by a behavioral health provider; and
(iii)
Recognized clinical quality metrics which may include patient experience measures.
Md. Code Ann., Health-Gen. § 13-4905 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 49. Behavioral Health Care Coordination Value-Based Purchasing Pilot Program. [Effective Until December 1, 2027]
§ 13–4905LinkCopy Citation
If necessary to implement the Pilot Program, the Department shall apply to the Centers for Medicare and Medicaid Services for an amendment to the State’s § 1115 HealthChoice Demonstration.
Md. Code Ann., Health-Gen. § 13-4906 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 49. Behavioral Health Care Coordination Value-Based Purchasing Pilot Program. [Effective Until December 1, 2027]
§ 13–4906LinkCopy Citation
(a)
For each of fiscal years 2025 through 2027, the Governor may include in the annual budget bill an appropriation of $600,000 for the Pilot Program.
(b)
Beginning in fiscal year 2026, the Department may allocate a percentage of the annual appropriation required under subsection (a) of this section to reimbursement paid based on the achievement of the outcome measures described in § 13–4904(e)(3) of this subtitle.
(c)
In fiscal year 2027, the Department may increase the percentage of the annual appropriation required under subsection (a) of this section allocated to reimbursement paid in accordance with subsection (b) of this section over the percentage allocated in fiscal year 2026.
Md. Code Ann., Health-Gen. § 13-4907 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 49. Behavioral Health Care Coordination Value-Based Purchasing Pilot Program. [Effective Until December 1, 2027]
§ 13–4907LinkCopy Citation
On or before November 1, 2027, the Department shall report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly on the Department’s findings and recommendations from the Pilot Program.
Subtitle 50. Rare Disease Advisory Council
Md. Code Ann., Health-Gen. § 13-5001 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 50. Rare Disease Advisory Council
§ 13–5001LinkCopy Citation
There is a Rare Disease Advisory Council.
Md. Code Ann., Health-Gen. § 13-5002 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 50. Rare Disease Advisory Council
§ 13–5002LinkCopy Citation
(a)
The Council consists of the following members:
(1)
One member of the Senate of Maryland, appointed by the President of the Senate;
(2)
One member of the House of Delegates, appointed by the Speaker of the House;
(3)
The Secretary, or the Secretary’s designee;
(4)
The chair of the State Advisory Council on Hereditary and Congenital Disorders, or the chair’s designee;
(5)
One representative of the Office of Minority Health and Health Disparities, designated by the Director of the Office;
(6)
One representative of the Maryland Medical Assistance Program, designated by the Secretary;
(7)
One representative of the Maryland Insurance Administration, designated by the Maryland Insurance Commissioner; and
(8)
The following members, appointed by the Governor:
(i)
One representative of an academic research institution that receives grant funding for rare disease research;
(ii)
One geneticist licensed and practicing in the State;
(iii)
One registered nurse or advanced practice registered nurse licensed and practicing in the State with experience treating rare diseases;
(iv)
One physician licensed in the State with experience treating rare diseases;
(v)
One hospital administrator, or the designee of a hospital administrator, from a hospital in the State that provides care to individuals diagnosed with a rare disease;
(vi)
One pharmacist licensed in the State with experience dispensing drugs used to treat rare diseases;
(vii)
Two individuals who have been diagnosed with a rare disease;
(viii)
One caregiver of an individual with a rare disease;
(ix)
One representative of a rare disease patient organization that operates in the State;
(x)
One representative of the biopharmaceutical industry;
(xi)
One representative of a health insurance carrier providing health insurance coverage in the State;
(xii)
One member of the scientific community who is engaged in rare disease research; and
(xiii)
One representative of an organization that provides care management for individuals enrolled in the State’s Rare and Expensive Case Management Program.
(b)
For the appointed members of the Council, the appointment process shall be conducted in a transparent manner to provide interested individuals an opportunity to apply.
(c)
All members of the Council must be full–time residents of the State.
(d)
(1)
The term of an appointed member is 3 years.
(2)
If a vacancy occurs on the Council, the members of the Council shall appoint an individual to fill the vacancy by majority vote.
(e)
(1)
The Governor shall designate the initial chair of the Council to serve a term of 3 years.
(2)
The initial chair designated by the Governor may not hold a position within State government.
(3)
At the end of the term of the initial chair, the members of the Council shall designate a new chair by majority vote.
(4)
Except as provided in paragraph (1) of this subsection, the term of a chair of the Council is 2 years.
(f)
The Department shall provide staff for the Council.
(g)
A member of the Council:
(1)
May not receive compensation as a member of the Council; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
(h)
(1)
The initial meeting of the Council shall occur on or before December 30, 2024.
(2)
On or before October 1, 2025, the Council shall meet at least once per month in person or through an online meeting platform at a time designated by the chair.
(3)
After October 1, 2025, the Council shall meet at least once per quarter in person or through an online meeting platform at a time designated by the chair.
Md. Code Ann., Health-Gen. § 13-5003 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 50. Rare Disease Advisory Council
§ 13–5003LinkCopy Citation
(a)
The Council shall:
(1)
Convene public hearings, make inquiries, and solicit comments from the public to assist the Council with a first–year survey of the needs of rare disease patients, caregivers, and health care providers in the State;
(2)
Consult with experts on rare diseases to develop policy recommendations to improve patient access to and the quality of rare disease specialists, affordable and comprehensive health care coverage, relevant diagnostics, timely treatment, and other needed services;
(3)
Research and make recommendations to State agencies and insurers that provide services to individuals with a rare disease on the impact of prior authorization, cost–sharing, tiering, or other utilization management procedures on the provision of treatment and care for patients;
(4)
Establish best practices and protocols to include in State planning related to natural disasters and public health emergencies or other emergency declarations to enable continuity of care for rare disease patients and ensure that safeguards against discrimination for rare disease patients are in place;
(5)
Evaluate and make recommendations regarding coverage of prescription drugs for rare disease patients, including patients with private health insurance coverage and patients enrolled in the Maryland Medical Assistance Program, to improve coverage of diagnostics, and to facilitate access to necessary health care providers with expertise in the treatment of rare diseases;
(6)
Publish a list of existing and publicly accessible resources on research, diagnosis, treatment, and education relating to rare diseases on the Council’s webpage;
(7)
Identify areas of unmet needs for research that can inform future studies and reports by the Council;
(8)
Identify and distribute educational resources for health care providers to foster recognition and optimize treatment of rare diseases in the State; and
(9)
Research and identify best practices to ensure continuity of care for rare disease patients transitioning from pediatric to adult care.
(b)
The Council shall provide opportunities for the public to hear updates and provide input on the Council’s activities.
(c)
The Council shall maintain a webpage for the purposes of:
(1)
Posting meeting minutes and notices of upcoming meetings;
(2)
Allowing the public to submit comments to the Council; and
(3)
Posting a list of resources as required under subsection (a)(7) of this section.
(d)
(1)
The Council may solicit funds on its behalf, including by applying for available federal or State grants.
(2)
The Council shall set up a method to securely hold and distribute funds to support the duties of the Council.
Md. Code Ann., Health-Gen. § 13-5004 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 50. Rare Disease Advisory Council
§ 13–5004LinkCopy Citation
(a)
On or before December 1 each year, beginning in 2024, the Council shall submit a report to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly.
(b)
The report required under subsection (a) of this section shall:
(1)
Describe the activities of the Council under § 13–5003(a) of this subtitle;
(2)
Describe the funding sources of the Council, including grants that were applied for and accepted and the remaining balances of any current grants; and
(3)
Provide recommendations on the ways to address the needs of individuals living with rare diseases in the State.
Subtitle 51. Commission on Public Health
Md. Code Ann., Health-Gen. § 13-5101 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 51. Commission on Public Health
§ 13–5101LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Commission” means the Commission on Public Health.
(c)
“Foundational public health services” includes:
(1)
The following foundational areas:
(i)
Communicable disease control;
(ii)
Chronic disease and injury prevention;
(iii)
Environmental public health;
(iv)
Maternal, child, and family health; and
(v)
Access to and linkage with clinical care; and
(2)
The following foundational capabilities:
(i)
Assessment and surveillance;
(ii)
Community partnership development;
(iii)
Equity;
(iv)
Organizational competencies;
(v)
Policy development and support;
(vi)
Accountability and performance management;
(vii)
Emergency preparedness and response; and
(viii)
Communications.
Md. Code Ann., Health-Gen. § 13-5102 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 51. Commission on Public Health
§ 13–5102LinkCopy Citation
There is a Commission on Public Health.
Md. Code Ann., Health-Gen. § 13-5103 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 51. Commission on Public Health
§ 13–5103LinkCopy Citation
(a)
The Commission consists of the following members:
(1)
One member of the Senate of Maryland, appointed by the President of the Senate;
(2)
One member of the House of Delegates, appointed by the Speaker of the House;
(3)
The Secretary of Budget and Management, or the Secretary’s designee;
(4)
The Secretary of Information Technology, or the Secretary’s designee;
(5)
The Deputy Secretary for Public Health, or the Deputy Secretary’s designee;
(6)
The Deputy Secretary for Operations, or the Deputy Secretary’s designee;
(7)
The Chief Executive Officer of the Chesapeake Regional Information System for Our Patients (CRISP), or the Chief Executive Officer’s designee; and
(8)
The following members, appointed by the Governor:
(i)
Three local health officers of whom:
(1)
One shall be from a rural jurisdiction;
(2)
One shall be from a suburban jurisdiction; and
(3)
One shall be from an urban jurisdiction;
(ii)
Two representatives from State academic institutions with expertise in public health systems; and
(iii)
A faculty member from a public health program at a historically Black college or university.
(b)
The Governor may appoint not more than two members of the public with experience in public health as additional members of the Commission.
(c)
(1)
The Commission may establish workgroups at the discretion of the Commission.
(2)
The chair of the Commission may appoint members of the public to a workgroup.
(d)
To the extent practicable and consistent with federal and State law, the membership of the Commission and workgroups established under this section shall reflect the racial, ethnic, and gender diversity of the State.
(e)
(1)
Subject to paragraph (2) of this subsection and except as provided in paragraph (3) of this subsection, the Commission shall select a chair and a vice chair from among its members.
(2)
To qualify to serve as chair of the Commission, the member must agree to provide staff for the Commission on selection as chair.
(3)
The members of the Commission may not select as chair a member listed in subsection (a)(3), (4), (5), or (6) of this section.
(f)
A member of the Commission:
(1)
May not receive compensation as a member of the Commission; but
(2)
Is entitled to reimbursement for expenses under the Standard State Travel Regulations, as provided in the State budget.
Md. Code Ann., Health-Gen. § 13-5104 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 51. Commission on Public Health
§ 13–5104LinkCopy Citation
(a)
The chair of the Commission shall provide staff support for the Commission.
(b)
If the chair fails to provide staffing for the Commission, the members shall select a new chair in accordance with § 13–5103(e) of this subtitle.
Md. Code Ann., Health-Gen. § 13-5105 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 51. Commission on Public Health
§ 13–5105LinkCopy Citation
(a)
The purpose of the Commission is to make recommendations to improve the delivery of foundational public health services in the State.
(b)
The Commission shall provide guidance for implementation of the Commission’s recommendations.
(c)
The Department shall provide an update regarding the implementation of the Commission’s recommendations to the Commission each quarter.
Md. Code Ann., Health-Gen. § 13-5106 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 51. Commission on Public Health
§ 13–5106LinkCopy Citation
(a)
The Commission shall assess the foundational public health capabilities of the Department and local health departments in the State.
(b)
(1)
In conducting the assessment required under subsection (a) of this section, the Commission shall:
(i)
Explain the impact of the foundational public health capabilities on the State’s ability to address foundational public health areas, including as the foundational public health areas relate to behavioral health;
(ii)
Explain the impact of the foundational public health capabilities on the State’s ability to respond to COVID–19, overdoses, maternal and infant mortality, and other major public health challenges as appropriate; and
(iii)
Provide public outreach to hold at least three public meetings in different areas of the State that include an opportunity for public comment.
(2)
In conducting the assessment required under subsection (a) of this section, the Commission may:
(i)
Request deidentified and publicly available data from the Department, local health departments, and the State–designated health data utility; and
(ii)
Request interviews with State and local health officials.
(c)
(1)
Based on the assessment conducted under subsection (a) of this section, the Commission shall make recommendations for reform in the following areas:
(i)
Organization of State and local public health departments;
(ii)
Information technology, information exchange, and data and analytics;
(iii)
Workforce, including human resources and use of the Maryland Medical Reserve Corps established under Title 2, Subtitle 11 of this article;
(iv)
Procurement, including oversight of contractors;
(v)
Funding;
(vi)
Communication and public engagement; and
(vii)
Any other area considered appropriate by the Commission.
(2)
The recommendations made under paragraph (1) of this subsection shall include the funding or legislation required to implement the recommendation, if any.
(3)
The Commission shall justify each recommendation made under paragraph (1) of this subsection based on how the recommendation contributes to the provision of foundational public health services.
(4)
(i)
The Commission shall make a draft of its recommendations available for public comment for 30 days.
(ii)
The final report of the Commission shall include a response to any substantive public comment received on the draft recommendations.
(5)
(i)
The Commission shall use best efforts to reach consensus on its recommendations.
(ii)
If the Commission cannot reach consensus on its recommendations, the Commission shall include the opportunity for dissenting comments in the Commission’s final report.
Md. Code Ann., Health-Gen. § 13-5107 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 51. Commission on Public Health
§ 13–5107LinkCopy Citation
On or before January 1 each year, the Commission shall submit a report on the implementation of its recommendations and barriers to implementation to the Governor and, in accordance with § 2–1257 of the State Government Article, the Senate Budget and Taxation Committee, the Senate Finance Committee, the House Appropriations Committee, and the House Health Committee.
Subtitle 52. Center for Firearm Violence Prevention and Intervention
Md. Code Ann., Health-Gen. § 13-5201 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 52. Center for Firearm Violence Prevention and Intervention
§ 13–5201LinkCopy Citation
In this subtitle, “Center” means the Center for Firearm Violence Prevention and Intervention.
Md. Code Ann., Health-Gen. § 13-5202 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 52. Center for Firearm Violence Prevention and Intervention
§ 13–5202LinkCopy Citation
(a)
There is a Center for Firearm Violence Prevention and Intervention in the Department.
(b)
The purpose of the Center is to reduce firearm violence, harm from firearm violence, and misuse of firearms in the State by partnering with federal, State, and local agencies and affected communities to implement a public health approach to firearm violence reduction.
Md. Code Ann., Health-Gen. § 13-5203 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 52. Center for Firearm Violence Prevention and Intervention
§ 13–5203LinkCopy Citation
(a)
The Secretary shall appoint the executive director of the Center.
(b)
The executive director shall appoint and remove all staff in accordance with the provisions of the State Personnel and Pensions Article.
(c)
The executive director shall coordinate and direct any planning related to the Center initiated by the Department.
(d)
The Center may apply for, receive, and spend federal grants–in–aid or any other federal funds made available to the Department for use in carrying out the powers and duties of the Secretary or the Department.
Md. Code Ann., Health-Gen. § 13-5204 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 52. Center for Firearm Violence Prevention and Intervention
§ 13–5204LinkCopy Citation
(a)
The Center shall:
(1)
Work in consultation with the Governor’s Office of Crime Prevention and Policy or any successor agency, the Maryland State Police, and any other relevant State or local agency to ensure a multidepartmental approach to reducing firearm violence;
(2)
Solicit and consider recommendations from:
(i)
Communities disproportionately impacted by firearm violence;
(ii)
Public health experts;
(iii)
Individuals or organizations with expertise in firearm safety and training; and
(iv)
Any other experts, groups, or organizations as the executive director determines appropriate and necessary; and
(3)
(i)
On or before May 1, 2025, submit a preliminary State Plan for a Public Health Approach to Reducing Firearm Violence to guide the work of the Center to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly; and
(ii)
On or before May 1, 2029, and every 4 years thereafter, submit a State Strategic Plan for Firearm Violence Reduction Using Public Health Strategies to the Governor and, in accordance with § 2–1257 of the State Government Article, the General Assembly.
(b)
The Center may:
(1)
Offer training and technical assistance to State and local agencies, health care professionals, and community and faith–based organizations to increase capacity to implement evidence–based firearm violence prevention and intervention strategies;
(2)
Issue best practice guidance and model processes in consultation with affected communities regarding implementation of evidence–based firearm violence prevention and intervention strategies;
(3)
In consultation with the Governor’s Office of Crime Prevention and Policy or any successor agency, facilitate cross–jurisdictional data and information sharing;
(4)
Conduct public awareness campaigns;
(5)
Share data and collaborate with higher education and research institutions regarding the prevention of firearm violence;
(6)
Promote the development of evidence–based firearm violence prevention initiatives in affected communities throughout the State; and
(7)
Engage in any other activity consistent with the Center’s mission.
Md. Code Ann., Health-Gen. § 13-5205 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 52. Center for Firearm Violence Prevention and Intervention
§ 13–5205LinkCopy Citation
For fiscal year 2026 and each fiscal year thereafter, the Governor may include in the annual budget bill an appropriation sufficient to fund the Center.
Subtitle 53. Nonoccupational Postexposure Prophylaxis (Npep) Standing Order Program
Md. Code Ann., Health-Gen. § 13-5301 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 53. Nonoccupational Postexposure Prophylaxis (Npep) Standing Order Program
§ 13–5301LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Board” means the State Board of Pharmacy.
(c)
“CDC Guidelines” means the “Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV – United States 2016” or any subsequent guidelines published by the Centers for Disease Control and Prevention.
(d)
“Nonoccupational postexposure prophylaxis” or “nPEP” means medication used in accordance with the most recent CDC Guidelines to reduce the chances of a patient developing HIV after potential exposure to the disease.
(e)
“Pharmacist” means a pharmacist licensed in the State under Title 12 of the Health Occupations Article.
(f)
“Program” means the Nonoccupational Postexposure Prophylaxis (nPEP) Standing Order Program.
(g)
“Standing order” means a directive authorizing pharmacists to dispense the nPEP regimens listed in the order without a prescription.
Md. Code Ann., Health-Gen. § 13-5302 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 53. Nonoccupational Postexposure Prophylaxis (Npep) Standing Order Program
§ 13–5302LinkCopy Citation
(a)
There is a Nonoccupational Postexposure Prophylaxis (nPEP) Standing Order Program.
(b)
The Program shall:
(1)
Authorize a pharmacist who is registered with the Program to dispense nPEP through a standing order in accordance with § 13–5203 of this subtitle; and
(2)
Operate in accordance with the procedures approved by the Department with the advice and approval of the Board.
(c)
The Department shall adopt regulations:
(1)
Necessary for the administration of the Program; and
(2)
That address the needs of specific populations including victims of sexual assault and pediatric patients.
(d)
The Department may:
(1)
Collect fees necessary for the administration of the Program, unless the patient qualifies for nPEP through the Program for Preventing HIV Infection for Rape Victims established under § 11–1008 of the Criminal Procedure Article;
(2)
Administer the Program and establish a standardized set of guidelines for pharmacists participating in the Program to use in developing and conducting patient education and training on nPEP that includes:
(i)
Avoiding exposure to HIV;
(ii)
Responding to exposure to HIV with the appropriate use of nPEP;
(iii)
Access to nPEP and the appropriate follow–up after the administration of nPEP; and
(iv)
Engagement in additional care including:
(1)
Access to pre–exposure prophylaxis (PrEP); and
(2)
Harm reduction programs for patients with continuing risk of exposures; and
(3)
Collect and report data on the operation and results of the Program.
Md. Code Ann., Health-Gen. § 13-5303 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 53. Nonoccupational Postexposure Prophylaxis (Npep) Standing Order Program
§ 13–5303LinkCopy Citation
(a)
At the time of dispensing nPEP, a pharmacist registered with the Program shall:
(1)
Screen the patient to determine that HIV exposure occurred within 72 hours before the dispensing;
(2)
Determine whether the patient meets clinical criteria consistent with the most recent CDC Guidelines, including:
(i)
The identification of any contraindicated medications; and
(ii)
If applicable, exposure as the result of an alleged rape or sexual offense or alleged child sexual abuse;
(3)
Subject to subsection (b) of this section, determine whether an available standing order is appropriate for the patient and dispense nPEP in accordance with the most recent CDC Guidelines;
(4)
Refer the patient to a disease intervention specialist within the Department for ongoing treatment; and
(5)
Determine whether the patient has a primary care provider and:
(i)
If the patient has a primary care provider, notify the provider that the patient was dispensed nPEP; or
(ii)
If the patient does not have a primary care provider, provide the patient with a list of local primary care providers and clinics provided by the Department.
(b)
If an available standing order is not appropriate for the patient, the pharmacist shall refer the patient to a primary care provider.
(c)
A pharmacist may dispense nPEP in accordance with a therapy management contract under Title 12, Subtitle 6A of the Health Occupations Article.
Subtitle 54. Reproductive Health Care Clinic Security Grant Program
Md. Code Ann., Health-Gen. § 13-5401 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 54. Reproductive Health Care Clinic Security Grant Program
§ 13–5401LinkCopy Citation
(a)
(1)
In this section the following words have the meanings indicated.
(2)
“Program” means the Reproductive Health Care Clinic Security Grant Program.
(3)
“Reproductive health care clinic” means a health care provider, as defined in § 4–301(h)(1)(ii) of this article, that provides legally protected health care, as defined in § 4–301(j) of this article.
(b)
There is a Reproductive Health Care Clinic Security Grant Program in the Department.
(c)
The Secretary shall administer the Program.
(d)
The purpose of the Program is to assist reproductive health care clinics in the State with the costs associated with security improvements, including interior and exterior facility hardening, perimeter lighting, fencing and other barriers, door locks and access control systems, security cameras, alarms, panic buttons, lockdown systems, and public address systems.
(e)
The Secretary shall establish procedures for:
(1)
The application and award processes; and
(2)
The criteria a reproductive health care clinic must meet to qualify for a grant under the Program.
(f)
The Department may not release, publish, or otherwise disclose:
(1)
The personal information of an individual applying for, participating in, or administering a grant under the Program; or
(2)
Information regarding a grant awarded under the Program if the disclosure would compromise the safety of the grant recipient.
(g)
(1)
For fiscal year 2026, the Governor may include in the annual budget bill an appropriation of $500,000 to the Program.
(2)
Up to 5% of the money appropriated to the Program may be used for administrative expenses.
Subtitle 56
Md. Code Ann., Health-Gen. § 13-5601 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 56
§ 13–5601LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“AHEAD Model” means the States Advancing All–Payer Health Equity Approaches and Development Model administered by the Center for Medicare and Medicaid Innovation.
(c)
“Fund” means the Population Health Improvement Fund.
(d)
“Statewide health equity plan” means the equity plan required under the AHEAD Model State Agreement with the Centers for Medicare and Medicaid Services.
Md. Code Ann., Health-Gen. § 13-5602 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 56
§ 13–5602LinkCopy Citation
(a)
There is a Population Health Improvement Fund.
(b)
The purpose of the Fund is to invest in population health improvements to support the statewide population health targets under the AHEAD Model and any successor models.
(c)
The Department and the Health Services Cost Review Commission jointly shall administer the Fund.
(d)
(1)
The Fund is a special, nonlapsing fund that is not subject to § 7–302 of the State Finance and Procurement Article.
(2)
The State Treasurer shall hold the Fund separately, and the Comptroller shall account for the Fund.
(e)
The Fund consists of:
(1)
The revenues from the uniform, broad–based assessment made under subsection (l) of this section;
(2)
Money appropriated in the State budget to the Fund;
(3)
Interest earnings; and
(4)
Any other money from any other source accepted for the benefit of the Fund.
(f)
(1)
Subject to paragraphs (2), (3), and (4) of this subsection and except as provided under paragraph (3) of this subsection, the Fund may be used only for expenses associated with statewide population health improvement initiatives in alignment with the statewide health equity plan as directed by the Secretary.
(2)
Except as provided under paragraph (3) of this subsection, activities paid for by the Fund must support the goal of meeting the statewide population health targets outlined in the AHEAD Model State Agreement with the Centers for Medicare and Medicaid Services and have at least one of the following functions:
(i)
Reducing rates of common preventable health conditions;
(ii)
Addressing health–related social needs; or
(iii)
Reducing or eliminating health disparities.
(3)
In calendar year 2026 only, up to $14,000,000 in the Fund may be used to fund expenses of the Medical Care Programs Administration within the Department if the Health Services Cost Review Commission increases hospital rates to provide financial assistance to Medicare Advantage Plans.
(4)
The Department and the Health Services Cost Review Commission may, in a manner consistent with the AHEAD Model State Agreement, transfer money from the Fund to the Public Health Workforce Development Fund established under § 24–2802 of this article.
(g)
(1)
The State Treasurer shall invest the money of the Fund in the same manner as other State money may be invested.
(2)
Any interest earnings of the Fund shall be credited to the Fund.
(h)
Expenditures from the Fund may be made only in accordance with the State budget.
(i)
Money expended from the Fund is supplemental to and is not intended to take the place of funding that would otherwise be appropriated for the Maryland Medical Assistance Program.
(j)
The Fund is subject to audit by the Office of Legislative Audits as provided in § 2–1220 of the State Government Article.
(k)
(1)
On or before July 1 each year, beginning in 2026, the Department shall submit a report to the General Assembly, in accordance with § 2–1257 of the State Government Article.
(2)
The report required under paragraph (1) of this subsection shall:
(i)
Reflect the required elements of the annual progress report as outlined in the State agreement and shall include:
(1)
Measures of effectiveness for funded programs and targeted populations;
(2)
Any impact on health outcomes and health disparities; and
(3)
Relevant components from hospital required reporting to the Health Services Cost Review Commission on population health improvement efforts; and
(ii)
Include:
(1)
An accounting of all sources of funding accepted for the benefit of the Fund and the amount of funding from each source; and
(2)
A summary of the extent to which public comments informed the work of the Department and the Commission.
(3)
The Department shall make a draft of its report available for public comment for 30 days.
(l)
(1)
Subject to paragraph (2) of this subsection, each year of the Total Cost of Care Model, the AHEAD Model, or any successor model, the Health Services Cost Review Commission may assess a uniform, broad–based, and reasonable amount in hospital rates to be credited to the Fund.
(2)
The Health Services Cost Review Commission shall include the full amount of the assessment authorized under paragraph (1) of this subsection in the hospital rates.
(3)
Any funds generated from the assessment authorized under paragraph (1) of this subsection may be used only for the expenses described in subsection (f) of this section.
Subtitle 57
Md. Code Ann., Health-Gen. § 13-5701 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 57
§ 13–5701LinkCopy Citation
(a)
(1)
The Department, in collaboration with the Commission on Health Equity, shall develop a clear and easy–to–understand graphic data dashboard that includes age–adjusted health disparity data disaggregated by race, ethnicity, and gender.
(2)
The data dashboard shall include information regarding the following health indicators:
(i)
Health insurance access;
(ii)
Cardiovascular disease;
(iii)
Chronic disease;
(iv)
Mental health and substance use;
(v)
Cancer;
(vi)
HIV/AIDS;
(vii)
Sexually transmitted infection;
(viii)
Body mass index; and
(ix)
Any other health indicators determined relevant by the Department.
(b)
The Department shall:
(1)
Update the data dashboard developed under subsection (a) of this section on a quarterly basis, as determined by data availability; and
(2)
Post the most recent updated data dashboard prominently on its website.
Subtitle 58
Md. Code Ann., Health-Gen. § 13-5801 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 58
§ 13–5801LinkCopy Citation
(a)
In this subtitle the following words have the meanings indicated.
(b)
“Paramedic” has the meaning stated in § 13–516 of the Education Article.
(c)
“Program” means the Buprenorphine Training Grant Program.
Md. Code Ann., Health-Gen. § 13-5802 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 58
§ 13–5802LinkCopy Citation
(a)
(1)
There is a Buprenorphine Training Grant Program in the Department.
(2)
The purpose of the Program is to assist a county with offsetting the cost of training paramedics to administer buprenorphine.
(b)
A county may apply to the Department for a grant from the Program.
(c)
A county may use a grant awarded under the Program only for training paramedics to administer buprenorphine.
(d)
The Governor shall include in the annual budget bill an appropriation of at least $50,000 from the Opioid Restitution Fund for the Program.
Subtitle 59
Md. Code Ann., Health-Gen. § 13-5901 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 59
§ 13–5901LinkCopy Citation
Md. Code Ann., Health-Gen. § 13-5902 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 59
§ 13–5902LinkCopy Citation
Md. Code Ann., Health-Gen. § 13-5903 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 59
§ 13–5903LinkCopy Citation
Md. Code Ann., Health-Gen. § 13-5904 (2026)
Title 13. Miscellaneous Health Care Programs
Subtitle 59